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Objective: The overall objective of this dissertation was to investigate the effect of 
depression on women’s contraceptive behaviors and teenage pregnancy.  
Methods: In the first study, the relationship between pre-abortion depressive 
symptoms and effectiveness level of contraceptive method chosen (low, moderately, 
or highly effective) after contraceptive counseling was examined using multinomial 
logistic regression in a group of women seeking abortion services. In the second study 
Cox proportional hazards models were used to estimate the hazard of contraceptive 
method discontinuation and unintended pregnancy among women experiencing any 
current and past elevated depressive symptoms in reproductive health settings. The 
third study examined the association between first depressive episode relative to age 
at first sex, and the hazard of first teenage pregnancy among girls participating in the 
National Comorbidity Survey–Adolescent Supplement.  
Results: More pre-abortion depressive symptoms were associated with higher odds of 
choosing a low contraceptive method than a moderately or a highly effective 
  
contraceptive method. Compared to non-depressed women, women exposed to 
baseline and a history of elevated depressive symptoms and those exposed to a 
history of elevated depressive symptoms had 39% and 12% increased hazards of 
contraceptive method discontinuation respectively; though the associations were not 
statistically significant when examining all contraceptive methods together. These 
associations were significant among patch and the injectable users. Finally, 
adolescent girls whose first depressive episode occurred at the same age as their 
sexual debut had a higher likelihood of experiencing first teenage pregnancy (HR: 
2.73, 95% CI 1.07, 6.97) than those experiencing no depression onset. Conclusion: 
This dissertation provides evidence for the critical role of timing of depression in 
determining women’s contraceptive behaviors and reproductive decisions. The 
findings collectively suggest that not only the presence or absence of depression, but 
also the time the condition manifests itself during the course of women’s live can 
predict women’s decisions surrounding contraceptive method choice, continuation, 
and pregnancy. Implications: The integration of mental and reproductive health as 
well as a more effective patient-physician communication are warranted in an effort 
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Chapter 1: Introduction 
Overview 
Almost fifty percent of all pregnancies in the United States are unintended and 
about 40% of them end in abortion (Finer & Zolna, 2016). The Centers for Disease 
Control and Prevention (CDC) defines an unintended pregnancy as a pregnancy that 
is unwanted—a pregnancy occurring when no children or no more children are 
desired—or mistimed—a pregnancy occurring earlier than desired (Centers for 
Disease Control and Prevention, 2015). Unmarried women, women 18-24 years old, 
those from minority backgrounds, those with lower incomes, and those having an 
abortion are more likely to experience unintended pregnancy in the United States 
(Finer & Zolna, 2016; Jones & Kavanaugh, 2011; Upadhyay, Brown, Sokoloff, & 
Raine, 2012).  
  Unintended pregnancies are associated with adverse health outcomes for 
mothers and their children. Women experiencing unwanted pregnancies are more 
likely to delay seeking prenatal care services, to have perinatal depression, to have 
lower educational attainment, and to have fewer career opportunities (Bahk, Yun, 
Kim, & Khang, 2015; Chang, Schwarz, Douglas, & Horon, 2009; Chiquero, 2010; 
Ferre, Gerstenbluth, Rossi, & Triunfo, 2013; Gipson, Koenig, & Hindin, 2008). 
Children born as a consequence of unintended pregnancies are at higher risk for 
experiencing child abuse and violence, delayed cognitive development during 
childhood, and psychiatric problems, and low self-esteem in adulthood (Axinn, 




Contraceptive behaviors are important determinants of unintended pregnancy. 
Forty-three percent of unintended pregnancies in the United States occur among 
contraceptive users while only about 5% of unintended pregnancies are the result of 
contraceptive method failure (Sonfield, Hasstedt, & Gold, 2014). Another 42% of 
unintended pregnancies are among those not using any method at the time they 
became pregnant (Sonfield, Hasstedt, & Gold, 2014). The failure rate of the typical 
contraceptive method use differs by method and is based on users’ behaviors 
(Trussell, 2011). Therefore, promoting the initiation and continuous use of effective 
contraceptive methods could help in preventing unintended pregnancy, particularly 
among women at high risk for unintended pregnancy.  
There are many factors influencing contraceptive method choice and accurate, 
consistent, and continuous use of contraceptives including women’s personal and 
intimate relationship characteristics, pregnancy desires, social and economic factors, 
access to services, and women’s attitudes and experiences towards using different 
contraceptive methods and their effectiveness (Frost & Darroch, 2008; Hall et al., 
2013b; Jones, Tapales, Lindberg, & Frost, 2015; Manlove, Ryan, & Franzetta, 2004; 
Moreau, Hall, Trussell, & Barber, 2013; Marrison et al., 2016). In addition, some 
research has shown mental health, in particular depression, to be associated with 
women’s contraceptive behaviors (Garber et al., 2010; Steinberg et al., 2013) and 
unintended pregnancy (e.g. Hall et al., 2017). However, gaps in the literature on the 
link between women’s mental health and their contraceptive behaviors and 
reproductive decision-making still exist. In particular, is it not clear whether the 




contraceptive method, their compliance with the method of their choice, and 
pregnancy.  
Unintended Pregnancy 
The term unintended pregnancy is defined as a pregnancy that is either 
mistimed or unwanted at the time of conception (CDC, 2015; Logan et al. 2007). If a 
pregnancy occurs at a time when the woman did not want to become pregnant but she 
did want to become pregnant at some point in the future, the pregnancy is classified 
as mistimed. If a woman did not want to become pregnant at the time of conception 
or at any time in the future, then the pregnancy is considered unwanted (Finer & 
Zolna, 2014).  According to the latest national records, in 2011, 45% of all 
pregnancies, in the United States, were unintended, a six percentage point decline 
from 2008 (Finer & Zolna, 2016). Despite these declines, unintended pregnancy rates 
in the United States are much higher than other industrialized countries (Sedgh, 
Singh, & Hussain, 2014). Furthermore, disparities in rates of unintended pregnancy 
based on women’s demographic characteristics still exist (Finer & Zolna, 2016). 
Young women are more likely to experience unintended pregnancy. In 2011, 
the rate of unintended pregnancy was highest among women 20-24 years old at 81 per 
1000 women in this age group and lowest among women 35 years and older at 16 per 
1000 women (Finer & Zolna, 2016; Finer & Zolna, 2014). Racial differences are also 
seen in rates of unintended pregnancy. Although there was a reduction in the rate of 
unintended pregnancy among all racial and ethnic groups from 2008 to 2011, black 
non-Hispanic women still had the highest rate of unintended pregnancy compared to 




& Zolna, 2016; Finer & Zolna, 2014). Low educational attainment and low-income 
levels are also associated with higher rates of unintended pregnancy. In 2011, poor 
women and women with less than a high school education experienced the highest 
percentages of unintended pregnancies compared to women with a college degree and 
income above 200% of the federal poverty level (Finer & Zolna, 2016). 
Among unintended pregnancies ending in childbirth in the United States, there 
was an overall 18% reduction between 2008 and 2011 (Finer & Zolna, 2016). 
Alternatively, the proportion of abortions due to unintended pregnancies, showed a 
two-percentage point increase, in the 2008-2011 time period (Finer & Zolna, 2016). 
Younger, unmarried, minority women, and those with income 100% below poverty 
level are at higher risk for abortions (Jones & Kavanaugh, 2011). In addition, 50% of 
women having an abortion have experienced an abortion before (Jones, Singh, Finer, 
& Frohwirth, 2006), and compared to women who are not having abortions, women 
experiencing an abortion are at a higher risk for becoming pregnant in the following 
year (Upadhyay, Brown, Sokoloff, & Raine, 2012). 
One of the main objectives in public health is to reduce the health risks related 
to their specific conditions. Experiences of pregnancy and childbirth are such 
conditions in which women often underestimate the maternal and perinatal health 
risks (Berg, MacKay, Qin, & Callaghan, 2009; Collaghan, Creanga, & Kuklina, 2012; 
Grotegut et al., 2014; Jolly, Sebire, Harris, Robinson, & Regan, 2000; Nelson & 
Rezvan, 2012; Speidel, Rocca, Thompson, & Harper, 2013). This lack of knowledge 
about pregnancy and childbirth can adversely affect reproductive decision-making by 




influence their contraceptive behaviors (Biggs & Foster, 2012). Therefore, by 
recognizing the potential health risk factors related to pregnancy and childbirth, 
women can decrease their risk of pregnancy complications through preventing 
unintended pregnancies (Speidel et al, 2013). 
Experiencing unintended pregnancy ending in birth is associated with several 
behavioral and health outcomes for women and their children, during and after 
pregnancy. Compared to those with an intentional pregnancy, women experiencing 
unintended pregnancies are more likely to delay prenatal care visits (Cheng et al., 
2009; Hulsey, Laken, Miller, & Ager, 2000; Logan et al. 2007), or engage in 
unhealthy behaviors during the prenatal period (Cheng et al., 2009; Orr, James, & 
Reiter, 2008). Using the national Pregnancy Risk Assessment Monitoring System 
(PRAMS), one study showed increased risks of smoking and being subject to 
domestic violence during pregnancy, and not-breastfeeding during the postpartum 
period in women with an unintended pregnancy (D’Angelo et al., 2004).  
A number of studies investigating the impact of unintended pregnancies 
carried to term on maternal mental health have found an association between 
unintended pregnancy and more post-pregnancy mental health problems in women 
(Bahk, Yun, Kim, & Khang, 2015; Beck, 2001; Gipson, Koenig, & Hindin, 2008; 
Lancaster et al., 2010; Tabet, Flick, Cook, Xian, & Change, 2016). Using Maryland’s 
PRAMS data, Cheng and colleagues found that women whose pregnancies were 
mistimed or unwanted were at a higher risk for reporting postpartum depression 
compared to women with intended pregnancies (Cheng et al., 2009). Studies looking 




found a positive association between unintended pregnancies ending in childbirth and 
later life depressive symptoms (Bahk et al., 2015; Herd, Higgins, Sicinski, & 
Merkurieva, 2016; Tabet et al., 2016). 
In addition to women, children who are born as the result of an unintended 
pregnancy experience negative outcomes. Using data from the National Longitudinal 
Survey of Youth (NLSY), Baydar found that children aged 1-2 years old born as a 
result of unplanned pregnancies are more likely to live away from their biological 
fathers and live in lower income households than children from planned pregnancies. 
Furthermore, children one or older born from an unintended pregnancy were provided 
with less resources at home for learning and developing skills, were more fearful, and 
had less receptive vocabulary (Baydar, 1995). Cognitive delays have also been seen 
in children resulting from unintended pregnancies (De La Rochebrochard & Joshi, 
2013).  
In addition to influencing maternal and child health, unintended pregnancy 
can also lead to economic costs for society. Trussell and colleagues estimated the 
annual total direct cost of unintended pregnancies in the United States to be $5.0 
billion, which includes the costs of births, induced abortions, and fetal losses 
(Trussell, 2007). In fact, preventing unintended pregnancies through provision of 
family planning services, pregnancy prevention programs, and media campaigns to 
encourage contraceptive use could be very cost effective (Monea & Thomas, 2011; 
Thomas, 2010; Tsui, McDonald-Mosley, & Burke, 2010). Moreover, Amaral and 




California $2.76 billion within 2 years and $5.33 billion within 5 years (Amaral et al., 
2007).  
Teenage Pregnancy 
During the time period of 2011-2013, 44% of unmarried 15-19 years old girls 
in the United States reported having had sexual intercourse and 13% of never-married 
girls reported having had sex before the age of 15 (Martinez & Abma, 2015). Sexual 
debut marks an important event in the lives of adolescent girls by placing them at risk 
for pregnancy. Teen pregnancy is defined as a pregnancy occurring in an adolescent 
girl between the ages of 13-19 (United Nations International Children’s Emergency 
Fund, 2008). Based on the latest national data in 2011, the pregnancy rate among 
adolescent girls 15-19 years old in the United States was 55 pregnancies per 1000 
women, a 21% decrease from 2008 (Finer & Zolna, 2016). Despite this decline, the 
rate of pregnancy among adolescents in the United States is still higher than other 
developed countries and racial differences also exist (Sedgh, Finer, Bankole, Eilers, 
& Singh, 2015; US Department of Health and Human Services, 2016). Factors such 
as living in low-income households, living in rural areas, low parental education, 
being from a minority background, and younger age at first sex are associated with 
teenage pregnancy (Dehlendorf, Rodriguez, Levy, Borrero, & Sterinauer, 2010; Hall 
et al., 2017; WHO, 2014). 
For some adolescents pregnancy is planned and wanted while for others it is 
not (World Health Organization, 2014). In the United States, the majority (75%) of 
the pregnancies in this age group, in 2011, were unintended (Finer & Zolna, 2016), 




effects of unintended pregnancy on general maternal and child health previously 
discussed, unintended pregnancy in teenagers poses unique challenges to adolescent 
mothers and their children. Adolescents are more likely to have shorter inter-
pregnancy intervals than adult women (Katz et al, 2011). A systematic review of 
studies looking at teenage pregnancy indicates that among adolescent mothers, on 
average, approximately 19% within 12 months and 40% within 18 months became 
pregnant again (Meade, & Ickovics, 2004). Furthermore, children born to teenage 
mothers are more likely to be pre-term, have low birth weight and become teenage 
mothers compared to children of adult mothers (Chen et al., 2007; Langille, 2007). 
Considering the adverse effects of unintended and teenage pregnancies on 
maternal and child health, investigating risk factors contributing to these outcomes 
beyond women’s socio-demographic characteristics is warranted. Previous research 
has shown that women’s contraceptive behaviors can directly influence their risk of 
unintended pregnancy (Blumenthal et al., 1994; Forrest, 1994). The latest national 
data on women’s contraceptive behaviors indicate that 95% of unintended 
pregnancies in the United States result from non-use, or incorrect or inconsistent use 
of contraceptive methods (Sonfield, Hasstedt, & Gold, 2014). Therefore, 
understanding determinants of women’s contraceptive behaviors is important for 
preventing unintended pregnancy.  
Contraception 
Family planning, described as pregnancy planning, is considered one of the 
greatest public health achievements of the 20th century. Planning when to have a 




birth spacing, family size, and reducing unintended pregnancies (CDC, 2015; United 
States Department of Health & Human Services, 2014). Women, in the United States, 
spend a large portion of their reproductive years trying to avoid pregnancy (Gold, 
Sonfield, Richards, & Frost, 2009). Studies have shown that a typical American 
woman experiences her first sexual intercourse at the median age of 17, her first 
pregnancy at the median age of 22.5, her first childbirth at the median age of 26, and 
menopause at the median age of 51 (Gold et al, 2009). Furthermore, by 31 years of 
age, half of women desire no more children (Gold et al, 2009). Therefore, women 
attempt to prevent pregnancy and childbearing for more than two decades of their 
lives (Gold et al, 2009), and their contraceptive behaviors during this time period are 
indicative of whether they will experience an unintended pregnancy.  
There are different traditional and modern family planning and contraceptive 
methods used by women and couples to avoid pregnancy. Traditional methods of 
contraception include abstinence, fertility awareness based method (FAM), and 
withdrawal, and modern contraceptive methods include spermicides, the sponge, 
female and male condoms, the diaphragm, the patch, the vaginal ring, the Depo-
Provera (DMPA) injection, oral contraceptive pills, intrauterine devices (IUDs), 
implants, and female and male sterilization (Hatcher et al., 1998). All of these 
methods with the exception of female and male sterilization are reversible. Each 
method has a different rate of effectiveness in preventing pregnancy which is directly 
associated with the contraceptive behaviors of the individual using the method. 
Perfect use indicates how effective a contraceptive method is at preventing pregnancy 




encounter. Typical use, on the other hand, is an indication of contraceptive method 
effectiveness at preventing pregnancy based on the actual use of the method by users, 
which may be inaccurate and inconsistent (Trussell, 2011). For instance, the long 
acting reversible contraceptive methods (LARCs) including implants and IUDs are 
considered the most effective reversible methods because they do not require user 
adherence to the method and therefore their failure rates (rates at which women 
become pregnant) based on typical and perfect use are similar at less than one 
pregnancy per 100 women in a year (Trussell, 2011). The DMPA injection, oral 
contraceptive pills, the patch, and the vaginal ring are associated with 6-12 
pregnancies per 100 women per year based on a typical use compared to less than one 
per 100 women per year based on perfect use. Male condoms, FAM, the sponge, 
spermicides, and withdrawal are considered the least effective contraceptive methods 
as they are associated with 13-28 pregnancies per 100 women per year based on 
typical use versus 2-18 based on perfect use (Jaccard, 2009; Trussell, 2011).  
Almost all sexually experienced women in the United States use a form 
(traditional or modern) of contraception at some point in their lives (Daniels, Mosher, 
& Jones, 2013). Based on the latest national data from 2011-2013, about 62% of all 
women 15-44 years old in the United States were currently using a form of 
contraception (Daniels, Daughtery, & Jones, 2014). The three most common 
contraceptive methods used in 2013 were oral contraceptives, female sterilization, 
and male condoms that were used by 16%, 15.5%, and 9.4% of all women 
respectively (Daniels et al., 2015). The type of contraceptive methods used, however, 




contraceptive methods including oral contraceptives and male condoms were the most 
common methods used by women aged 15-24 years, while female and male 
sterilization were the most common methods used by women aged 35-44 years. Being 
of white non-Hispanic background, holding a college education or higher, never 
having been married, and having no children were positively associated with the use 
of oral contraceptives among women (Daniels et al., 2015). Furthermore, current 
contraceptive use was highest among white non-Hispanic women (65.3%), and 
women with some college education (69.2%), (Daniels et al., 2014).  
Despite being the most effective reversible contraceptive methods, LARCs 
(IUDs and implant) are not the most common reversible methods used among 
women. However, population based studies show an increasing trend in the use of 
LARC methods over the past decade among all women of reproductive age, 
particularly younger and low-income women who are at higher risk for unintended 
pregnancy (Finer, Jerman, & Kavanaugh, 2012; Kavanagh, Jerman, & Finer, 2015). 
In 2012, the use of LARC methods was highest among women 25-34 years old, 
foreign born women, and women with one or two previous births, and 89% of LARC 
users used an IUD compared to 11% who used an implant (Kavanagh, Jerman, & 
Finer, 2015). 
Although oral contraceptives and condoms are the most common reversible 
contraceptive methods used in the United States, women may not use these methods 
consistently or correctly when trying to avoid pregnancy (Daniels et al., 2015; Finer 
& Zolna, 2014). Population based projections have shown that over half of American 




abortion by the age of 45 (Allen Guttmacher Institute, 2016; Jones & Kavanaugh, 
2011).  Research has also shown that 53% of unintended pregnancies occur due to 
nonuse while 42% are due to incorrect or inconsistent use, and only about 5% are the 
result of method failure during the months of conception (Frost & Darroch, 2008; 
Sonfield, Hasstedt, & Gold, 2014). These data show that contraceptive behaviors are 
key determinants of unwanted or mistimed pregnancies among women of 
reproductive age (Daniels, Daughtery, Jones, & Mosher, 2015), and merely 
promoting the uptake of contraceptives cannot address the problem of unintended 
pregnancies. Encouraging adherence to the contraceptive method regimen is also 
important in avoiding unwanted or mistimed pregnancies (Jaccord, 2009; Potter, 
Leon-Wong, & Canamar, 1996; Trussell, Vaughan, & Stanford, 1999).   
  Contraceptive behaviors of women consist of the choice of contraceptive 
method (both traditional and modern methods), accuracy in use, consistency and 
continuation of method, and switching between methods (Hynie & Lydon, 1996; 
Jaccord, Helbig, Wan, Gutman, & Kritz-Silverstein, 1996; Jaccard, 2009). 
Contraceptive behaviors are, in part, influenced by individuals’ knowledge about the 
contraceptive methods (Hynie & Lydon, 1996; Johnson, Pion, & Jennings, 2013). 
Using the National Survey of Reproductive and Contraceptive Knowledge, which 
sampled men and women aged 18-29, Frost et al. (2012) found that women with more 
objective knowledge of different contraceptive methods had 9% lower odds of 
expecting to have unprotected sexual intercourse in the next three months preceding 
the survey (p < 0.05), 17% higher odds of currently using hormonal contraceptives (p 




compared to women with less objective knowledge of contraceptive methods (Frost, 
Lindberg, & Finer, 2012).  
Choice of contraceptive methods 
For a woman, to obtain and use a contraceptive method, the first major step is 
to choose a method (Jaccard et al., 1996). Choice of a less effective contraceptive 
method can place women at a higher risk for unintended pregnancies (Jaacard, 2009; 
Jaacard & Levitz, 2013). The decision of what contraceptive method to obtain 
requires women’s active choice of a contraceptive method and for most modern 
methods, women must make a visit to health care provider to obtain their chosen 
contraceptive method. Previous research has shown that patient-provider 
communication can influence women’s contraceptive decision-making process 
(Wyatt et al., 2014). For some women the preferred decision making process is 
through a mutual agreement with their provider (Makoul & Clayman, 2006), while 
other women desire an autonomous decision making process with input from the 
provider on their specific concerns and questions (Dehlendorf, Diedrich, Drey, 
Postone, & Steinauer, 2010; Dehlendorf, Levy, Kelley, Grumbach, & Steinauer, 
2013). Some factors that may influence women’s decisions in choosing a particular 
contraceptive method include costs, concerns about side effects, dissatisfaction with 
specific methods, and ambivalence about becoming pregnant (Frost & Darroch, 
2008). Therefore, the healthcare provider may play an important role in providing 
women with accurate information about different methods available and their 




ultimately choose which method is most appropriate for their life circumstances 
(Branden, 1998; Frost & Dorrach, 2008).   
Contraceptive method continuation  
Access to effective contraceptive methods helps enable women and couples to 
control the timing and spacing of their pregnancies, which in turn can lead to better 
maternal and child health outcomes (Kavanaugh & Anderson, 2013; Sonfield et al., 
2014). Contraceptive continuation can be described as an individual using a method 
of contraception, though not always consistently and correctly, without stopping for a 
certain period of time (Jaccard et al., 1996). Despite an increase in the use of modern 
reversible contraceptive methods over the years, the rates of method continuation are 
still low (Peipert et al., 2011). Using a cohort of 1387 women aged 15-24 over a 12 
month period, Raine et al examined the continuation rate of hormonal contraceptives 
including the patch, the ring, the pill, and the injection and found low continuation 
rates for all four contraceptive methods by 12 months follow up (18.5 women per 100 
person-years), with the lowest rates of continuation for the patch and the injection 
initiators at 10.9 and 12.1 per 100 person-years (p< 0.003) respectively, and highest 
rates of continuation for oral contraceptive pill initiators at 32.7 per 100 person-years 
(Raine et al., 2011). Furthermore, using data from a randomized controlled trial of 
college and graduate students, Gilliam and colleagues found continuation rates of 
only 26% and 29% for oral contraceptives and vaginal rings at 6 months follow up 
from the baseline time point (Gilliam et al., 2010).  
The continuation rates for LARC methods are higher compared to other 




common contraceptive methods used by women in the United States (Obijuru, 
Bumpus, Auinger, & Baldwin, 2016; Soriano, Wallander, Andersson, Filonenko, & 
Rodriguez, 2015). For instance, using data from the Contraceptive CHOICE Project, 
Peipert et al. found that the 12-month continuation rate of LARC methods was 88% 
compared to 55% for oral contraceptives (Peipert et al., 2013). Similarly, using the 
Contraceptive CHOICE Project data, Diedrich and colleagues found that the 3-year 
continuation rate for users of LARC methods (67.2%) was significantly higher than 
the rate for users of non-LARC methods (31%) (Diedrich, Zhao, Madden, Secura, & 
Peipert, 2015).  
The low continuation rate of contraceptive methods increases women’s risk of 
unintended pregnancy, posing an important national public health issue in the field of 
maternal and child health.  Some factors associated with contraceptive method 
discontinuation include perceived weight change, other perceived side effects, 
dissatisfaction with contraceptive method, and feelings of ambivalence about 
becoming pregnant (Hall, O’Connell White, Rickert, Reame, & Westhoff, 2013c; O’ 
Connell, Davis, & Kerns, 2007; Westhoff et al., 2008).  
Accuracy, consistency, and switching in contraceptive use 
Other contraceptive behaviors include accuracy of and consistency in method 
use, and switching between methods. Accuracy is an indication of the correctness in 
use of the chosen contraceptive method at every incident of sexual encounter (Jaccard 
& Levitz, 2013). Women with low perceived risk of becoming pregnant and negative 
attitudes toward a method are at higher risk of inaccurate contraceptive use (Jaccard 




Consistency in contraceptive use is the proportion of times an individual uses 
the contraceptive method of her choice relative to the total number of sexual 
encounters she experiences during a specific time period (Jaccord et al., 1996; 
Jaccard, 2009). For some forms of contraceptives, accuracy is equivalent to 
consistency in use. For instance, consistency in taking oral contraception includes 
remembering to take the pill as often as directed and obtaining refills of the 
prescription when needed (Jaccard, 2009).  Factors such as minority race and 
ethnicity, younger age at first sexual intercourse, higher number of sexual partners, 
more sexual encounter, not expecting to have sexual intercourse at the time of 
incident, low desire for avoiding pregnancy, having fewer children, ambivalence 
about becoming pregnant, dissatisfaction with contraceptive method, and more stress 
and depressive symptoms have been shown to be associated with lower rates of 
consistent contraceptive use (Frost & Darroch, 2008; Hall et al., 2013b; Jones, 
Tapales, Lindberg, & Frost, 2015; Manlove, Ryan, & Franzetta, 2004; Moreau, Hall, 
Trussell, & Barber, 2013; Marrison et al., 2016). 
Contraceptive switching can be described as when an individual changes from 
one method to another (Jaccard & Levitz, 2013). Periods between switching from one 
method to another can place the individual at risk for unintended pregnancy either 
because the individual is not using any method or is learning how to use the new 
method (Jaccard, 2009). Urban residency, higher levels of education, dissatisfaction 
with method of choice at contraception initiation, and concerns about the side effects 
are factors associated with contraceptive method switching (Curtis & Blanc, 1997; 




Speizer, 2011; Raine et al., 2011). Assisting women who decide to switch methods in 
choosing a more effective method can decrease the potential risk of unintended 
pregnancy (Frost & Darroch, 2008).  For instance, women dissatisfied with a 
hormonal method other than LARCs are more likely to switch to a LARC method 
than women who were satisfied with the non-LARC hormonal method of their choice 
(Kavanaugh et al., 2015; Secura et al., 2010). 
In addition to factors discussed above, women’s mental health, particularly 
depression, has been shown to be associated with unintended and teen pregnancies, 
and contraceptive behaviors including method choice, continuation, and consistency 
(Daniels, et al, 2015; Francis et al. 2015; Frost et al, 2007; Frost et al., 2012; Garber 
et al., 2010; Hall, Richards, & Harris, 2017; Hall et al., 2014; Hall, Steinberg, Cwiak, 
Allen, & Marcus, 2015; Morrison et al., 2016; Raine et al., 2011; Steinberg et al., 
2013; Steinberg & Rubin, 2014).  
Depression 
Depression is one of the most common mental health problems worldwide and 
it has a negative impact the lives of individuals (Bromet et al., 2011). In the United 
States, the population-based 12-month prevalence of major depression, for adults, is 
6.6% (Center for Behavioral Health Statistics and Quality, 2015). Sex differences in 
depression rates also exist, with women being twice as likely as men to experience 
depression at some point in their lifetime (Kessler et al., 2003). According to the 
latest data from the National Comorbidity Survey Replication (NCS-R) the lifetime 
prevalence of major depression among women 18 or older is 20.2% compared to 




depression may also exist, which could be attributable to social factors such as access 
to care and lack of health insurance in minority populations (Bailey, Patel, Barker, 
Ali, & Jabeen, 2011; Dunlop, Song, Lyons, Manheim, & Chang, 2003). Although 
depression is a common mental health problem in adults, it is also prevalent among 
adolescents 13-18 years of age, with a population based lifetime and 12-month 
prevalence of 11.0% and 7.5% respectively (Avenevoli, Swendsen, He, Burstein, & 
Merikangas, 2015). In particular, the lifetime prevalence of major depression among 
girls age 13-18 is approximately 16% compared to 7.7% in adolescent boys (National 
Comorbidity Survey, Appendix Tables 1&2, N.D.), raising a public health concern.  
In non-pregnant women aged 18 and older, in the United States, the 
prevalence of major depression in a given year is estimated to be 8.1%—with a 
higher prevalence (15%) among low-income women compared to higher income 
women (2%) (Farr, Bitko, Hayes, & Dietz, 2010; Farr, Dietz, Williams, Gibbs, & 
Tregear, 2011a; Vesga-Lopez et al., 2008). A limited number of studies have looked 
at the correlates of depression among non-pregnant women. Using a sample of low 
income women aged 12-40, Berenson and colleagues found that current depression in 
women was associated with demographic factors such as minority race and ethnicity, 
younger age, less education, unemployment, and sexual or contraceptive health 
factors including having multiple sexual partners, first use of hormonal contraception 
at 12 years of age or younger, not using birth control at the last intercourse, and not 
having sex in the past three months (Berenson, Breitkopf, & Wu, 2003).  
According to the World Health Organization’s Global Burden of Disease 




Health Organization, 2004) and it may negatively influence women’s reproductive 
health including their contraceptive behaviors and unintended pregnancy (Hall et al., 
2015; Steinberg & Rubin, 2014). Depression leads to negative cognitive frameworks, 
lower self-efficacy, lower autonomy and self-agency, and lower motivation in 
individuals. The depression literature has shown that depression may alter the 
decision-making process in individuals (Hindmarch, Hotopf, & Owen, 2013). 
Depressed individuals may be indecisive or make judgments that are not based on 
rational thinking (Leahy, 2001; Leykin, Robersts, DeRubies, 2011). Depression may 
also decrease the individual’s sense of self-efficacy and care leading the individual to 
underestimate their risk (Bandura, 1977; Beck, 1987; Sacco & Bykowski, 2010). 
Depression may also reduce motivation in individuals (Austin, Mitchell, & Goodwin, 
2001) and therefore, it may increase the risk of medical non-compliance and 
adherence to prescription medication in women (DiMatteo, Lepper, & Croghan, 
2000; Osterberg & Blaschke, 2005). Considering these mechanisms, depression may 
influence women’s contraceptive behaviors in such a way that places them at a higher 
risk for experiencing unintended pregnancy. Therefore, further investigation of the 
association between depression and contraceptive behaviors, and pregnancy among 
women of reproductive age is warranted.  
Overview of Studies  
Studies comprising this dissertation are secondary analyses of three 
independent datasets. The first study examined the relationship between depressive 




seeking abortion services in a cross sectional study (Steinberg, Tschann, Furgerson, & 
Harper, 2016).  
Using time-to-event analysis, the second study investigated 1) the independent 
relationship between a combined past and baseline measurement of depressive 
symptoms and the hazard of contraceptive method discontinuation in a 12-month 
study period and 2) the independent relationship between a combined past and 
baseline measurement of depressive symptoms and the hazard of experiencing an 
unintended pregnancy during the same time period among women seeking family 
planning or abortion services in the prospective cohort of the National Trial of 
Contraceptive Acceptability Study (NTCAS) (Harper et al., 2015).  
The third study investigated whether timing of depression onset with respect 
to age at sexual debut was associated with a higher probability of first pregnancy 
among adolescent girls 13-18 years old participating in the National Comorbidity 
Survey – Adolescent Supplement (NCS-A).  
The use of time-to-event analysis is a novel approach in the context of this 
research topic. In present studies, time-to-event analysis is advantageous compared to 
ordinary logistic regression. In logistic regression the odds of the event is estimated in 
a fixed time period and the information from the subjects who have not completed the 
study period—those who left the study before the end of study period without 
experiencing the event—is unknown. Therefore the information pertaining to these 
subjects would not be considered in the calculation of the odds ratio. In time-to-event 
analysis, however, the hazard of the event is a function of time and the information 




period and did not experience the event—will be considered in the calculation of 
hazard ratio. This method will therefore produce more informative results about the 
association between depression and contraceptive behaviors or teenage pregnancy 
and is the preferred method in this dissertation.  
Theoretical Framework: How Depression Influences Contraceptive 
Behaviors and Unintended/Teenage Pregnancy 
Although the exact mechanisms by which depression may influence women’s 
contraceptive behaviors and reproductive decision-making have not been thoroughly 
examined, various mechanisms can be conceived. An understanding of the specific 
mechanisms moves toward a more thorough understanding of the effect of depression 
on women’s reproductive health and decisions, thus, better informing public health 
initiatives and policies. Figure 1 in Appendix B provides a schematic overview of 
various mechanisms that may explain the relationship between depression, 
contraceptive behaviors, and unintended or teenage pregnancy.  
Depression and decision-making 
Depression can alter the decision-making process in individuals, which may 
have a negative or positive influence on contraceptive method choice. Decision-
making is a compound process which may be influenced by elements of decision 
maker’s intrapersonal environment interact and elements of external world. When 
making a single decision, a decision maker’s personal preferences and personality, 
emotional state at the time of decision making, the characteristics of the options 




decision-making act together influencing the individual to recognize and evaluate all 
the options available and produce the best possible outcome (Lerner, Li, Valdesolo, & 
Kassam, 2015). Hence, any change in one of these components may affect the 
decision being made.  
Depression has been shown to negatively influence emotions and the 
regulation of emotions in individuals (Joornann & Vanderlind, 2014). Depressed 
individuals tend to engage more in thinking about their depressive symptoms and are 
preoccupied with the potential implications that these symptoms have on their lives. 
These are behaviors that perpetuate and exacerbate the depressed mood, producing 
negative thoughts in the depressed individual, which consequently can lead to 
increased dissatisfaction with life  (Lewinsohn, Rohde, & Seeley, 1998; Nolen-
Hoeksema, Wisco, & Lyubomirsky, 2008). Depressed individuals may, therefore, 
experience anhedonia together with a low sense of motivation. They may also have 
less sense of control over life events. Depression can also lead individuals to focus 
more on the negative affects while simultaneously diminishing positive affects, and to 
avoid taking risks compared to non-depressed individuals (Leahy, 2001; Raes, Smets, 
Nelis, & Schoofs, 2012; Werner-Seidler, Banks, Dunn, & Moulds, 2013). These 
emotional and behavioral changes, therefore, may influence the rational thinking, and 
decision-making process and the outcome of that process as a whole in depressed 
individuals.  
Depression and its influence on decision-making process may also play a role 
in pregnancy intention. The low levels of self-efficacy and motivation for 




behaviors, such as contraceptive choice or continuation, and consequently teenage 
pregnancy (Carvajal et al., 2014). Furthermore, as mentioned previously, depression 
may lead to feelings of ambivalence about becoming pregnant especially among 
adolescent girls (Francis et al., 2015a).  
Depression and contraceptive method choice 
With respect to reproductive health decisions, when facing a decision about 
what contraceptive method to choose, compared to their non-depressed counterparts, 
depressed women may focus more on the negative side effects of contraceptive 
methods such as oral contraception or LARCs, may be less likely to perceive 
potential benefits from using these methods to prevent pregnancy, and consequently 
choose a less effective method of contraception (Garbers et al, 2010). In turn, these 
decisions could influence discontinuation of their contraceptive method and place 
depressed women at a higher risk for unintended pregnancy. Alternatively, however, 
the feeling of risk aversion and anhedonia about motherhood in depressed women 
may lead them to choose a more effective contraceptive method to avoid the risk of 
becoming pregnant in the future. Some studies have shown that women with more 
depressive symptoms are more likely to choose or use a more effective contraceptive 
method compared to women with less depressive symptoms (Callegari et al., 2014; 
Farr et al., 2011b; Francis et al., 2015b; Steinberg et al., 2013). However, it is unclear 
how depression impacts contraceptive choice among women seeking abortion 
services, who may experience a transient elevated level of depressive symptoms 
immediately before undergoing the abortion procedure, rather than a long-lasting 




Depression and contraceptive method continuation 
Depression may also influence contraception continuation. Depressed 
individuals demonstrate a low sense of self-efficacy, viewing themselves as incapable 
and incompetent of performing a particular task or behavior to achieve an expected 
outcome (Bandura, 1977). Depression may also influence motivation, affecting an 
individual’s ability to conduct and continue a behavior (Bolles, 1972). Furthermore, 
depressed individuals feel a low sense of predictability and a lowered sense of control 
over future events (Leahy, 2001). These factors together may—concurrently or 
independently from each other—interfere with depressed individuals’ health 
behaviors, including contraceptive behaviors. Empirical studies have shown that 
depressed women are less likely to comply with their medication regimen compared 
to their non-depressed counterparts (e.g. DiMatteo et al., 2000). Therefore, when 
using a contraceptive method, depressed women may view themselves as incapable of 
using the contraceptive method or be less motivated to utilize the method and 
consequently discontinue contraception. In fact, compared to non-depressed women, 
depressed women are more likely to discontinue their contraceptive method over time 
(Hall et al., 2012; Westhoff et al., 1998a; Westhoff et al., 1998b; Zink et al., 2002). 
Depression may lead to feelings of ambivalence about pregnancy (Francis et al., 
2015a), which, in turn, may result in contraception discontinuation.  
Depression and unintended pregnancy/teenage pregnancy 
The potential choice of less effective contraceptive methods and higher 




for unintended pregnancy, or for adolescents, a teen pregnancy compared to non-
depressed women. Figure 1 in Appendix B provides an overview of the mechanisms. 
Covariates associated with contraceptive behaviors and teenage pregnancy 
Sociodemographic characteristics 
As mentioned previously, choice of contraceptive methods and the decision to 
continue a particular method, as well as rates of unintended and teenage pregnancies 
differ by women’s sociodemographic characteristics such as race and ethnicity, age, 
material status, and socioeconomic status (Daniels et al., 2015; Dehlendorf et al., 
2010; Hall et al., 2014; Hall et al., 2017; Peipert et al., 2011). Therefore, these 
variables will be controlled for in all three studies of this dissertation.     
Pregnancy related characteristics 
Number of previous abortions, parity, and feelings about becoming pregnant 
have also been shown to be associated with women’s choice of contraceptive methods 
and continuation in reproductive health literature (Berlan, Mizraji, & Bonny, 2016; 
Garbers et al., 2010; Peipert et al., 2011; Steinberg et al., 2013) and therefore will be 
examined as covariates in the three studies in this dissertation.  
Experience of past adversities 
Women’s experience of past adversities including childhood adversities, 
intimate partner violence, and experience of reproductive coercion have also been 
shown to be associated with women’s depressive symptoms (Steinberg et al., 2016). 




Sexual behavior of women 
Women’s age at first sex as well as previous use of contraceptive methods 
have shown to be associated with contraceptive behaviors and teenage pregnancy 
(Hall et al., 2012; Hall et al., 2012; Hall et al., 2017). Therefore, these variables were 
examined in analyses using contraceptive method discontinuation and teenage 
pregnancy as outcomes.  
Conclusion   
Considering the negative impact of unintended pregnancy on maternal and 
child health and society, the debilitating effects of depression on the reproductive 
decision making of women, and the interrelatedness of contraceptive behaviors and 
unintended pregnancy, further investigation of the relationship between depression, 
and contraceptive behaviors and teenage pregnancy among women of reproductive 
age is warranted. 
Therefore, the overall objective of this dissertation was to further investigating 
the relationship of depression with contraceptive behaviors, teen pregnancy, and 
unintended pregnancy. To do this, I first examined the independent association 
between depressive symptoms and contraceptive method choice. Second, I 
investigated the association between depressive symptoms and contraceptive 
continuation and unintended pregnancy. Third, I assessed the independent association 





Aim 1: To examine the relationship between pre-abortion depressive symptoms and 
effectiveness level of contraceptive method choice after contraceptive counseling 
among women seeking abortion services. 
Hypothesis 1: Women with higher pre-abortion depressive symptoms are more likely 
to choose a less effective contraceptive method after contraceptive counseling 
compared to women with lower depressive symptoms. 
Aim 2: To examine the relationship between the experience of past and current 
depressive symptoms and contraception continuation and unintended pregnancy over 
12 months among women seeking reproductive health services.  
Hypothesis 2: Women experiencing past and current elevated depressive symptoms 
are more likely to discontinue their contraceptive method and experience an 
unintended pregnancy over 12 months than those with no depressive symptoms.  
Aim 3: To examine whether the timing of depression onset relative to sexual debut is 
associated with an increased likelihood of experiencing first pregnancy among 
adolescent girls aged 13-18.  
Hypothesis 3: Adolescent girls who have depression onset before the age at first sex 






Chapter 2: Literature Overview  
 
This chapter provides a summary of studies examining the associations 
between depression/depressive symptoms and women’s contraceptive behaviors, 
unintended pregnancy, and teenage pregnancy.  
Depression and Contraception  
The literature at the intersection of contraceptive behaviors and mental health 
has examined the bidirectional relationship between mental health and contraception. 
Most research had examined the effect of contraceptive methods (hormonal 
contraceptives in particular) on women’s mental health (Moller, 1981). Research 
done in the 1970s when doses of hormones used in birth control were higher than 
now, found that consuming hormonal contraception was associated with depression in 
women (Kay et al., 1974). More recently, a study based in Denmark also found that 
compared to non-users, users of hormonal contraceptive methods were at an increased 
risk for subsequent antidepressant medication (Skovlund, Morch, Kessing, & 
Lidegaard, 2016). In contrast to these findings, many studies usually find no 
independent association (e.g. Duke, Sibbritt, & Young, 2007; Hall et al., 2015; 
O’Connell, Davis, & Kerns, 2007; Robinson, Dowell, Pedulla, & McCauley, 2004) or 
find that use of hormonal contraceptive methods to be associated with decreased 
levels of depressive symptoms (Keyes et al., 2013).  
In contrast to examining the effects of contraception on depression, emerging 
research has investigated how experiencing depression may influence women’s 




et al., 2015; Steinberg et al., 2013; Steinberg & Rubin, 2014; Takahashi et al., 2012). 
Specifically, some studies have empirically examined the association between 
depression and contraceptive choice (e.g., Garbers et al., 2010), depressive symptoms 
and method continuation (e.g. Hall, White, Rickert, Reame, & Westhoff, 2012), and 
depressive symptoms and method use and consistency (e.g., Hall et al., 2013a; Hall et 
al., 2013b). 
Depression and choice of contraceptive methods 
A few studies have investigated the association between depression and 
contraceptive method choice and they have contradictory findings. In a cross-
sectional study of adult women seeking reproductive services in New York City, 
Garbers and colleagues found that women with depression had lower odds of 
choosing any modern contraceptive method including injection, patch, contraceptive 
sponge, diaphragm, emergency contraception, female condoms, IUD, implant, oral 
contraception, spermicide and condom, and tubal ligation) than women who did not 
have depression (Garbers et al., 2010). In contrast, Steinberg et al found that among 
women seeking abortions, those with severe depressive symptoms had higher odds of 
choosing more versus less effective contraceptive methods than women without 
severe depressive symptoms (Steinberg et al., 2013). Similarly, using a sample of 
minority adolescents 15-19 years old, attending a health center, Francis et al (2015) 
found that compared to girls with no elevated depressive symptoms, those with 
elevated depressive symptoms were more likely to select a LARC method than the 




association between perinatal depressive symptoms and the choice of contraceptive 
methods among postpartum women was found (Faisal-Cury et al, 2013).  
Depression and contraceptive method continuation 
The effect of depression on women’s contraception discontinuation has been 
examined for specific contraceptive methods in four studies. The overall findings of 
the studies investigating this relationship indicate that women with elevated levels of 
depressive symptoms may be at a higher risk for discontinuation of contraceptive 
methods (Hall et al., 2012; Westhoff et al., 1998). Three of the studies measured 
depressive symptoms at baseline (Hall et al., 2012; Westhoff et al., 1998a; Westhoff 
et al., 1998b) and one study measured presence of depression retrospectively using 
medical records (Zink Shireman, Ho, & Buchanan, 2002). Specifically, in a study of 
young women (13-24 years old) and oral contraception, compared to less depressed 
women, women with more depressive symptoms at baseline were more likely to 
discontinue their method at 6 months’ follow-up due to perceiving more weight gain 
than those who has less depressive symptoms (Hall et al., 2012). Furthermore, 
Westhoff et al. (1998) found that adult women who continued using implant for 6 
months had  lower baseline depressive symptoms scores than those with discontinued 
their method at 6 months. Similar result was found for depot shot at 12 months 
(Westhoff et al., 1998a; Westhoff et al., 1998b). Finally, in the retrospective 
examination of billing statements of adolescent girls 12-19 years old, Zink et al found 
that presence of mood disorders including depression was associated with 12-month 





Depression and other contraceptive behaviors  
Depression has also been shown to be associated with contraceptive non-use 
and inconsistent use (Berenson, Breitkopf, & Wu, 2003; Hall et al., 2014; Hall et al., 
2013a; Morrison et al., 2016). Examining the weekly diaries of women aged 18-20, 
Hall and colleagues found that in a period of 12 months, women with depression had 
47% reduced odds of consistent use of contraceptive methods compared to women 
with no depression (Hall et al., 2013b). Also, in a cross-sectional examination of 
AddHealth participants, Morrison and colleagues found a significant association 
between more depressive symptoms and 91% increased odds of inconsistent 
contraceptive use in 12-month among women 18-24 years old (Morrison et al., 2016). 
Furthermore, depressed women may be more likely to be involved in 
relationships with controlling partners and have less reproductive freedom and 
therefore more likely to be subjected to reproductive coercion (Azevedo, Araujo, 
Valongueiro, & Ludermir, 2013; Miller et al., 2010; Miller et al., 2014). Reproductive 
coercion may place depressed women at increased risk of not using contraception or 
using contraceptive methods incorrectly and inconsistently, leading to increased rates 
of unintended pregnancy.  
In addition to the negative effect of depression on contraceptive behaviors, 
depressive symptoms are shown to be associated with other related reproductive 
behaviors, experiences, or outcomes such as substance use during the last sexual 
intercourse, earlier coitarche, non-consensual sex, experience of intimate partner 
violence, and higher rates of sexually transmitted infections (Lehrer, Shrier, 




effect of depression on contraceptive and other related reproductive behaviors may 
place women at a higher risk for unintended pregnancies during adolescents and 
adulthood.  
Depression and Unintended Pregnancy 
Previous research has shown an association between elevated levels of 
depressive symptoms or depression and unintended pregnancy in women of 
reproductive age (DiClemente et al., 2001; Hall et al., 2014; Hall et al., 2017; Nelson 
& Lepore, 2013; Takahashi et al., 2011). Using data from women aged 18-20 with a 
strong desire to avoid pregnancy in the subsequent year, Hall and colleagues found 
that women with co-occurring depressive and stress symptoms at baseline were at 2.3 
times higher risk of pregnancy within a year than women with no symptoms (Hall et 
al., 2014). Similarly, using an urban sample of pregnant women 14-40 years old, 
Nelson and Lepore (2013), found that women with more depressive symptoms had 
2.14 times higher odds of reporting their pregnancies as unintended than those with 
less depressive symptoms. Takahashi et al also found that a history of depression was 
associated with mistimed pregnancy among a group of adult Japanese women 
(Takahashi et al., 2012).  
Depression and Teenage Pregnancy 
As mentioned in the previous chapter, 16% of girls aged 13-18 years old have 
already experienced depression during their lifetime (National Comorbidity Survey, 
Appendix Table 2, N.D.). Additionally, according to the National Comorbidity 




sometime in their lifetime (Kessler & Walters, 1998). Depression has been shown to 
influence feelings of pregnancy ambivalence, especially among adolescent girls 
(Francis et al., 2015a). Francis and colleagues found that among minority adolescent 
girls ages 15-18 years old in the United States, living in an urban setting, girls with 
more depressive symptoms had higher odds of pregnancy ambivalence compared to 
those with no depressive symptoms (Francis et al., 2015a). In another study, using 
data from 522 unmarried black women aged 14-18 years old, DiClemente and 
colleagues found that those experiencing psychological distress at baseline were at a 
higher risk for pregnancy at 6 months follow up compared to those with no 
psychological distress (DiClemente et al., 2001). Similarly, using AddHealth data, 
Hall et al., that moderate/severe depressive symptoms increased the risk of 
unintended first pregnancy among adolescent girls (Hall et al., 2017). While 
pregnancy intentions among teens may vary, the majority of teenage pregnancies in 
the US are unintended (Finer & Zolna, 2016) and lower rates of compliance to 
contraceptive methods among adolescents with mental health conditions can place 
them at a higher risk for unintended pregnancy (Zink et al., 2002).  
Summary 
The reproductive health literature on the association between depression and 
contraceptive behaviors and teenage pregnancy carries several limitations. First, there 
are only a few studies that measure the association between depression and the 
effectiveness of contraceptive method choice at the healthcare provider setting, and 
among these studies the findings are inconsistent (Francis, Presser, Malbon, Braun-




2010; Steinberg et al., 2013). This inconsistency in findings may be attributable to 
differences in operationalization of the contraceptive method choice and sample 
characteristics in each study.  Second, studies examining the association between 
depression and contraception continuation use a single measure of depressive 
symptoms usually at baseline, and the effect of multiple measures of depression over 
time on contraceptive continuation and pregnancy is missing from the literature (Hall 
et al., 2013a). Although the findings from these studies uniformly confirm a positive 
association between elevated levels of depressive symptoms and higher rates of 
discontinuation over time, it is still unclear whether persistence of depressive 
symptoms over time influences women’s contraception continuation rates. Using 
multiple measures of depression can provide us with a better understanding of the 
nature of depressive mood and whether what is being picked up is a transient versus a 
more persistent depression and how each can predict women’s contraceptive method 
continuation. Finally, despite the high prevalence of lifetime depression in adolescent 
girls, there is no evidence on whether the timing of depression onset can influence the 





Chapter 3: Study One  
 
Title: The effects of pre-abortion depressive symptoms on post-abortion 
contraceptive method choice among women seeking abortion services 
Forthcoming; Vafai, Y., Steinberg, J. R. (2018). The effects of pre-abortion 
depressive symptoms on post-abortion contraceptive method choice among women 
seeking abortion services. Contraception, 97(4), 335-340. 
Abstract 
Objective: Ninety-five percent of abortions are due to an unintended pregnancy and 
compared to women seeking contraceptive services, women seeking abortion services 
are at an increased risk for experiencing a subsequent unintended pregnancy. Some 
women experience high levels of mental distress before an abortion, which may 
influence their contraceptive decisions in the abortion setting. Method: Using 
multinomial logistic regression models and a sample of 345 adult women seeking 
abortions due to an unintended pregnancy at three different community health clinics 
in northern California, we examined the relationship between pre-abortion depressive 
symptoms and effectiveness level of contraceptive method chosen (low, moderately, 
or highly effective) after contraceptive counseling. Results: After adjusting for 
women’s race/ethnicity, marital status, education, age, abortion trimester, abortion 
type, experiences of IPV and reproductive coercion in the past 6 months, adversities 
experienced during childhood, previous number of abortions and children, and future 
pregnancy desires, women with more depressive symptoms had 1.054 times higher 




(95% CI: 1.008-1.102, p=0.020). Women with more depressive symptoms also had 
1.045 times higher odds of choosing a low effective than a highly effective 
contraceptive method, however the differences were only marginally significant (95% 
CI: 0.998-1.093, p=0.060). Conclusion: More pre-abortion depressive symptoms 
were associated with choosing a less effective contraceptive method placing women 
at a higher risk for subsequent unintended pregnancies. Implications: Reproductive 
health care providers should consider the impact of women’s psychological 






Ninety-five percent of abortions are the result of an unintended pregnancy 
(Finer & Zolna, 2011). Women seeking abortions are at a higher risk for experiencing 
a subsequent unintended pregnancy than women seeking contraceptive services 
(Upadhyay et al., 2012). While 96% of clinics offering abortion services also offer 
post-abortion contraception services (Kavanaugh, Jones, & Finer, 2010), there is still 
a dearth of evidence on what factors influence women’s contraceptive choices in an 
abortion care setting. A broader understanding of what factors are associated with 
women’s choice of more versus less effective contraceptive methods may better 
enable reproductive health and abortion providers to help women prevent subsequent 
unintended pregnancies.  
Previous studies have found that factors such as younger age, lower education 
level, experience of intimate partner violence, having a desire for future pregnancy, 
no history of abortion, and not wanting contraceptive information during 
contraceptive counseling are associated with women choosing less versus more 
effective contraceptive methods in abortion care settings (Moslin & Rochat, 2011; 
Steinauer et al., 2015; Taylor, Connolly, Ingles, Watson, & Segall-Gutierrez, 2014). 
Another factor that has been shown to be associated with women’s contraceptive 
choices after an abortion is pre-abortion psychological health, particularly depressive 
symptoms (Steinberg et al., 2013). This study extends Steinberg et al.’s (2013) study, 
which sampled women from one urban hospital abortion clinic providing patient-




psychological health is associated with the effectiveness level of contraception chosen 
among women seeking abortions at three community reproductive health clinics. 
 Only a handful of studies have examined the relationship between depressive 
symptoms or depression and the effectiveness of the contraceptive method chosen or 
used among reproductive-aged women (Callegari et al., 2014; Faisal-Curry, Menezes, 
& Huang, 2013; Farr, Curtis, Robbins, Zapata, & Dietz, 2011; Francis et al., 2015b; 
Garbers et al., 2010; Hall, Moreau, Trussell, & Barber, 2013a; Steinberg et al., 2013). 
Findings from these studies were inconsistent and may have varied due to selection of 
participants from different reproductive health settings, or variation in 
operationalization of the outcome. Some studies found that elevated depressive 
symptoms were associated with choosing or using a less effective contraceptive 
method (Farr et al., 2011; Garbers et al., 2010; Hall et al., 2013a), while others found 
that more depressive symptoms were associated with choosing or using a more 
effective contraceptive method (Callegari et al., 2014; Francis et al., 2015b; Steinberg 
et al., 2013). Finally, others have found no association between more depressive 
symptoms and the effectiveness of contraceptive methods chosen or being used 
(Faisal-Curry et al., 2013; Farr et al., 2011). Only one study has focused on the 
association between depressive symptoms and the effectiveness of contraceptive 
method choice in an abortion setting (Steinberg et al., 2013). Women seeking 
abortions represent a critical population for addressing factors that influence 
contraceptive decision-making. Given the inconsistency in findings of these studies 
and the little research on the effect of women’s pre-abortion mental health symptoms 




women’s pre-abortion depressive symptoms and effectiveness level of contraceptive 
method chosen among women seeking abortions is warranted.  
The current study aims to add to antecedent literature: (1) factors that 
influence women’s contraceptive choice in the abortion care setting, and (2) the 
extent to which depression influences the effectiveness level of contraception that 
women select to use. Findings from this study may also be used to inform clinical 
practice. Research has consistently shown that women seeking abortions experience 
higher levels of depressive symptoms just before compared to just after an abortion 
(Cozzarelli, 1993; Major et al., 2000). If more pre-abortion depressive symptoms are 
associated with the effectiveness levels of women’s contraceptive choices, then those 
involved in contraceptive counseling among women seeking abortions should be 
aware of this. 
In this paper, we build on Steinberg et al. (2013), by testing the association 
between pre-abortion depressive symptoms and the effectiveness levels of 
contraceptive methods women chose to use at three different community reproductive 
health clinics. We included the same covariates as Steinberg et al. (2013) as well as 
covariates that have recently been found to be associated with pre-abortion depressive 
symptoms (Steinberg, Tschann, Furgerson, & Harper, 2016) to examine whether pre-
abortion depressive symptoms are independently associated with effectiveness level 




Material and Methods 
Participants 
Women 18 years of age or older seeking surgical or medication abortions not 
due to fetal anomaly or a medical condition at three community reproductive health 
centers in Northern California between July 2012 and February 2013 were recruited 
to participate in a study on decisions women make about contraception following an 
abortion. 
Procedure 
At each recruitment site, the self-administered questionnaire was answered at 
two time points. Women answered Part 1 of the questionnaire in waiting rooms 
before contraceptive counseling and Part 2 was completed after contraceptive 
counseling before women left the clinic. Part 1 of the questionnaire assessed women’s 
socio-demographics, current mental health, pregnancy history, recent and past 
adverse experiences, relationship characteristics, contraceptive attitudes, beliefs, and 
self-efficacy, future pregnancy desires, and past contraceptive use. The question 
relevant to this study on Part 2 was the question assessing the main contraceptive 
method women planned to use after their abortion. We used this variable because 
some women at these sites did not receive their contraceptive method on the same day 







Outcome – Post-abortion Method Choice Effectiveness Level 
The effectiveness level of participants’ main contraceptive method choice 
after abortion was defined based on a question in Part 2 answered after contraceptive 
counseling. Women were asked: “What is the main method of pregnancy prevention, 
if any, you plan to use in the next 6 months to prevent you from getting pregnant? 
(Please choose only one)”. The response options included “the pill, the patch (Ortho 
Evra), the vaginal ring (Nuva Ring), the shot (Depo-Provera, injectable), implant 
(Implanon), Mirena (hormone IUD), ParaGard (copper IUD), condom or rubber (for 
partner), diaphragm, spermicide, emergency contraception (Plan B, Next Choice, 
Morning After pill), pulling out or withdrawal, rhythm method or natural family 
planning, abstinence (no heterosexual intercourse), tubal ligation (tying your tubes), I 
do not plan to use any method, and other, please specify”. The effectiveness level of 
the intended contraceptive method choice post-abortion was categorized into three 
categories of low, moderately, and highly effective contraceptive methods based on 
the methods’ typical use failure rates (Trussell, 2011). Based on participants answers 
to this question, methods with typical use failure rates greater than 10% were 
classified as low effective (no methods, abstinence, and condom), those with failure 
rates between 1 to 10% were classified as moderately effective (the pill, patch, 
vaginal ring, and shot), and those with failure rates less than 1% were classified as 





Main predictor – Depression 
Participants’ depressive symptoms were assessed with the Center for 
Epidemiologic Studies Depression (CES-D) Scale (Radloff, 1977) on the first part of 
the questionnaire. Sample items include “I was bothered by things that usually don’t 
bother me”, “I did not feel like eating”, and “My appetite was poor”. The scale 
assessed how often (0= not at all to 3= extremely) women experienced each item in 
the past 2 weeks. Similar to Steinberg et al. (2013), we created both a continuous 
measure of depressive symptoms score and a dichotomous measure to categorize 
those with elevated depressive symptoms. The continuous measure was the sum of 
the 20 items. Women could be missing on up to 5 items in which case mean 
imputation was used to create a sum on 20 items for the missing items (n=21). To 
create the dichotomous measure of the elevated depressive symptoms, we coded 
women with depressive symptoms scores at or above one standard deviation above 
the mean (1 SD above the mean was 35.21) as experiencing elevated depressive 
symptoms, while women with scores below 35.21 were coded as not experiencing 
elevated depressive symptoms. This cut-off was chosen over the other common CES-
D cut offs of 16 and 20 because depressive symptoms have been shown to be elevated 
just before an abortion, compared to just after the procedure (Cozzarelli, 1993; Major 
et al., 2000). Using this method, 17.1% of the participants were categorized as 
experiencing elevated depressive symptoms.  
 
Covariates 
Based on the literature, we included the following covariates due to their 




depressive symptoms: socio-demographic characteristics including race and ethnicity 
(non-Hispanic white, non-Hispanic black, Hispanic, other), marital status (never 
married, married, widowed/separated/divorced, cohabiting), education (less than high 
school, high school graduate, some college, college degree or higher), and age; 
pregnancy characteristics included abortion trimester (second vs. first),  type of 
abortion (surgical vs. medication); past adversities included whether or not the 
woman experienced intimate partner violence (yes vs. no) and reproductive coercion 
(yes vs. no) in the past 6 months, and number of childhood adversities; relationship 
context included number of sexual partners in the past six months (one vs. multiple 
partners); previous pregnancies characteristics included number of previous children 
(none vs. one or more), and number of previous abortions (none vs. one or more); and 
future pregnancy desires included the importance of avoiding pregnancy in the next 
year, and desire to become pregnant in the future (less than 3 years vs. 3 years or 
more or never).  
Analyses 
We first examined the bivariate relationships between depressive symptoms, 
contraceptive method choice effectiveness, and all study covariates. Correlations 
were used when two variables were continuous, chi square tests when two variables 
were categorical, and Student’s t-test and one-way ANOVA F-tests when one 
variable was categorical and the other continuous to examine their relationships. If 
the general ANOVA F-test was significant with p<0.05 and there were three or more 
categories for the categorical variable, we performed Tukey’s Honestly Significant 




multinomial logistic regression analysis for the three-level categorical variable of 
post-abortion contraceptive method choice effectiveness. First, in Model 1, we 
examined the unadjusted multinomial regression models in which the three-level 
effectiveness coding (low, moderately, and highly effective) was regressed on the 
continuous measure of depressive symptoms. Second, in Model 2 we examined the 
adjusted multinomial regression model using the same covariates as those used in 
Steinberg et al. (2013)—age, race/ethnicity, marital status, education level, trimester 
of abortion, previous number of children, previous number of abortions, and the 
importance of avoiding pregnancy in the next year. Finally, in Model 3 we examined 
the adjusted multinomial model using all covariates in Model 2 and type of abortion, 
any experience of IPV in the past 6 months, any experience of reproductive coercion 
in the past 6 months, number of childhood adversities (0 to 8), number of sexual 
partners in the past 6 months (2 or more vs. 1), and the desire to become pregnant in 
three or more years or never, based on findings from Steinberg et al. (2016). We then 
repeated the procedure using the dichotomous measure of elevated depressive 
symptoms. All analyses were completed using IBM SPSS version 23.  
Results  
Four hundred and eighty-seven women 18 years or older presenting for 
abortion due to an unintended pregnancy at three community reproductive health 
centers filled out Part 1 of the survey. We excluded 38 women because it was unclear 
whether they followed through with the abortion procedure (n=10), their responses 
were questionable (n=1), they were missing on most items in Part 1 (n=16), or they 




remaining, we excluded women who were missing on all or most of the items in Part 
2 of the survey (n=36), where the question on contraceptive choice after contraceptive 
counseling was asked. Finally, from the 413 women remaining we excluded those 
that were missing on the outcome variable (n=12) and those that were missing on any 
of the covariates (n=56), leaving 345 women in the analytic sample. There were no 
statistically significant differences between those 56 women missing on the covariates 
and the 345 women that were not on both the effectiveness level of post-abortion 
contraceptive method choice (p=0.993) and women’s depressive symptom scores 
(p=0.255). 
Descriptive information of women’s demographic characteristics, pregnancy 
characteristics, experiences of past adversities, relationship characteristics, 
characteristics of previous pregnancies, and desire for future pregnancies are 
presented in Table 1-1. The majority of women identified as non-white (72.8%), were 
never married (52.8%), and had a household income at or below $10,000 per year 
(61%). Women’s average age was 26 years old (ranging from 18 to 48 years) and 
66% of women reported having some college or higher education. The majority of 
women were having a first trimester (93%) abortion and a surgical (68%) abortion. 
Most women reported not experiencing any IPV (66%) or reproductive coercion 
(84%), and the majority (76%) reported having only one sexual partner in the 6 
months prior to the study respectively. Furthermore, women in the sample reported 
experiencing an average of 2.7 (SD =2.1) adversities during childhood. Fifty-three 
percent of the women in the sample were seeking abortion services for the first time 




reported a strong desire to avoid becoming pregnant in the following year and most 
(66%) reported a desire to become pregnant in more than three years or never. Thirty-
five percent of women selected contraceptive pills and 30% chose IUDs. Thirty-eight 
percent of women in the sample reported choosing a highly effective, 55% reported 
choosing a moderately effective, and 7% reported choosing a low effective 
contraceptive method after contraceptive counseling. The mean depressive symptoms 
score was 23.2 (SD =12.0) ranging from 0 to 57.    
Table 1-2 presents the bivariate relationships between women’s depressive 
symptoms and the study covariates. There were significant differences in women’s 
mean depressive symptoms scores with respect to covariates including women’s age, 
experience of past adversities, relationship context, and previous pregnancy 
characteristics. Women who were younger (p=0.01), had experienced any IPV 
(p<0.001) in the past 6 months, had experienced any reproductive coercion (p=0.001) 
in the past 6 months, had experienced more adversities during childhood (p<0.001), 
had multiple sexual partners in the past 6 months (p=0.055), and had one or more 
prior children (p=0.001) had higher (or marginally higher in the case of multiple 
sexual partners) mean depressive symptoms scores.  
 Table 1-3 presents the bivariate relationship between the study covariates and 
women’s contraceptive choice effectiveness level. There were significant 
relationships between women’s contraceptive choice effectiveness on different levels 
of covariates including current pregnancy characteristics, experience of past 
adversities, relationship context, previous pregnancy characteristics, and desire for 




abortion (p=0.045), one or more prior children (p=0.019), experienced any IPV in the 
past 6 months (p=0.045), a higher number of adversities during childhood (p=0.022), 
reported having more than one sexual partner in the 6 months prior to the study 
(p=0.003), did not say it was very important to prevent pregnancy in the next year 
(p=0.039) and reported having the desire to become pregnant in less than three years 
(p=0.017) were more likely to choose a low effective method than a moderate or a 
highly effective method of contraception.  
 We examined the association between women’s depressive symptoms and the 
effectiveness level of contraceptive method selected in unadjusted and adjusted 
multinomial regression models (Table 1-4). In the unadjusted model (Model 1a), 
using the continuous depressive symptoms, we found that with each unit increase in 
depression score (or as depressive symptoms increased), women had significantly 
higher odds of choosing a low effective versus a moderately effective (OR = 1.051, 
95% CI: 1.016-1.087, p=0.004) or a highly effective contraceptive method (OR = 
1.046, 95% CI: 1.011-1.083, p=0.011) respectively. However, there was no 
significant association between depressive symptoms and choosing a moderately 
effective versus a highly effective contraceptive method (OR = 0.996, 95% CI: 0.977-
1.015, p=0.656). Similarly, using the dichotomous measure of elevated depressive 
symptoms, in the unadjusted model (Model 1b), women with elevated depressive 
symptoms had higher odds of choosing a low effective versus a moderately effective 
(OR = 1.896, 95% CI: 0.732-4.913, p=0.188) and a highly effective contraceptive 




elevated depressive symptoms, although these findings were not statistically 
significant.  
In the adjusted models, we first adjusted the regression model for all 
covariates used in Steinberg et al. (2013), (Table 1-4, Model 2a and Model 2b). In 
Model 2a, with each increase in depression score (or as depressive symptoms 
increased), women had higher odds of choosing a low effective than a moderately 
effective (aOR = 1.063, 95% CI: 1.022-1.105, p=0.002) and a highly effective 
contraceptive method (aOR = 1.051, 95% CI: 1.010-1.093, p=0.014). Using the 
dichotomous measure of elevated depressive symptoms (Model 2b), compared to 
those with no elevated depressive symptoms, women with elevated depressive 
symptoms had higher odds of choosing a low effective than a moderately effective 
(aOR = 2.152, 95% CI: 0.772-6.000, p=0.143) and a highly effective contraceptive 
method (aOR = 2.235, 95% CI: 0.764-6.534, p=0.142). However, these associations 
were not statistically significant (p>0.1). 
Next, we conducted models adjusted for all covariates in Model 2 plus type of 
abortion, experience of IPV in the past 6 months, experience of reproductive coercion 
in the past 6 months, number of childhood adversities, number of sexual partners in 
the past 6 months, and the desire to become pregnant in three or more years or never. 
After adjusting for all covariates in the study (Table 1-4, Model 3a), compared to 
women with fewer depressive symptoms, those with more depressive symptoms had 
higher odds of choosing a low effective than a moderately effective contraceptive 
method (aOR = 1.054, 95% CI: 1.008-1.102, p=0.020) and marginally higher odds of 




p=0.060). This meant that after adjusting for all covariates in Model 3a, one unit 
increase in women’s depressive symptoms score was associated with 5.4% higher 
odds of choosing a low effective than a moderately effective and 4.5% higher odds of 
choosing a low than a highly effective contraceptive method.  Similarly, in the 
adjusted models using dichotomous measure of elevated depressive symptoms, 
(Model 3b), the odds of choosing a low versus a moderately effective (aOR = 1.679, 
95% CI: 0.548-5.143, p=0.364) and highly effective (aOR = 1.844, 95% CI: 0.572-
5.945, p= 0.305) contraceptive methods remained higher for women with elevated 
depressive symptoms, though the associations were not statistically significant. There 
were no significant associations between more depressive symptoms or elevated 
depressive symptoms and choosing a moderately effective than a highly effective 
contraceptive method in the adjusted models (p>0.1).  
We also ran the regression models using the CES-D cut-off of 20 for elevated 
depressive symptoms (Andersen, Malmgren, Carter, & Patrick, 1994) and we found 
comparable but statistically significant results to those when using the higher cut-off 
score of 35.21. In the unadjusted model (Model 1b), women with elevated depressive 
symptoms had higher odds of choosing a low effective than a moderately (OR = 
4.620, 95% CI: 1.527-13.975, p=0.007) and a highly effective (OR = 3.522, 95% CI: 
1.144, 10.843, p=0.028) contraceptive method compared to women with no elevated 
depressive symptoms using the cut off of 20. Similarly, in Model 2b, compared to 
those with no elevated depressive symptoms, women with elevated depressive 
symptoms were more likely to choose a low effective than a moderately (aOR = 




1.127-13.044, p=0.031) contraceptive method. Furthermore, in the fully adjusted 
model (Model 3b), compared to women with no elevated depressive symptoms, those 
with elevated depressive symptoms had higher odds of choosing a low effective 
versus a moderately effective (aOR = 3.999, 95% CI: 1.149-13.917, p=0.029) 
contraceptive method. The odds of choosing a low versus a highly effective (aOR = 
2.634, 95% CI: 0.733-9.468, p=0.138) contraceptive method was not statistically 
significant, but in the same direction compared to when using the other cut-off value 
of 35.21.  
 Table 1-5 presents the adjusted multinomial regression model (Model 3a) for 
the continuous measure of depressive symptoms. Having a second trimester abortion 
was significantly associated with choosing a low effective versus a moderately 
effective contraceptive method (aOR = 0.192, 95% CI: 0.040-0.928, p=0.040). 
Similarly, having multiple sexual partners in the past 6 months was significantly 
associated with higher odds of choosing a low effective than a moderately effective 
(aOR = 2.866, 95% CI: 1.050-7.824, p=0.040) or a highly effective (aOR = 3.308, 
95% CI: 1.166-9.389, p=0.025) contraceptive method. Furthermore, the only factors 
significantly associated with selecting a moderately versus a highly effective 
contraceptive method post-abortion were having a surgical abortion (aOR = 0.526, 
95% CI: 0.308-0.988, p=0.019) and having previous children (aOR = 0.535, 95% CI: 
0.296, 0.967, p=0.038).  
Discussion 
The purpose of this study was to investigate the independent relationship 




levels of contraceptive method chosen after contraceptive counseling among women 
seeking abortion services at multiple community reproductive health centers in 
Northern California. After controlling for all study covariates, a one-unit increase in 
pre-abortion depressive symptoms was associated with 5.4% higher odds of choosing 
a low effective versus a moderately effective contraceptive method. This means that 
if the depressive symptoms score for two women were 10 and 30 respectively, the 
latter woman would have a 176% increased odds of choosing a low versus a 
moderately effective contraceptive method post-abortion. Similarly, a one-unit 
increase in women’s depressive symptoms was associated with 4.1% increased odds 
of selecting a low effective than a highly effective contraceptive method post-
abortion, though this was only marginally significant in the fully adjusted model. 
Furthermore, we found similar odds ratios when comparing Model 1 (unadjusted), 
Model 2 (adjusted for variables used in Steinberg et al.’s (2013) study), and Model 3 
(the fully adjusted model), except that there was only a marginally significant 
association between more depressive symptoms and choosing low versus highly 
effective methods in Model 3.  
While we were unable to test the mechanism by which more depressive 
symptoms may have led to this effect, it is possible that since more depressive 
symptoms prompt more negative emotions, a negative cognitive framework, and a 
reduced sense of motivation and control  (Joormann & Vanderlind, 2014; Leahy, 
2001; Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008; Raes, Smets, Nelis, & 
Schoofs, 2012; Werner-Seidler, Banks, Dunn, & Moulds, 2013), more depressive 




moderately or highly effective methods, or lack motivation for choosing more 
effective contraceptive methods. Past research has found that among women using 
oral contraception, those with more depressive symptoms are more likely to perceive 
side effects, such as gaining more weight and worsening of mood, and to stop using 
the method (Hall, White, Rickert, Reame, & Westoff, 2012).   
Our findings are consistent with some previous studies that found women with 
more psychological distress or depressive symptoms are more likely to choose or use 
less effective contraceptive methods (DiClemente et al., 2001; Farr et al., 2011; 
Garbers et al., 2010, Hall et al., 2013). Our findings, however, are in contrast to other 
studies, which found that more depressive symptoms were associated with choosing 
or using more effective contraceptive methods (Callegari et al., 2014; Francis et al., 
2015b; Steinberg et al., 2013), or found no association between depressive symptoms 
and effectiveness levels of contraceptive method being used (Faisal-Cury, Menezes, 
& Huang, 2013; Farr et al., 2011). The inconsistencies in findings could be 
attributable to differences in operationalizing the outcome in different studies 
(Callegari et al., 2014; Francis et al., 2015b). For instance Francis et al., 2015 defined 
contraceptive method choice as short acting (pill, patch, ring, depo injections) vs. 
long acting (IUD) and did not include condoms and implants (Francis et al., 2015b). 
Furthermore differences in the contraceptive counseling offered at different 
reproductive health settings, may have given rise to differences in findings.   
Although the current study is similar to Steinberg et al. (2013) study in that 
both used samples of women with similar sociodemographic characteristics 




similar covariates, there are some differences that may explain the inconsistency in 
findings between the two studies. In our sample, more than 90% of the women were 
seeking first trimester abortions compared to 40% in Steinberg et al. (2013). Women 
seeking second trimester abortions may experience more psychological distress 
before their abortion compared to women seeking first trimester abortions, which may 
consequently affect their contraceptive method choice differently compared to those 
than those having first trimester abortions. Therefore, future research should focus on 
the interaction between trimester of abortion and depressive symptoms on 
contraceptive method effectiveness level selected.   
Alternatively, the delivery of contraceptive counseling at clinics in our study 
may have been different from that in the Steinberg et al. (2013) study. The 
proportions of women choosing highly, moderately, and low effective contraceptive 
methods after contraceptive counseling in our sample (38%, 55%, and 7% 
respectively) were somewhat different from those in Steinberg et al., (2013; 42%, 
43%, and 15% respectively). Delivery of contraceptive counseling (or other aspects 
of the abortion care visit) may have interacted with women’s depressive symptoms to 
influence women’s post-abortion contraceptive choices. To better inform the research 
on depressive symptoms’ influence on contraceptive choice in an abortion setting, 
future research should further explore this. That is, are there certain contraceptive 
counseling strategies that can help women with more depressive symptoms choose 





Another difference between the current study and Steinberg et al. (2013) 
worth mentioning is that in the current study, we measured contraceptive method 
choice effectiveness after contraceptive counseling by asking women what 
contraceptive method they planned to use in the next 6 months. We used this question 
because at our study sites, many women (62%) did not receive their contraceptive 
method on the same day they received their contraceptive counseling or abortion 
procedure.  This was different from Steinberg et al. (2013) study in which 
contraceptive method choice after contraceptive counseling was measured by asking 
women what contraceptive method they were leaving the clinic with.  
Furthermore, women seeking abortion services are a unique population as 
they may experience transient high levels of emotional distress immediately before 
going through the abortion procedure, rather than long-lasting periods of elevated 
depressive symptoms. Indeed, prior research has found that women’s distress 
decreases from just before to just after an abortion (Bradshaw & Slade, 2003; 
Cozzerelli, 1993; Lowensein et al., 2006; Major et al., 2000). Therefore, to better 
understand the relationship between depression and contraceptive choice, future 
research should examine the effect of a more chronic clinical depression versus 
transient depressive symptoms on contraceptive behaviors.   
In addition to depressive symptoms, having multiple sexual partners in the 6 
months prior to the study was an independent predictor of women’s contraceptive 
method choice. Women who reported having more than one sexual partner in the past 
6 months were more likely to choose a low than a moderately or a highly effective 




contraceptive choice and depressive symptoms in the bivariate analyses, experiencing 
adversities during childhood and experiencing intimate partner violence in the 6 
month prior to the study were not significantly associated with effectiveness level of 
contraceptive method selected in the adjusted multinomial logistic regression models. 
Considering childhood adversities and intimate partner violence have been shown to 
be predictors of both depression and contraceptive method non-use and unintended 
pregnancy (Pallitto & O’Campo, 2004; Williams, Larsen, & McCloskey, 2008), 
depressive symptoms may mediate the relationship between these adversities and 
contraceptive behaviors.  
The current study has limitations that may influence the interpretation of these 
findings. First, even though depressive symptoms were assessed in the abortion care 
visit before the contraceptive choice was made, due to the cross-sectional design of 
the current study the causal nature of the association between women’s depressive 
symptoms and contraceptive choice cannot be determined with certainty. Second, as 
mentioned above, it is ambiguous whether we are measuring transient distress or 
tapping the construct of depression given that previous research has found women’s 
depressive, anxiety, and stress symptoms are elevated immediately before compared 
to immediately after an abortion (Cozzarelli, 1993; Lowenstein et al., 2006; Major et 
al., 2000). If we had information on women’s mental health history and their 
depressive symptoms after the procedure, we would be able to shed some light on this 
matter. Finally, the convenient sample may limit the generalizability of our findings; 
however, the demographic characteristics of the women in our sample are similar to 




marital status, and trimester of abortion (Jatlaoui et al., 2013; Jones & Finer, 2012; 
Jones & Kavanaugh, 2011).    
These findings contribute to the research on what influences contraceptive 
choice in the abortion care setting as well as research on the role of depression in 
contraceptive behaviors. Together with Steinberg et al’s (2013), these findings cast 
doubt on the notion that depressive symptoms uniformly influence women’s 
reproductive decisions and behaviors. Therefore, future research should explore 
possible moderating factors—in this case contraceptive counseling practices—that 
may interact with depressive symptoms to influence effectiveness levels of 
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Table 1-1. Descriptive characteristics of the of the sample (N=345) 
Variables % (N) or Mean (SD & 
Range) 
Demographic Characteristics   
Race and Ethnicity   
  White, Non-Hispanic 27.2 (94) 
  Black, Non-Hispanic 20.3 (70) 
  Hispanic 28.4 (98) 
  Other 24.1 (83) 
Education  
  Less than High School  10.7 (37) 
  High School  23.5 (81) 
  Some College 43.8 (151) 
  College Graduate or More 22.0 (76) 
Household Income   
  $10,000 or Less 60.6 (209) 
  $10,001 to 49,999  27.8 (96) 
  $50,000 or More   5.8 (20) 
  Missing   5.8 (20) 
Marital Status  
  Married 11.0 (38) 
  Never Married 52.8 (182) 
  Widowed, Separated, or Divorces   9.6 (33) 
  Cohabiting 26.7 (92) 
Age   26.0 (6.0, 18-48) 
Pregnancy Characteristics  
Abortion Trimester  
 First 93.0 (321) 
 Second   7.0 (24) 
Abortion Type  
  Surgical 68.4 (236) 
  Medication 31.6 (109) 
Past Adversities  
Intimate Partner Violence in the Past 6 Months  
  Yes 33.9 (117) 
  No 66.1 (228) 
Reproductive Coercion in the Past 6 Months  
  Yes 16.2 (52) 
  No 83.8 (289) 




Relationship Context  
Number of Sexual Partners in the Past 6 Months  
  One Partner 75.7 (261) 
  Multiple Partners 24.3 (84) 
Previous Pregnancies Characteristics  
Prior Abortions   
  None 53.3 (184) 
  One or More 46.7 (161) 
Prior Children   
  None 49.0 (169) 
  One or More 51.0 (176) 
Future Pregnancy Desires   
Very Important to Prevent Pregnancy in the Next 
Year  
 
  Yes 74.5 (257) 
  No 25.5 (88) 
Desire to Become Pregnant in 3 Years or More or 
Never  
 
  Yes 66.4 (229) 
  No 33.6 (116) 
Post Counseling Contraceptive Method Choice  
  No Method   0.6 (2) 
  Abstinence   1.4 (5) 
  Condoms   5.2 (18) 
  Birth Control Pills  34.8 (120) 
  Patch   3.2 (11) 
  Ring   4.6 (16) 
  Shot 11.9 (41) 
  IUD 29.9 (103) 
  Tubal Ligation   1.2 (4) 
  Vasectomy    0.6 (2) 
  Implant   6.7 (23) 
Post Counseling Contraceptive Choice Effectiveness  
  High 38.3 (132) 
  Moderate 54.5 (188) 
  Low   7.2 (25)  
Depression Score  
  Below 35 82.9 (286) 
  At or above 35 17.1 (59) 





Table 1-2. Bivariate relationship between depressive symptoms and the covariates (N=345) 
Variables  
Demographic Characteristics  Mean Depression Score 
(SD) 
Race and Ethnicity   
  White, Non-Hispanic 21.9 (10.9)  
  Black, Non-Hispanic 23.3 (12.4) 
  Hispanic 24.2 (12.8) 
  Other 23.5 (11.7) 
Education   
  Less than High School  20.6 (11.6) 
  High School  22.9 (11.3) 
  Some College 24.2 (12.0) 
  College Graduate or More 22.9 (12.8) 
Marital Status  
  Married 20.8 (11.6) 
  Never Married 24.2 (11.9) 
  Widowed, Separated, or Divorces 23.5 (11.4) 
  Cohabiting 22.3 (12.3) 
  
Age* (correlation coefficient) -0.13 
Pregnancy Characteristics  
Abortion Trimester  
  First 23.5 (12.0) 
  Second 20.4 (11.7) 
Abortion Type   
  Surgical 22.9 (11.6) 
  Medication 23.9 (12.6) 
Past Adversities  
Intimate Partner Violence in the Past 6 Months***  
  Yes 27.5 (11.8) 
  No 21.1 (11.5) 
Reproductive Coercion in the Past 6 Months**  
  Yes 28.0 (11.9) 
  No 22.3 (11.8) 
Total Number of Childhood Adversities*** 
(correlation coefficient)  
 0.34 
Relationship Context  
Number of Sexual Partners in the Past 6 Months++  
  One partner 22.5 (12.3) 
  Multiple Partners 25.4 (10.7) 
Previous Pregnancies Characteristics  
Prior Abortions   




  One or More 22.6 (12.3) 
Prior Children**   
  None 25.5 (11.9) 
  One or More 21.1 (11.6) 
Future Pregnancy Desires   
Important to Prevent Pregnancy in the Next Year   
  Yes 22.8 (11.9) 
  No 24.5 (12.1) 
Desire to Become Pregnant in 3 Years or More or 
Never  
 
  Yes 22.6 (12.1) 
  No 24.5 (11.6) 
Notes. One-way ANOVA F-tests were used to test whether there were differences in depressive 
symptoms score by race/ethnicity, education, and marital status. Student’s t-tests were used to test the 
differences in depressive symptoms score by binary variables.    





Table 1-3. Bivariate relationship between the level of contraceptive choice effectiveness and 
the covariates (N= 345) 
Variables Effectiveness Levels of Contraceptive 
Choice, % 






Race and Ethnicity     
  White, Non-Hispanic 20.0 28.7 26.5 
  Black, Non-Hispanic 36.0  17.6  21.2  
  Hispanic 24.0  29.3  28.0  
  Other 20.0  24.5 24.2  
Education    
  Less than High School 4.0  10.1  12.9  
  High School  28.0 22.9 23.5 
  Some College 52.0  43.6  42.4  
  College Graduate or More 16.0  23.4 21.2  
Marital Status    
  Married 4.0 10.1 13.6 
  Never Married 68.0 54.3 47.7 
  Widowed, Separated, or Divorces 12.0 9.0 9.6 
  Cohabiting 16.0 26.6 28.8 
Age [Mean (SD)] 26.8 (6.3)  25.9 (6.0) 25.9 (6.1) 
Pregnancy Characteristics    
Abortion Trimester*    
 First 84.0 95.7 90.9 
 Second 16.0 4.3 9.1 
Abortion Type*    
  Surgical 72.0  62.2  76.5  
  Medication 28.0  37.8  23.5 
Past Adversities    
Intimate Partner Violence in the Past 6 
Months* 
   
  Yes 56.0  33.5  30.3 
  No 44.0  66.5  69.7 
Reproductive Coercion in the Past 6 
Months 
   
  Yes 16.0  14.4  18.9  
  No 84.0  85.6 81.1  
Number of Childhood Adversities* 
[Mean (SD)] 
3.7a  (1.7) 2.5b  (2.2) 2.8ab  (2.0) 
Relationship Context    
Number of Sexual Partners in the Past 6 
Months** 
   




  Multiple Partners 52.0  23.4  20.5  
Previous Pregnancies Characteristics    
Prior Abortions    
  None 64.0 55.9 47.7  
  One or More 36.0  44.1  52.3  
Prior Children*    
  None 56.0  54.8  39.4  
  One or More 44.0  45.2  60.6  
Future Pregnancy Desires    
Important to Prevent Pregnancy in the 
Next Year* 
   
  Yes 60.0 71.8  81.1  
  No 40.0  28.2  18.9 
Desire to Become Pregnant in 3 Years or 
More or Never* 
   
  Yes 44.0  64.9  72.7  
  No 56.0  35.1  27.3 
Depression Score    
 Below 35 72.0  83.0  84.8 
 At or above 35 28.0  17.0 15.2  
Depressive Symptoms* [Mean (SD)] 30.0a 
(9.4) 
22.4b (11.9) 23.1b (12.1) 
Notes. Chi square tests were conducted to find the differences for categorical variables and one-way 
ANOVA F-tests were used to find mean and standard deviations for age and total number of childhood 
adversities.  
For depressive symptoms and number of childhood adversities, means with different superscripts are 
significantly different at p< 0.05. 
 *p<0.05, **p<0.01, ***p<0.001. 




Table 1-4. The unadjusted and adjusted relationship between depressive symptoms and the 
effectiveness levels of contraceptive method choice using continuous and dichotomized 
depressive symptoms score (N=345) 
Variables  Effectiveness Levels of Contraceptive Choice, OR (95% 
CI) 
 Low vs. 
Moderate 
Low vs. High Moderate vs. 
High 
Depressive Symptoms Score Continuous  






Adjusted Model 2a  1.063** 











Depressive Symptoms Score Dichotomized at 35 


















Notes.  Regression Model 2 was adjusted for Race and ethnicity (ref. White, non-Hispanic); Education 
(ref. College graduate or more); Marital status (ref. never married); Trimester of abortion (1= second, 0= 
first); Number of previous children (1= one or more, 0 = none); Number of previous abortions (1= one or 
more, 0 = none); Very important to avoid pregnancy in the next year (1= yes, 0= no); Regression Model 3 
was adjusted for Race and ethnicity (ref. White, non-Hispanic); Education (ref. College graduate or more); 
Marital status (ref. never married); Trimester of abortion (1= second, 0= first); Type of abortion (1= 
surgical, 0= medication); Experiencing any IPV (1 = none, 0= yes); Experiencing any pregnancy coercion 
(1= none, 0= yes); Number of sex partners in the past 6 months (0= one sex partner, 1=more than one 
partner); Number of previous children (1= one or more, 0 = none); Number of previous abortions  (1= one 
or more, 0 = none); Very important to avoid pregnancy in the next year (1= yes, 0= no);  and Desire to 
have children in three or more years or never (1= yes, 0 = no). 





Table 1-5. The unadjusted and adjusted relationship between depressive symptoms and the 
effectiveness levels of contraceptive method choice (N=345)  
Variables  Effectiveness Levels of Contraceptive Choice~, 
 OR (95% CI) 
 Low vs. 
Moderate 
Low vs. High Moderate vs. 
High 









Race and Ethnicityb    


























Marital Statusc    
























Educationd    







































Intimate Partner Violence 











the Past 6 Monthsh (0.189, 2.582) (0.126, 1.844) (0.355, 1.341) 
Number of Sexual Partners 



















Important to Prevent 








Desire to Become Pregnant 








   Notes. a= Continuous measure of depressive symptoms score; b=Race and ethnicity (ref. White, non-
Hispanic);  c=Education (ref. College graduate or more); d=Marital status (ref. never married); 
e=Trimester of abortion (1= second, 0= first); f=Type of abortion (1= surgical, 0= medication); 
g=Experiencing any IPV (1 = none, 0= yes); h=Experiencing any pregnancy coercion (1= none, 0= yes); 
i=Number of sex partners in the past 6 months (0= one sex partner, 1=more than one partner); 
j=Number of previous children (1= one or more, 0 = none); k=Number of previous abortions  (1= one or 
more, 0 = none); l=Very important to avoid pregnancy in the next year (1= yes, 0= no); m=Desire to 
have children in three or more years or never (1= yes, 0 = no). 
++ p<0.1, *p<0.05; ~ multinomial logistic regression models were used to produce the ORs for the three 





Chapter 4: Study Two 
 
Title: Association between depressive symptoms and contraceptive method 
discontinuation  
Abstract 
Objective: To examine the association between depressive symptoms and 
contraception discontinuation and pregnancy among young adult women using 
contraceptive methods. Method: We used survival analysis to determine the 
incidence rates of contraceptive method discontinuation and pregnancy among 666 
women initiating a new method in reproductive health visits during a 12-month study 
period. We used Cox proportional hazards models  to assess the independent 
association between a four-level measure of depressive symptoms (no depressive 
symptoms, history of elevated depressive symptoms only, baseline elevated 
depressive symptoms only, baseline and history of elevated depressive symptoms) 
and contraceptive method discontinuation and pregnancy, adjusting for relevant 
covariates Results: We found that compared to women with no history of elevated 
depressive symptoms (IR: 2.48/1000 woman-day, 95% CI 2.20, 2.81), those with a 
history of elevated depressive symptoms only (IR: 2.74/1000 woman-day, 95% CI 
2.10, 3.57) and those with both baseline and history of elevated depressive symptoms 
(IR: 2.98/1000 woman-day, 95% CI 2.01, 4.41) had higher incidences of 
contraception discontinuation respectively. However, these differences were not 
statistically significant. Examining the Cox proportional hazard models for all 




depressive symptoms only (HR: 1.12, 95% CI 0.86, 1.47) and women experiencing 
baseline and history of elevated depressive symptoms (HR: 1.39, 95% CI 0.91, 2.11) 
had a higher hazard of discontinuing their contraceptive methods during the 12 
months of study period than those with no experience of elevated depressive 
symptoms. However, these differences were not statistically significant at p<0.05. 
Similar results were found for pregnancy outcome. When stratified by contraceptive 
method type, we found that among patch users, those with a history of elevated 
depressive symptoms only had a higher probability of discontinuing their 
contraceptive method (HR: 269.12, 95% CI 14.81, 4891.08) than women with no 
elevated depressive symptoms. Similarly, among injectable users, compared to 
women with no elevated depressive symptoms, those with both baseline and history 
of elevated depressive symptoms had a higher hazard of discontinuing their shots 
(HR: 10.29, 95% CI 2.81, 37.67). Conclusion: Although not statically significant for 
all contraceptive methods combined, the findings suggest that experiencing elevated 
depressive symptoms may negatively influence women’s decision to continue 
contraception and may increase their risk of becoming pregnant compared to non-
depressed women. Future studies are needed to further explore the link between 






Forty-three percent of unintended pregnancies in the United States occur 
among contraception users (Sonfield, Hasstedt, & Gold, 2014). Women’s 
contraceptive behaviors can influence their risk of unintended pregnancy (Blumenthal 
et al., 1994; Forrest, 1994). Considering the failure rates of contraceptive methods are 
in part dependent on user behaviors (Trussell, 2011), promoting the initiation and 
continuous use of effective contraceptive methods can help prevent unintended 
pregnancies. 
Despite an increase in the use of modern reversible contraceptive methods 
over the years, the rates of method continuation are still low in the US (Peipert et al., 
2011). Common factors associated with contraceptive method discontinuation include 
perceived weight gain from hormonal contraceptive methods, other perceived side 
effects, dissatisfaction with the contraceptive method, and feelings of ambivalence 
about becoming pregnant (Hall, White, Rickert, Reame, & Westhoff, 2013c; Moreau, 
Cleland, & Trussell, 2007; O’Connell, Davis, & Kerns, 2007; Westhoff et al., 2007). 
In addition to these factors, mental health conditions, particularly depression, has 
been shown to be associated with women’s contraceptive behaviors and unintended 
pregnancy (Daniels, Daughtery, Jones, & Mosher, 2015; Francis, Presser, Malbon, 
Braun-Couville, & Linares, 2015; Frost, Singh, & Finer, 2007; Frost, Lindberg, & 
Finer, 2012; Garbers, Correa, Tobier, Blust, Chiasson, 2010; Hall Yasamin, Gatny, & 
Barber, 2014; Hall, Steinberg, Cwiak, Allen, & Marcus, 2015; Morrison et al., 2016; 




A few previous studies examining the relationship between depression and 
contraceptive method continuation have found that women experiencing depressive 
symptoms are more likely to discontinue their contraceptive method over time than 
women with no depressive symptoms (Hall et al., 2012; Westhoff et al., 1998a; 
Westhoff et al., 1998b; Zink et al., 2002). For instance, using a sample of young 
women 13-24 years old initiating oral contraceptives, Hall and colleagues found that 
women with more depressive symptoms had higher odds of discontinuing their 
method after six months (Hall et al., 2012). Similarly, Zink et al, found that 
adolescent girls with mental distress were less likely to continue their prescription 
contraception compared to girls with no mental distress after 12 months (Zink et al, 
2002). Two other studies found that women who discontinued their implant and the 
Depot-Provera shot had higher depressive symptoms score at baseline than those who 
were still continuing their methods at 6 and 24 months follow-ups (Westhoff et al., 
1998a; Westhoff et al., 1998b). Three of these studies used only a baseline measure of 
depressive symptoms (Hall et al., 2012; Westhoff et al., 1998a; Westhoff et al., 
1998b) and one used a retrospective measurement of mood disorders including 
depression based on medical records (Zink et al, 2002). Therefore, these findings do 
not adequately address whether the persistence of depressive symptoms in women 
influences their contraceptive method continuation over time. Examining women’s 
current depressive symptoms and their depressive mood history can provide a broader 
understanding of how persistence of depressive symptoms over time may influence 
women’s compliance with their contraceptive methods and how it may be associated 




The purpose of this study is, therefore, to investigate the independent 
association between history and current depressive symptoms—both separately and 
combined—and contraceptive method discontinuation and pregnancy during a 12-
month time period among low-income women seeking family planning or abortion 
services in different regions of the United States. While other studies have looked at 
these outcomes separately for different contraceptive methods, this study will 
examine the association for all contraceptive methods combined, separately for each 
individual method, and for three groups of methods based on their effectiveness level.   
Material and Methods  
Data 
Data for this study were collected from a cohort of 1,500 women seeking 
abortions or other reproductive health services at 40 Planned Parenthood Federation 
of America (PPFA) health clinics across the United States. This cohort was part of the 
National Trial of Contraceptive Acceptability (NTOCA), which was a clustered 
randomized control trial at 40 PPFA clinics, that provided contraceptive training on 
long-acting reversible contraceptive (LARC) methods to providers at 20 randomly 
selected sites from 2011-2013. The recruitment of a cohort of women took an average 
of 2 months at each site. Women were surveyed on contraceptive use, knowledge, 
attitudes and beliefs, pregnancy history, experiences with healthcare providers, and 
partner’s attitude toward contraception at baseline, 3, 6, 9, and 12 months (Harper et 
al., 2015). In addition, at baseline, 6, and 12 months, depressive symptoms were 




Scale (Anderson, Malmgren, Carter, & Patrick, 1994). The lifetime history of 
experiencing depressive symptoms was also measured at the 12-month follow-up 
using Patient Health Questionnaire (PHQ) 9-item Primary Care Evaluation of Mental 
Disorders (PRIME-MD) instrument (Spitzer, Kroenke, & Williams, 1999). The 12-
month patient follow-up rate was 84% (Bixby Center for Global Reproductive Health, 
2016). The study was limited to women 18-25 years old who were sexually active 




Primary outcome: Incidence of contraceptive method discontinuation in 12 months 
We defined the incidence of contraceptive method discontinuation during the 
12-month study period for women who initiated a new contraceptive method at 
baseline (n=831). Information on the incidence of contraception discontinuation was 
drawn from variables assessing the most effective method women initiated at 
baseline, whether they discontinued the method at any time during the 12 months of 
the study, and how many days after baseline they stopped using the method. Using 
this information, a continuous variable for the number of days from initiation until 
discontinuation of method was created. Women who reported discontinuing their 
initial contraceptive method at any time during the 12-month study period were 
classified as having discontinued their contraceptive method. Women still using their 
initial contraceptive method at the time of the 12-month interview— i.e. the end of 
study period—and those exiting the study prior to the end of study period for any 




Secondary outcome: Incidence of pregnancy in 12 months (367 days) 
We defined pregnancy incidence during the 12-month study period for women 
who initiated a contraceptive method at baseline (n=831). Information on incidence of 
pregnancy was drawn from variables assessing whether women initiating a new 
contraceptive method at baseline became pregnant at anytime during the 12-month 
study period, and how many days from baseline they became pregnant. Using this 
information, a continuous variable for the number of days from the baseline until 
pregnancy event was created. Women who reported becoming pregnant at any time 
during the 12-month study period were classified as pregnant. Women who did not 
report becoming pregnant by the time of the 12-month interview—i.e. the end of 
study period— and those who exited the study prior to the end of study period for any 
reason other than pregnancy were right censored.  
 
Exposure:  Depression status 
Women’s depression status was defined based on the scores of the baseline 
and history measures of depressive symptoms. Baseline depressive symptoms scores 
were computed using the 10-item CES-D Scale (Andresen et al., 1994) administered 
at baseline after contraceptive counseling or prior to abortion procedure for those 
seeking abortion services.  The CES-D 10 instrument assessed how often (0= Never 
to 3=Often) women experienced depressive symptoms in the past 2 weeks. The scores 
were the sum of the 10 items and women could be missing data on up to 3 items (n=5 
women missed on 4 or more items). For these women, the mean score on the other 
items was used. Women scoring at or above one standard deviation of the mean (cut-




abortion procedure) CES-D 10 score (mean score =18.86) were coded as experiencing 
elevated baseline depressive symptoms.  
Women’s history of elevated depressive symptoms was defined based on the 
9-item PRIME-MD scores (Spitzer et al., 1999), and age at which a woman had first 
experienced the depressive symptoms, both assessed at the 12-month follow-up 
survey. The PRIME-MD instrument assessed how often (0=Not at all to 3= Nearly 
every day) ever during their lifetime before the past two weeks, women had 
experienced any of the depressive symptoms for a period of 2 weeks or more. The 
lifetime depression scores were the sum of the 9 items and women could be missing 
data on up to 3 items (n=94 missed on 4 or more items). For these women, the mean 
score on the other items was used. Women scoring at or above 10 on the PRIME-MD 
(the standard cut-off used for depression) were coded as experiencing depressive 
symptoms sometime before the past two weeks. Based on PRIME-MD scores and the 
reported age at first experience of depressive symptoms, we determined whether 
women had elevated past depressive symptoms before the baseline. Women who had 
PRIME-MD scores at or above 10 and reported an age at first experience of the 
symptoms younger than their age at baseline were coded as experiencing history of 
elevated depressive symptoms. Women who had PRIME-MD scores of less than 10 
or reported their age at first experience of elevated depressive symptoms as the same 
age or older than their baseline age were coded as not experiencing history of 
elevated depressive symptoms.  
Using the past and the baseline depression scores, women’s depression status 




elevated depressive symptoms, 2) history of elevated depressive symptoms only, 3) 
elevated baseline depressive symptoms only, and 4) baseline and history of elevated 
depressive symptoms.   
 
Covariates 
Based on the literature we examined the effects of the following baseline 
characteristics shown to be associated with the outcome of contraceptive 
discontinuation (Diedrich, Zhao, Madden, Secura, & Peipert, 2015; Grunloh, Casner, 
Secura, Peipert, & Madden, 2013; Raine et al., 2011): race/ethnicity (non-Hispanic 
white, non-Hispanic black, Hispanic, Others); type of insurance (private, Medicaid or 
state insurance, no insurance); use of public assistance (yes/no); type of services 
sought at baseline (abortion, family planning); partner type (primary, casual, no 
partner); number of prior abortions (none, one or more); parity (none, one or more); 
women’s feelings about becoming pregnant in the next year (happy, unhappy); the 
type of contraceptive method used in the last 3 months prior to the study (no 
method/condoms, hormonal methods, LARC); and the most effective method used at 
baseline (low, moderate, high). We also controlled for study arm (intervention vs. 
control) in all models.  
Analyses  
We compared baseline characteristics of women who discontinued their 
contraceptive method to those who did not during the 12-month study period using 
chi-square tests for categorical variables and student t-test for women’s age. 




those who did not during the 12-month study period using chi-square tests for 
categorical variables and student t-test for women’s age. We performed similar 
analysis to compare women in different depression groups on the baseline 
characteristics. The incidence rate of contraceptive method discontinuation was 
determined by dividing the number of women who discontinued their contraceptive 
methods by the total number of person-days accumulated in the study population at 
baseline.  
To examine the relationship between depression status and contraceptive 
method discontinuation over 12 months, we employed Cox proportional hazards 
models with adjusted standard errors for clustered data. The study time began at 
baseline (origin) and it ended for women when they reported discontinuing their 
initial contraceptive method, were lost to follow-up, or when study ended at the 12-
month survey interview, whichever came first. Hazard ratios and 95% confidence 
intervals were then estimated for all contraceptive methods combined, for the three 
levels of contraceptive method effectiveness (Trussell, 2011), and for each specific 
contraceptive method initiated at baseline (supplementary analyses). We examined 
the unadjusted and then the adjusted Cox proportional hazard models for baseline 
characteristics shown to be associates with contraception discontinuation based on the 
literature (Diedrich et al., 2015; Grunloh et al., 2013; Raine et al., 2011) or those that 
were associated with either the discontinuation or depression status in our sample. We 
conducted the same analyses for our secondary outcome, incidence of pregnancy 





Descriptive characteristics of sample 
From 831 women initiating a new method at baseline interview, 165 were 
missing data on depression status or any of the covariates and therefore were 
excluded from the final analysis leaving 666 in the analytic sample. The total time at 
risk to contraceptive method discontinuation was 151,634.55 woman-days; the 
median at-risk time was 273.6 days and ranged from 4 to 364.8 days. Table 2-1 
presents the baseline characteristics of the sample. The mean age of the participants 
was 21, ranging from 18 to 25 years old. Forty-nine percent of women reported being 
from a non-Hispanic white background, 39% reported not having any insurance, and 
the majority (73%) reported using public assistance. Approximately 83% of women 
reported having a primary partner, and 63% and 73% of women reported having no 
children and no prior abortions respectively. Most women (83%) reported feeling 
unhappy about becoming pregnant in the next year. More than 60% of women 
reported using condoms or no contraception during the three months prior to the 
beginning of the study. At baseline, 35% reported initiating birth control pills while 
only 7.5% of women reported initiating implants. Approximately 58% of women 
discontinued their contraceptive method at some point during the 12-month follow-
up. The majority of women (68%) had no experience of elevated depressive 
symptoms, 13% had a history of elevated depressive symptoms only, 12% were 
experiencing elevated depressive symptoms at baseline only, and 7% had an 




Differences by contraceptive method discontinuation 
Women who discontinued their contraception during the study period (n=383) 
were more likely to have no partner (11% vs. 7%) or a casual partner (10% vs. 4%) 
than those who did not discontinue their contraceptive method respectively (p-
values<0.05) during the study period. Furthermore, women who discontinued their 
contraceptive methods during the study period were more likely to feel happy about 
becoming pregnant in the next year (20% vs. 14%, p=0.041) and to have initiated 
condom use at baseline (18% vs. 8%, p<0.001) than those who did not discontinue 
their contraceptive method. There were no other differences between women who 
discontinued their contraceptive methods and those who did not with respect to other 
baseline characteristics (Table 2-1). 
Differences by pregnancy status 
As presented in Table 2-2, of the 666 women in the final analysis, 108 became 
pregnant during the study period. Pregnant women were more likely to be black, non-
Hispanic (27% vs. 15%, p=0.007) than non-pregnant women; pregnant women were 
also more likely to report having one child (34% vs. 18%, p<0.001) and one or more 
prior abortions (39% vs. 24%, p=0.002) compared to their non-pregnant counterparts. 
Pregnant women were also more likely to feel happy about becoming pregnant in the 
next year (24% vs.16%, p=0.041) than those who did not become pregnant. 
Furthermore, pregnant women were different from their non-pregnant counter parts in 
the type of contraceptive method used in three months prior to the study (p=0.001), 




Differences by depression status 
Table 2-3 presents a comparison of women in different depression groups on 
baseline characteristics. Women in depression group were different from each other 
with respect to women’s race/ethnicity (p=0.002), use of public assistance (p=0.015), 
type of partner (p=0.001), feeling happy about becoming pregnant in the next year 
(p=0.020), type of contraceptive method used three months prior to the study 
(p=0.035), the contraceptive method initiated at baseline (p=0.005), and type of 
service sought at enrollment visit (p<0.001).  
Incidence rate of contraceptive method discontinuation 
The overall incidence rate of contraceptive method discontinuation was 
2.53/1,000 woman-days (95% CI 2.28, 2.79). The incidence rate of contraception 
discontinuation was higher for women experiencing both baseline and history of 
depressive symptoms (2.98/1,000 woman-days, 95% CI 2.01, 4.41) than for those 
with no depressive symptoms (2.48/1,000 woman-days, 95% CI 2.20, 2.81) but this 
difference was not statistically significant (overlapping confidence intervals). The 
incidence rate of discontinuation was 0.78/1,000 woman-days (95% CI 0.45, 1.39) for 
women initiating an implant at baseline and it was significantly lower than in women 
initiating any other contraceptive method except IUD (95% CI 0.45, 1.34). Similarly, 
the incidence rate of contraception discontinuation was significantly four times higher 
in women initiating a low effectiveness contraceptive method (4.05/1,000 woman-
days, 95% CI 3.20, 5.14) than in women initiating a high effectiveness contraceptive 




discontinuation did not differ with respect to other baseline characteristics (Table 2-
4).  
Incidence rate of pregnancy 
As shown in Table 2-5 the overall incidence rate of pregnancy was 
4.89/10,000 woman-days (95% CI 4.05, 5.90) and it was about two times higher in 
women experiencing both baseline and history of depressive symptoms (8.71/10,000 
woman-days, 95% CI 4.82, 15.73) than in women with no depression (4.92/10,000 
woman-days, 95% CI 3.92, 6.18), however this difference was not statistically 
significant. The incidence rate of pregnancy was significantly two times higher in 
black non-Hispanic women (8.40/10,000 woman-days, 95% CI 5.83, 12.08) than in 
white non-Hispanic women (4.11/10,000 woman-days, 95% CI 3.07, 5.50). Similarly, 
the incidence rate of pregnancy was significantly 2.5 times higher in women who had 
one previous birth (8.76/10,000 woman-days, 95% CI 6.35, 12.10) than those with no 
previous births (3.52/10,000 woman-days, 95% CI 2.69, 4.61). The incidence of 
pregnancy was also significantly higher in women with one or more prior abortions 
(7.48/10,000 woman-days, 95% CI 5.53, 10.13) than in those with no previous 
abortions (4.00/10,000 woman-days, 95% CI 3.14, 5.10).  Furthermore, the incidence 
of pregnancy was significantly higher for those using a LARC method (10.91/10,000 
woman-days, 95% CI 5.87, 20.27) three months prior to the beginning of the study 
than those who used hormonal method during the same time period (2.92/10,000 
woman-days, 95% CI 1.92, 4.43). The incidence of pregnancy was also 




woman-days, 95% CI 5.16, 8.33) than in those seeking family planning (3.45/10,000 
woman-days, 95% CI 2.54, 4.68).  
Hazard of contraceptive method discontinuation 
The results of the crude and the adjusted hazard ratios and the corresponding 
95% confidence intervals for different depression groups in the model examining all 
contraceptive methods combined, are presented in Table 2-6. In the unadjusted model 
compared to women with no elevated depressive symptoms, women with a history of 
elevated depressive symptoms (HR: 1.08, 95% CI 0.84, 1.40) and women with both 
baseline and history of elevated depressive symptoms (HR: 1.18, 95% CI 0.79, 1.78) 
were at higher hazards of contraceptive method discontinuation respectively; 
however, these associations were not statistically significant (p-values >0.1). After 
adjusting for all baseline characteristics, the hazard of contraceptive method 
discontinuation remained higher for women with a history of elevated depressive 
symptoms (HR: 1.12, 95% CI 0.84, 1.47) and women with both baseline and history 
of elevated depressive symptoms (HR: 1.39, 95% CI 0.91, 2.11) than those with no 
depressive symptoms, but they did not reach statistical significance (p-values > 0.1).   
In the fully adjusted model, compared to women with a primary partner at 
baseline, women with no partner (HR=1.48, 95% CI: 1.11, 1.96; p=0.007) and 
women with a casual partner (HR=1.80, 95% CI: 1.38, 2.36; p<0.001) had increased 
hazards of discontinuing their initial contraceptive method over 12 months 
respectively. Using a LARC method in the three months prior to the start of the study 
compared to using condoms or no method was also associated with a higher hazard of 




p=0.043). Furthermore, compared to women initiating highly effective methods, those 
initiating a contraceptive method of low (HR=4.29; 95% CI: 2.88, 6.40; p<0.001) or 
moderate levels effectiveness (HR=3.69; 95% CI: 2.61, 5.23; p<0.001) at baseline 
had a higher hazard of discontinuation during the study period.  
Hazard of pregnancy 
As presented in Table 2-7, with respect to pregnancy outcomes, in the 
unadjusted Cox proportional hazards model, compared to women with no elevated 
depressive symptoms, women with a history of elevated depressive symptoms had 
lower hazard of becoming pregnant during the 12-month study follow-up, though the 
difference was only marginally significant (HR= 0.53, 95% CI: 0.28, 1.02; p=0.058). 
After adjusting for all baseline characteristics, this association was no longer 
marginally significant (HR=0.62; 95% CI: 0.31, 1.24; p=0.179). There were no 
significant associations between other depression groups and the hazard of pregnancy 
over 12 months of study period.  
In the adjusted model for pregnancy, women with one previous birth had an 
increased hazard of becoming pregnant over 12 months compared to women with no 
previous births (HR= 1.90, 95% CI: 1.30, 2.80; p=0.001). Similarly, women with one 
or more previous abortions compared to those with no abortions had an increased 
hazard of becoming pregnant in the follow-up period (HR= 1.60, 95% CI: 1.01, 2.53; 
p=0.044). The hazard of becoming pregnant during the study period decreased by 
28% in women who expressed feeling unhappy about becoming pregnant compared 
to those who expressed happiness in becoming pregnant in the next year (aHR=0.62; 




months prior to the study had a higher likelihood of experiencing pregnancy during 
the study period (HR=2.47; 95% CI: 1.17, 5.22; p=0.018). Finally, initiating a 
contraceptive method of moderate effectiveness compared to high effectiveness at 
baseline was associated with an increased hazard of experiencing pregnancy during 
the study period (HR=2.03; 95% CI: 1.16, 3.57; p=0.014).  
Supplementary analyses 
Table 2-A1 in Appendix A presents the unadjusted and adjusted hazard ratios 
of contraceptive method discontinuation and the corresponding 95% confidence 
intervals associated with depression status for each contraceptive method and the 
effectiveness level of methods initiated at baseline.  
Unadjusted models 
In the unadjusted models, among women who reported using birth control 
pills, compared to those with no elevated depressive symptoms, women with both 
baseline and history of elevated depressive symptoms had an increased hazard of 
discontinuing their contraceptive method during the study period (HR= 1.90, CI: 
1.16, 3.09; p=0.01). Among women who reported initiating a patch at baseline, 
compared to women with no elevated depressive symptoms, those with the history of 
elevated depressive symptoms only had 3.88 higher hazards of discontinuing their 
patch during study follow-up (95% CI: 1.87, 8.07; p<0.001). Among women who 
reported initiating a ring at baseline, women with elevated baseline depressive 
symptoms only, had a higher likelihood of discontinuing their method during the 12-




symptoms (HR=2.11; 95% CI: 1.08, 4.12; p=0.029). Furthermore, among women 
who reported using the injectable at baseline, women with both baseline and history 
of elevated depressive symptoms had an increased hazard of discontinuing their shots 
during the 12 months of study period (HR= 4.40, 95% CI: 2.83, 6.86; p<0.001). 
Finally, among women initiating any contraception of moderate effectiveness, those 
with a baseline and history of elevated depressive symptoms were at 84% increased 
risk of discontinuing their method compared to women with no elevated depressive 
symptoms (HR= 1.84, 95% CI: 1.23, 2.76; p=0.003).  
Adjusted models 
In the adjusted models, among patch users, women with a history of elevated 
depressive symptoms had a higher hazard of contraceptive method discontinuation 
(HR=269.12; 95% CI: 14.81, 4891.08; p<0.001) and among the injectable users, 
women with both baseline and history of elevated depressive symptoms had a higher 
hazard of contraception discontinuation (HR=10.29; 95% CI: 2.81, 37.67; p<0.001) 
compared to never depressed women respectively. In the adjusted models among 
those who reported initiating an implant at baseline, women with a history of 
depression also had higher hazard of discontinuing their implant than those with no 
experience of depression (HR=14.71; 95% CI: 1.23, 2.76; p=0.034).  
Discussion 
To our knowledge this is the first study to examine the association between 
depression and contraceptive method discontinuation using a combination of baseline 




discontinuation for all contraceptive methods combined, we found that a history of 
elevated depressive symptoms only, and a combination of baseline and history of 
elevated depressive symptoms increased the hazard of contraceptive method 
discontinuation by 39% and 12% respectively, though these findings did not reach 
statistical significance.  
In this study we do not know whether elevated depressive symptoms in 
women experiencing the symptoms only in the past persisted over time or not; 
however, using a combination of history and baseline depressive symptoms—
measured at the time of contraceptive method initiation—to define the depression 
status allowed for a distinction between women experiencing both baseline and 
history of depressive symptoms (indicative of a more chronic condition) and women 
experiencing elevated depressive symptoms only at present time (indicative of more 
short-term condition). This distinction provides a more comprehensive picture of how 
differences in manifestation of depression may influence women’s compliance to 
their contraceptive methods. Future studies can benefit from a prospective design 
collecting multiple measures of depressive symptoms over time to establish a timeline 
for women’s experience of chronic versus transient depression.  
Previous studies examining the link between depression and contraceptive 
method discontinuation are methodologically different from the current study (Hall et 
al., 2012; Westhoff et al., 1998a; Westhoff et al., 1998b; Zink et al., 2002). Three of 
these studies only considered exposure to elevated depressive symptoms at baseline 
(Hall et al., 2012; Westhoff et al., 1998a; Westhoff et al., 1998b), and the other used 




disorders including depression recorded in the medical and insurance records of the 
study participants as a measure (Zink et al., 2002). Furthermore, in all four studies a 
single type of method was considered as opposed to a broad range of methods.  
As mentioned above other studies in the field have found significant 
associations between depression and contraceptive method discontinuation for 
specific methods. In our method specific analyses (Appendix A) we also found 
independent associations between depression status and hazard of discontinuation for 
the patch and the injectable users. The effectiveness of contraceptive methods in 
preventing pregnancy is in part dependent on user’s contraceptive behaviors 
(Trussell, 2011). Previous research has indicated that different contraceptive methods 
have different discontinuation rates (Grunloh et al., 2013; Peipert et al., 2011; Raine 
et al., 2011). For instance, compared to non-LARC methods, LARC methods have 
shown to have a lower discontinuation rate (Dierdrich et al., 2015; Rosenstock, 
Peipert, Madden, Zhao, & Secura, 2012). These differences in adherence to the 
contraceptive methods are attributable to factors such as user sociodemographic 
characteristics and levels of user’s satisfaction with the method (Grunloh et al., 2013; 
Peipert et al., 2011; Raine et al., 2011).  Studies have also shown depressed women 
are more likely to stop using certain methods due to their perceived side effects (Hall 
et al., 2012). In the method specific analyses of this study, depression was 
significantly associated with discontinuation of the patch and the injectable, adjusting 
for all covariates. These hormonal methods require effort from the user to be 
maintained over time and women experiencing depression may be less motivated to 




contraceptive method women use may be a moderating factor in the relationship 
between depressive mood and contraceptive discontinuation and therefore the effect 
of depression on women’s compliance with contraception may depend on the type of 
method being used.  
Furthermore, differences in sample characteristics between the present study 
and previous ones may have influenced the findings. For instance, 92% of women in 
Hall et al., (2012) study reported being from a Hispanic ethnic background, while our 
sample was more racially/ethnically diverse (Table 1). Since, rates of contraceptive 
use and discontinuation differ by racial/ethnic groups (Diedrich et al., 2015; Jackson, 
Karasek, Dehlendorf, & Foster, 2016; Werth, et al., 2015), it is possible that a more 
heterogeneous sample would mitigate any user specific effects that may influence the 
contraceptive discontinuation independently of depression status.  
Finally, the present study included a sample of women attending both family 
planning and abortion service clinics, which was different from other studies. Other 
studies examined sample of women attending a university-affiliated health clinic 
(Hall et al., 2012), and a sample of women attending family planning clinics within 
urban hospitals (Westhoff et al., 1998a; Westhoff et al., 1998b). Therefore, different 
characteristics of contraceptive counseling presented to women at each site in these 
studies may have influenced what contraception women initiated the study with and 
whether they complied with their respective method (e.g. Hall et al., 2012).  
We also found that type of sexual partner was independently associated with 
the hazard of contraceptive method discontinuation among women during the study 




consistency in their sexual activity and therefore are more likely to be inconsistent in 
the use of their contraceptive method than women with a primary partner.  
Furthermore, we found that compared to those using no method or condoms, 
women who reported using a LARC method three months prior to the study were at 
an increased hazard of discontinuing the contraceptive method they initiated at 
baseline. In addition, these women had a higher hazard of becoming pregnancy 
during the 12-month study period. In this study approximately 47% of women who 
reported using LARC methods in the past three months prior to the study, initiated the 
study with non-LARC methods. Considering LARC methods are the most effective 
types of contraception in pregnancy prevention with higher user adherence rates 
(Trussell, 2011) than other methods, women initiating a non-LARC method may have 
been more likely to discontinue the method and thus have a higher probability of 
experiencing pregnancy during the study period.   
With respect to pregnancy outcome, we found no independent association 
between depressive symptoms and the hazard of pregnancy during the 12-month 
follow-up period. This finding is inconsistent with previous studies that found women 
with more depressive symptoms were at a higher risk for becoming pregnant (Hall et 
al., 2014; Hall et al., 2017; Takahashi et al., 2012). It is possible that in our study the 
type of contraceptive method initiated at the beginning of the study moderated the 






The present study has some limitations that should be considered when 
interpreting the findings. The small number of discontinuation event per depression 
group may explain the lack of statistical significance in the overall findings of the 
present study (n= 258 cases in no depression vs. n=25 cases in past and baseline 
depression groups). Future research should investigate the association between 
depression status and hazard of contraception discontinuation in a larger sample of 
women. Therefore, future research should employ more rigorous ways for recruitment 
of the subjects and consider the recruitment and follow-up time in the calculation of 
sufficient sample size (Zwiener, Blettner, & Hommel, 2011). 
Although in this study multiple measures of depressive symptoms were used 
to define the exposure, we were only able to rely on baseline and lifetime measures of 
depressive symptoms. Therefore, we were unable to measure the effect of change in 
depressive symptoms over the 12-month follow-up period on the probability of 
contraception discontinuation. For those women with baseline depressive symptoms 
only or past depressive symptoms only, we do not know whether we are measuring 
transient depressive symptoms or a more continuous condition that could have been 
detected if there were multiple measures of depressive symptoms over time. Future 
research should use multiple prospective measures of depressive symptoms to 
determine whether persistence of depressive symptoms over time would have a 
different effect on the contraceptive behaviors of women.  
Finally, in this study the contraceptive method initiator comprised of women 




beginning of the study versus those who had switched from a previously used LARC 
or hormonal method (38%). The characteristics of these two groups and their 
contraception preferences may be different thus influencing their baseline 
contraception initiation and continuation behaviors independently of their mental 
health status. Future research should stratified analyses based on recent user type.   
Despite the lack of statistical significance in findings, the results of this study 
begin to shed light on the possible role of depression history in women’s 
contraceptive continuation. By addressing the limitations of this study, future research 
can further investigate the role of women’s history of mental health in addition to 
their current mental health status and provide a more in-depth explanation of how 
women’s mental health is associated with their contraceptive behavior.  Furthermore, 
examining women’s history of mental health together with monitoring their current 
mental status should be part of best practices for contraceptive counseling.  
Practitioners providing contraceptive counseling to women at reproductive health or 
abortion settings should be aware of women’s history of mental health and tailor the 
counseling sessions to the special needs of the women in order to increase women’s 
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Table 2-1. Baseline characteristics of the sample by contraceptive method discontinuation 









Depression Status    0.75 
  No depression  68.32 67.36 69.61  
  Depression history only 13.06 14.10 11.66  
  Baseline depression 
only 
12.46 12.01 13.07  
 History and baseline 
depression  
6.16   6.53   5.65  
Current Age  (Mean ± 





21.61 ±0.13  
(21.36, 21.86) 
0.11 
Race/ Ethnicity    0.25 
  White, Non-Hispanic 48.95 50.13 47.35  
  Black, Non-Hispanic 16.67 16.97 16.25  
  Hispanic 26.58 26.89 26.15  
  Asian/Others   7.81   6.01 10.25  
Insurance Status    0.23 
  Medicaid/State 
insurance 
28.53 26.37 31.45  
  Private 32.43 34.73 29.33  
  No insurance  39.04 38.90 39.22  
Public Assistance     0.85 
 Yes 27.18 26.89 27.56  
 No 72.82 73.11 72.44  
Partner Type     0.003 
  None 9.31 10.97 7.07  
  Casual  7.51   9.92 4.24  
  Primary 83.18 79.11 88.69  
Parity    0.45 
  No children 66.37 66.32 66.43  
  One child 20.72 21.93 19.08  
  Two or more children 12.91 11.75 14.49  





  No abortion 73.27 74.15 72.08  
 One or more  26.73 25.85 27.92  
Happiness about 
 Pregnancy in the Next 
Year 
   0.04 
  Happy 17.27 19.84 13.78  
  Unhappy 82.73 80.16 86.22  
First Most Effective 
Method Used at 
Baseline  
   >0.001 
  Condom 13.81 17.75 8.48  
  Pill 34.53 39.95 27.21  
  Patch   4.35   6.27 1.77  
  Ring    9.76 11.75 7.07  
  Injectable 11.26 12.01 10.25  
  Implant   7.51   3.13 13.43  
  IUD 18.77   9.14 31.80  
First Method Used at 
Baseline (Effectiveness 
Level)a 
   >0.001 
  Low 13.81 17.75 8.48  
  Moderate 59.91 69.97 46.29  
  High 26.28 12.27 45.23  
Most Effective Method 
Used 3 Months Prior to 
Study  
   0.58 
  None/Condoms 62.31 61.88 62.90  
  Hormonal 33.18 32.90 33.57  
  LARCb   4.50   5.22 3.53  
Service at Enrollment 
Visit 
   0.15 
  Abortion  47.75 50.13 44.52  
  Family planning 52.25 49.87 55.48  
Arm of the Study    0.048 
  Control 46.85 50.13 42.40  
  Intervention 53.15 49.87 57.60  
Contraceptive 
Discontinuation in 12 
Months 
 ---------  ---------- 
 Yes 57.51    
  No 42.49    
Pregnancy Status in 12 
Months 
   >0.001 




  No 83.78 76.76 23.24  
a. Contraceptive method effectiveness level was determined according to methods’ failure 




Table 2-2. Baseline characteristics of the sample by pregnancy status 









Depression Status    0.080 
  No depression  68.32 68.52 68.28  
  Depression history only 13.06 7.41 14.16  
  Baseline depression only 12.46 13.89 12.19  
History and baseline 
depression  
6.16 10.19 5.38  
Current Age  (Mean± 
SD, 95% CI) 
21.45 ±2.19 
(18-25) 
21.33 ± 0.21 
(20.92, 21.74) 
21.47  ± 0.09 
(21.29, 21.66)  
0.544 
Race/ Ethnicity    0.007 
  White, Non-Hispanic 48.95 41.67 50.36  
  Black, Non-Hispanic 16.67 26.85 14.70  
  Hispanic 26.58 27.78 26.34  
  Asian/Others   7.81 3.70 8.60  
Insurance Status    0.347 
  Medicaid/State insurance 28.53 34.26 27.42  
  Private 32.43 30.56 32.80  
  No insurance  39.04 35.19 39.78  
Public Assistance     0.697 
 Yes 27.18 28.70 26.88  
 No 72.82 71.30 73.12  
Partner Type     0.209 
  None 9.31 11.11 8.96  
  Casual  7.51 11.11 6.81  
  Primary 83.18 77.78 84.23  
Parity    <0.001 
  No children 66.37 49.07 69.71  
  One child 20.72 34.26 18.10  
  Two or more children 12.91 16.67 12.19  
Number of Prior 
Abortions 
   0.002 
  No abortion 73.27 61.11 75.63  
 One or more  26.73 38.89 24.37  
Happiness about 
Pregnancy in the Next 
Year 
   0.041 
  Happy 17.27 24.07 15.95  
  Unhappy 82.73 75.93 84.05  
First Most Effective 
Method Used at Baseline  
   0.034 




  Pill 34.53 33.33 34.77  
  Patch   4.35 8.33 3.58  
  Ring    9.76 13.89 8.96  
  Injectable 11.26 14.81 10.57  
  Implant   7.51 2.78 8.42  
  IUD 18.77 14.81 19.53  
First Method Used at 
Baseline (Effectiveness 
Level)a 
   0.042 
  Low 13.81 12.04 14.16  
  Moderate 59.91  70.37 57.89  
  High 26.28 17.59 27.96  
Most Effective Method 
Used 3 Months Prior to 
Study  
   0.001 
  None/Condoms 62.31 70.37 60.75  
  Hormonal 33.18 20.37 35.66  
  LARCb   4.50 9.26 3.58  
Service at Enrollment 
Visit 
   0.001 
  Abortion  47.75 62.04 44.98  
  Family planning 52.25 37.96 55.02  
Arm of the Study    0.016 
(0.900) 
  Control 46.85 46.30 46.95  
  Intervention 53.15 53.70 53.05  
Contraceptive 
Discontinuation over 12 
Months 
   >0.001 
 Yes 57.51 82.41 47.31  
  No 42.49 17.59 52.69  
Pregnancy Status Over 
12 Months 
 __________  ______ 
  Yes 16.22    
  No 83.78    
a. Contraceptive method effectiveness level was determined according to methods’ failure 
rates in a typical use as described in Trussell, 2011. 





Table 2-3. The bivariate relationship between depression status and the study variables  

















    0.75 
  Yes 56.70 62.07 55.42 60.98  
  No 43.30 37.93 44.58 39.02  
Pregnancy Status Over 
12 Months 
    0.08 
  Yes 16.26 9.20 18.07 26.83  
  No 83.74 90.80 81.93 73.17  
Current Age  










Race/ Ethnicity     0.002 
  White, Non-Hispanic 45.27 56.32 50.60 70.73  
  Black, Non-Hispanic 18.46 11.49 16.87   7.32  
  Hispanic 30.11 18.39 24.10   9.76  
  Asian/Others 6.15 13.79 8.43 12.20  
Insurance Status     0.068 
  Medicaid/State 
insurance 
27.69 19.54 34.94 43.90  
  Private 33.63 31.03 30.12 26.83  
  No insurance  38.68 49.43 34.94 29.27  
Public Assistance      0.015 
 Yes 25.93 20.69 31.33 46.34  
 No 74.07 79.31 68.67 53.66  
Partner type      0.001 
  None 7.25 9.20 12.05 26.83  
  Casual  7.25 11.49 3.61 9.76  
  Primary 85.49 79.31 84.34 63.41  
Parity     0.129 
  No children 64.84 75.86 61.45 73.17  
  One child 22.42 14.94 18.07 19.51  
  Two or more children 12.75 9.20 20.48 7.32  
Number of Prior 
Abortions 
    0.11 
  No abortion 76.04 68.97 65.06 68.29  
 One or more  23.96 31.03 34.94 31.71  
Happiness about 
Pregnancy in the Next 
Year 




  Happy 20.00 9.20 15.66 7.32  
  Unhappy 80.00 90.80 84.34 92.68  
First Most Effective 
Method Used at 
Baseline  
    0.005 
  Condom 14.95 13.79 10.84 7.32  
  Pill 33.85 31.03 40.96 36.59  
  Patch 4.84 1.15 4.82 4.88  
  Ring  9.45  17.24 3.61 9.76  
  Injectable  12.75 10.34 8.43 2.44  
  Implant 8.13 10.34 4.82 0.00  
  IUD 16.04 16.09 26.51 39.02  
First Method Used at 
Baseline (Effectiveness 
Level)a 
    0.35 
  Low 14.95 13.79 10.84 7.32  
  Moderate 60.88 59.77 57.83 53.66  
  High 24.18 26.44 31.33 39.02  
Most Effective Method 
Used 3 Months Prior to 
Study  
    0.035 
  None/Condoms 58.90 60.92 74.70 78.05  
  Hormonal 35.82 36.78 21.69 19.51  
  LARCb 5.27 2.30 3.61 2.44  
Service at Enrollment 
Visit 
    <0.001 
  Abortion  37.80 43.68 90.36 80.49  
  Family planning 62.20 56.32 9.64 19.51  
Arm of the Study     0.68 
  Control 48.13 41.38 46.99 43.90  
  Intervention 51.87 58.62 53.01 56.10  
a. Contraceptive method effectiveness level was determined according to methods’ failure 
rates in a typical use as described in Trussell, 2011. 





Table 2-4. Incidence rates for contraceptive method discontinuation by study variables 
Characteristics Number of women 
discontinued 
Woman-days Incidence rate*  
(95% CI) 
Overall 383 151634.55 2.53 (2.28, 2.79) 
Depression 
   No depression 
   Past depression 
   Baseline depression 













2.48 (2.20, 2.81) 
2.74 (2.10, 3.57) 
2.33 (1.75, 3.12) 
2.98 (2.01, 4.41) 
Race/ Ethnicity 
  White, Non-Hispanic 
  Black, Non-Hispanic 
  Hispanic 












2.59 (2.25, 2.99) 
2.65 (2.08, 3.38) 
2.58 (2.13, 3.13) 
1.75 (1.16, 2.63) 
Insurance Status 
  Medicaid/State insurance 
  Private 










2.27 (1.87, 2.76) 
2.73 (2.31, 3.24) 
2.54 (2.17, 2.99) 
Public Assistance 
  Yes 








2.53 (2.09, 3.07) 
2.52 (2.24, 2.84) 
Partner Type 
  None 
  Casual 










3.25 (2.40, 4.40) 
4.54 (3.30, 6.24) 
2.32 (2.08, 2.60) 
Parity 
  No children 
  One child 










2.51 (2.22, 2.84) 
2.84 (2.29, 3.52) 
2.14 (1.60, 2.87) 
Number of Prior 
Abortions 
  No abortions 








2.57 (2.29, 2.89) 
2.41 (1.98, 2.93) 
Happiness about 
Pregnancy in the Next 
Year 
  Happy 











3.19 (2.55, 3.99) 
2.40 (2.15, 2.69) 
First Most Effective 
Method Used at Baseline 
  Condom 
  Pill 
  Patch 















4.05 (3.20, 5.14) 
3.14 (2.68, 3.68) 
5.76 (3.86, 8.60) 




  Injectable 
  Implant 







2.63 (1.97, 3.51) 
0.78 (0.45, 1.39) 
0.96 (0.69, 1.34) 
First Method Used at 
Baseline (Effectiveness 
Level)a 
  High 
  Moderate 













0.91 (0.68, 1.21) 
3.22 (2.85, 3.63) 
4.05 (3.20, 5.14) 
Most Effective Method 
Used 3 Months Prior to 
Study 
  None/Condoms 
  Hormonal 













2.46 (2.17, 2.80) 
2.58 (2.17, 3.07) 
3.05 (1.97, 4.72) 
Service at Enrollment 
Visit 
  Abortion 








2.71 (2.36, 3.13) 
2.36 (2.05, 2.72) 
Arm of the Study 
  Intervention 








2.29 (1.99, 2.64) 
2.81 (2.44, 3.23) 
* Per 1,000 women-day 
a. Contraceptive method effectiveness level was determined according to methods’ failure 
rates in a typical use as described in Trussell, 2011. 





Table 2-5. Incidence rates for pregnancy by study variables  
Characteristics Number of women 
discontinued 
Woman-days Incidence rate*  
(95% CI) 
Overall 108 221000.50 4.89 (4.05, 5.90) 
Depression 
   No depression 
   Past depression 
   Baseline depression 













4.92 (3.92, 6.18) 
2.64 (1.32, 5.28) 
5.44 (3.28, 9.02) 
8.71 (4.82, 15.73) 
Race/ Ethnicity 
  White, Non-Hispanic 
  Black, Non-Hispanic 
  Hispanic 












4.11 (3.07, 5.50) 
8.40 (5.83, 12.08) 
5.11 (3.57, 7.30) 
2.20 (0.82, 5.85) 
Insurance Status 
  Medicaid/State insurance 
  Private 










5.85 (4.24, 8.08) 
4.66 (3.31, 6.55) 
4.37 (3.18, 6.01) 
Public Assistance 
  Yes 








5.14 (3.61, 7.31) 
4.79 (3.83, 5.99) 
Partner Type 
  None 
  Casual 










5.98 (3.40, 10.53) 
7.54 (4.28, 13.28) 
4.54 (3.67, 5.62) 
Parity 
  No children 
  One child 










3.52 (2.69, 4.61) 
8.76 (6.35, 12.10) 
6.36 (4.01, 10.10) 
Number of Prior 
Abortions 
  No abortions 








4.00 (3.14, 5.10) 
7.48 (5.53, 10.13) 
Happiness about 
Pregnancy in the Next 
Year 
  Happy 











7.21 (4.91, 10.59) 
4.43 (3.57, 5.50) 
First Most Effective 
Method Used at Baseline 
  Condom 
  Pill 
  Patch 















4.24 (2.46, 7.31) 






  Injectable  
  Implant 







7.11 (4.29, 11.80) 
6.52 (3.99, 10.64) 
1.71 (0.55, 5.31) 
3.80 (2.32, 6.20) 
First Method Used at 
Baseline (Effectiveness 
Level)a 
  High 
  Moderate 













3.18 (2.03, 4.99) 
5.81 (4.64, 7.28) 
4.24 (2.46, 7.31) 
Most Effective Method 
Used 3 Months Prior to 
Study 
  None/Condoms 
  Hormonal 













5.57 (4.45, 6.97) 
2.92 (1.92, 4.43) 
10.91 (5.87, 
20.27) 
Service at Enrollment 
Visit 
  Abortion 








6.56 (5.16, 8.33) 
3.45 (2.54, 4.68) 
Arm of the Study 
  Intervention 








4.80 (3.64, 6.34) 
4.96 (3.84, 6.42) 
* Per 10,000 women-days 
a. Contraceptive method effectiveness level was determined according to methods’ failure 
rates in a typical use as described in Trussell, 2011. 





Table 2-6. Hazard ratios and 95% CIs for the association between all study variables and 
contraceptive method discontinuation (all methods combined) during the 12 month of follow 
up period 
Characteristics Unadjusted HR  
(95% CI)  
Adjusted HR 
(95%CI) 
Depression Status   
  Depression history only 1.08 (0.84, 1.40) 1.12 (0.86, 1.47) 
  Baseline depression only 0.93 (0.68, 1.27) 1.03 (0.74, 1.43) 
  History and baseline 
depression  
1.18 (0.79, 1.78) 1.39 (0.91, 2.11) 
  No depression 1.00 1.00 
Current Age  0.97 (0.93, 1.01) 0.99 (0.93, 1.05) 
Race/ Ethnicity   
  Black, Non-Hispanic 1.02 (0.75, 1.40) 0.92 (0.69, 1.23) 
  Hispanic 0.97 (0.81, 1.23) 1.10  (0.87, 1.39) 
  Asian/Others 0.68 (0.44, 1.05) 0.73 (0.47, 1.11) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.85 (0.66, 1.09) 0.86 (0.64, 1.16) 
  No insurance 0.94 (0.76, 1.15) 0.98 (0.80, 1.20) 
  Private 1.00 1.00 
Public Assistance    
 Yes 1.002 (0.78, 1.28) 1.11 (0.84, 1.49) 
 No 1.00 1.00 
Partner type    
  None 1.36 (1.005, 1.83) 1.48 (1.11, 1.96) 
  Casual  1.80 (1.36, 2.38) 1.80 (1.38, 2.36) 
  Primary 1.00 1.00 
Parity   
  One child 1.13 (0.88, 1.45) 1.28 (0.96, 1.70) 
  Two or more children 0.87 (0.61, 1.24) 1.11 (0.76, 1.64) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.95 (0.75, 1.19) 0.89 (0.69, 1.16) 
  No abortion 1.00 1.00 
Happiness about Pregnancy 
in the Next year 
  
  Unhappy 0.77 (0.62, 0.95) 0.82 (0.66, 1.03) 
  Happy 1.00 1.00 
Most Effective Method Used 3 
Months Prior to Study  
  
  Hormonal 1.98 (1.06, 3.70) 1.17 (0.93, 1.49) 
  LARCa 4.04 (2.23, 7.34) 1.65 (1.02, 2.67) 
 None/Condoms 1.00 1.00 




  Family planning 0.89 (0.72, 1.09) 0.82 (0.66, 1.01) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.83 (0.68, 1.01) 0.93 (0.77, 1.12) 
  Control 1.00 1.00 
First Method Effectiveness 
Levelb 
  
  Low Effectiveness 4.00 (2.77, 5.79) 4.29 (2.88, 6.40) 
  Moderate Effectiveness 3.28 (2.36, 4.54)  3.69 (2.61, 5.23) 
  High Effectiveness 1.00 1.00 
a. Long acting reversible contraception 
b. Contraceptive method effectiveness level was determined according to methods’ failure 





Table 2-7. Hazard ratios and 95% CIs for the association between all study variables and 
pregnancy during the 12-month follow up period 
Characteristics Unadjusted HR  
(95% CI)  
Adjusted HR 
(95%CI) 
Depression Status   
  Depression history only 0.53 (0.28, 1.02) 0.62 (0.31, 1.24) 
  Baseline depression only 1.10 (0.69, 1.75) 0.82 (0.51, 1.32) 
  History and baseline depression  1.78 (0.87, 3.62) 1.86 (0.86, 4.04) 
  No depression 1.00 1.00 
Current Age  0.97 (0.90, 1.05) 0.93 (0.85, 1.02) 
Race/ Ethnicity   
  Black, Non-Hispanic 2.04 (1.28, 3.27) 1.46 (0.86, 2.47) 
  Hispanic 1.24 (0.79, 1.96) 1.15  (0.75, 1.77) 
  Asian/Others 0.53 (0.20, 1.40) 0.60 (0.22, 1.58) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 1.25 (0.82, 1.91) 1.32 (0.85, 2.04) 
  No insurance 0.94 (0.65, 1.34) 1.09 (0.72, 1.64) 
  Private 1.00 1.00 
Public Assistance    
 Yes 1.07 (0.75, 1.53) 0.80 (0.50, 1.28) 
 No 1.00 1.00 
Partner type    
  None 1.31 (0.69, 2.49) 1.13 (0.55, 2.32) 
  Casual  1.66 (0.88, 3.12) 1.42 (0.73, 2.75) 
  Primary 1.00 1.00 
Parity   
  One child 2.49 (1.76, 3.55) 1.90 (1.30, 2.80) 
  Two or more children 1.80 (1.03, 3.15) 1.49 (0.79, 2.78) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 1.87 (1.30, 2.70) 1.60 (1.01, 2.53) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in 
the Next year 
  
  Unhappy 0.61 (0.42, 0.90) 0.62 (0.39, 0.98) 
  Happy 1.00 1.00 
Most Effective Method Used 3 
Months Prior to Study  
  
  Hormonal 0.52 (0.32, 0.86) 0.73 (0.40, 1.35) 
  LARCa 1.95 (1.08, 3.51) 2.47 (1.17, 5.22) 
 None/Condoms 1.00 1.00 
 Service at Enrollment Visit   




  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 1.03 (0.65, 1.64) 1.18 (0.84, 1.66) 
  Control 1.00 1.00 
First Method Effectiveness 
Levelb 
  
  Low Effectiveness 1.33 (0.70, 2.53) 1.70 (0.80, 3.61) 
  Moderate Effectiveness 1.83 (1.13, 2.95) 2.03 (1.16, 3.57) 
  High Effectiveness 1.00 1.00 
a. Long acting reversible contraception 
b. Contraceptive method effectiveness level was determined according to methods’ failure 






Table 2-A1. Hazard ratios and 95% CIs for the association between depression status and 
contraceptive method discontinuation for individual methods and contraceptive method 
effectiveness tiers during the 12 months of study period  
Characteristics Unadjusted HR  
(95% CI) 
Adjusted HR  
(95% CI)  
Condoms (n=92)   
Depression Status   
  Depression history only 1.01 (0.60, 1.68) 1.04 (0.56, 1.95) 
  Baseline depression only 0.83 (0.36, 1.95) 0.65 (0.26, 1.66) 
  History and baseline depression  0.34 (0.04, 3.04)  0.32 (0.02, 4.09) 
  No depression 1.00 1.00 
Pill (n=230)     
Depression Status   
  Depression history only 1.27 (0.80, 2.01) 1.22 (0.74, 2.00) 
  Baseline depression only 1.10 (0.78, 1.57) 1.08 (0.67, 1.75) 
  History and baseline depression  1.90 (1.16, 3.09) 1.46 (0.75, 2.85) 
  No depression 1.00 1.00 
Patch (n=29)   
Depression Status   
  Depression history only 3.88 (1.87, 8.07) 269.12 (14.81, 
4891.08) 
  Baseline depression only 0.84 (0.26, 2.67)  3.65 (0.31, 43.48) 
  History and baseline depression  0.91 (0.37, 2.25)  1.12 (0.60, 20.94) 
  No depression 1.00 1.00 
Ring (n=65)   
Depression Status   
  Depression history only 1.02 (0.52, 2.01) 0.70 (0.29, 1.67) 
  Baseline depression only 2.11 (1.08, 4.12) 2.37 (0.94, 6.01) 
  History and baseline depression  1.61 (0.43, 6.12) 2.27 (0.56, 9.21) 
  No depression 1.00 1.00 
 Injectable (n=75)   
Depression Status   
  Depression history only 1.27 (0.62, 2.62) 2.18 (0.78, 6.04) 
  Baseline depression only 1.40 (0.52, 3.76) 1.25 (0.35, 4.42) 
  History and baseline depression  4.40 (2.83, 6.86) 10.29 (2.81, 37.67) 
  No depression 1.00 1.00 
Implant (n=50)   
Depression Status   
  Any depression  0.82 (0.27, 2.51) 15.57 (2.12, 114.24) 
  No depression 1.00 1.00 
IUD (n=125)   




  Depression history only 1.01 (0.36, 2.84) 1.00 (0.25, 3.90) 
  Baseline depression only 0.74 (0.26, 2.07) 0.63 (0.20, 1.96) 
  History and baseline depression  1.13 (0.40, 3.14) 1.46 (0.30, 7.12) 
  No depression 1.00 1.00 
Low Effectiveness Methodsa 
(n=92) 
  
Depression Status   
  Depression history only 1.01 (0.60, 1.68) 1.04 (0.56, 1.95) 
  Baseline depression only 0.83 (0.36, 1.95) 0.65 (0.26, 1.66) 
  History and baseline depression  0.34 (0.39, 3.04) 0.32 (0.02, 4.09) 
  No depression 1.00 1.00 
Moderate Effectiveness Methodsb 
(n=399) 
  
Depression Status   
  Depression history only 1.18 (0.85, 1.64) 1.18 (0.83, 1.68) 
  Baseline depression only 1.16 (0.83, 1.62) 1.17 (0.79, 1.74) 
  History and baseline depression  1.84 (1.23, 2.76) 1.55 (0.91, 1.04) 
  No depression 1.00 1.00 
High Effectiveness Methodsc 
(n=175) 
  
Depression Status   
  Depression history only 0.93 (0.42, 2.03) 1.00 (0.40, 2.35) 
  Baseline depression only 0.64 (0.24, 1.70) 0.59 (0.18, 1.93) 
  History and baseline depression  1.16 (0.44, 3.10) 1.89 (0.48, 7.49) 
  No depression 1.00 1.00 
a. Low effectiveness includes condoms 
b. Moderate effectiveness includes pill, patch, ring, and shot  

















Table 2-B1. Hazard ratios for baseline characteristics for condom users (n=92)   
Characteristics Unadjusted HR 
 (95% CI)  
Adjusted HR  
(95%CI) 
Current Age  1.02 (0.91, 1.15) 1.10 (1.00, 1.25) 
Race/ Ethnicity   
  Black, Non-Hispanic 0.44 (0.20, 0.99) 0.42  (0.20, 0.88) 
  Hispanic 1.07  (0.65, 1.75) 0.81  (0.43, 1.53) 
  Asian/Others 0.96 (0.45, 2.05) 0.74 (0.32, 1.68) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 1.37 (0.72, 2.62) 1.63 (0.80, 3.29) 
  No insurance 0.85 (0.54, 1.34) 0.77 (0.48, 1.23) 
  Private 1.00 1.00 
Public Assistance    
 Yes 0.94 (0.60, 1.48) 0.73 (0.43, 1.23) 
 No 1.00 1.00 
Partner type    
  None 1.29 (0.59, 2.81) 1.13 (0.45, 2.85) 
  Casual  1.26 (0.52, 3.04) 0.87 (0.36, 2.10) 
  Primary 1.00 1.00 
Parity   
  One child 0.60 (0.27, 1.34) 0.76 (0.31, 1.83) 
  Two or more children 3.71 (2.76, 4.99) 6.23 (2.06, 18.82) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.68 (0.40, 1.16) 0.63 (0.39, 1.04) 
  No abortion 1.00 1.00 
Happiness about Pregnancy 
in the Next year 
  
  Unhappy 0.99 (0.62, 1.58) 1.13 (0.66, 1.94) 




Most Effective Method Used 
in 3 Months Prior to Study  
  
  Hormonal 1.98 (1.06, 3.70) 1.31 (0.68, 2.53) 
  LARC 4.04 (2.23, 7.34) 4.16 (1.72, 10.08) 
  None/Condoms 1.00 1.00 
 Service at Enrollment Visit   
  Family planning 1.46 (0.94, 2.27) 1.39 (0.81, 2.40) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 1.22 (0.77, 1.93) 1.37 (0.81, 2.30) 





Table 2-B2. Hazard ratios for baseline characteristics for birth control pill users (n=230)   
Characteristics Unadjusted HR (95% CI)  Adjusted HR (95%CI) 
Current Age  1.01 (0.94, 1.09) 0.96 (0.89, 1.04) 
Race/ Ethnicity   
  Black, Non-Hispanic 1.22 (0.90, 1.66) 0.99 (0.70, 1.42) 
  Hispanic 0.91 (0.64, 1.30) 0.85 (0.59, 1.24) 
  Asian/Others 0.46 (0.22, 0.95) 0.51 (0.24, 1.10) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.87 (0.60, 1.25) 0.71 (0.46, 1.07) 
  No insurance 1.01 (0.69, 1.48) 1.13 (0.80, 1.60) 
  Private 1.00 1.00 
Public Assistance    
 Yes 1.16 (0.82, 1.64) 1.32 (0.87, 2.01) 
 No 1.00 1.00 
Partner type    
  None 1.63 (1.03, 2.58) 1.47 (0.85, 2.53) 
  Casual  2.56 (1.56, 4.21) 2.17 (1.27, 3.72) 
  Primary 1.00 1.00 
Parity   
  One child 1.51 (1.05, 2.19) 1.46 (0.97, 2.19) 
  Two or more children 1.26 (0.71, 2.23) 1.45 (0.79, 2.69) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 1.65 (1.13, 2.40) 1.46 (0.92, 2.33) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in the 
Next year 
  
  Unhappy 0.86 (0.61, 1.21) 0.80 (0.60, 1.07) 
  Happy 1.00 1.00 
 Most Effective Method Used in 3 
Months Prior to Study  
  
  Hormonal 1.18 (0.55, 2.57) 1.07 (0.64, 1.79) 
  LARC 1.17 (0.52, 2.66) 0.64 (0.25, 1.64) 
  None/Condoms 1.00 1.00 
 Service at Enrollment Visit   
  Family planning 0.75 (0.58, 0.98) 0.85 (0.58, 1.22) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.88 (0.67, 1.17) 0.91 (0.65, 1.27) 





Table 2-B3. Hazard ratios for baseline characteristics for patch users (n=29)   
Characteristics Unadjusted HR (95% CI)  Adjusted HR (95%CI) 
Current Age  0.94 (0.78, 1.13) 0.69 (0.43, 1.12) 
Race/ Ethnicity   
  Black, Non-Hispanic 4.96 (2.01, 12.21) 37.64 (3.49, 405.38) 
  Hispanic 0.93 (0.36, 2.39) 1.09 (0.30, 3.89) 
  Asian/Others 0.64 (0.32, 1.27) 0.08 (0.0001, 53.67) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.86 (0.37, 1.99) 0.03 (0.002, 0.46) 
  No insurance 0.84 (0.33, 2.12) 0.10 (0.01, 1.10) 
  Private 1.00 1.00 
Public Assistance    
 Yes 1.41 (0.76, 2.60) 3.10 (0.34, 28.30) 
 No 1.00 1.00 
Partner type    
  None 1.24 (0.72, 2.13) 3.52 (0.27, 45.30) 
  Casual  1.24 (0.71, 2.15) 1.82 (0.26, 12.69) 
  Primary 1.00 1.00 
Parity   
  One child 1.25 (0.56, 2.79) 7.32 (0.28, 193.53) 
  Two or more children 0.45 (0.10, 2.10) 1.69 (0.04, 65.27) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.97 (0.44, 2.13) 0.55 (0.062, 4.82) 
  No abortion 1.00 1.00 
Happiness about Pregnancy 
in the Next year 
  
  Unhappy 0.71 (0.36, 1.38) 0.62 (0.06, 6.86) 
  Happy 1.00 1.00 
Most Effective Method Used 
in 3 Months Prior to Study  
  
  Hormonal 1.36 (0.58, 3.20) 1.99 (0.41, 9.58) 
  LARC Omitted Omitted 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 0.98 (0.49, 1.94) 2.72 (0.39, 18.75) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.99 (0.53, 1.86) 0.27 (0.03, 2.10) 





Table 2-B4. Hazard ratios for baseline characteristics for ring users (n=65)   
Characteristics Unadjusted HR (95% CI)  Adjusted HR (95%CI) 
Current Age  1.04 (0.92, 1.17) 1.18 (0.95, 1.45) 
Race/ Ethnicity   
  Black, Non-Hispanic 1.00 (0.44, 2.29) 1.43 (0.39, 5.19) 
  Hispanic 1.53 (0.87, 2.69) 1.51 (0.72, 3.19) 
  Asian/Others 2.12 (0.82, 5.49) 3.35 (0.71, 15.89) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.49 (0.23, 1.04) 0.59 (0.19, 1.78) 
  No insurance 0.61 (0.32, 1.16) 0.62 (0.33, 1.18) 
  Private 1.00 1.00 
Public Assistance    
 Yes 0.69 (0.37, 1.28) 0.49 (0.14, 1.68) 
 No 1.00 1.00 
Partner type    
  None 1.23 (0.61, 2.48) 0.97 (0.32, 2.96) 
  Casual  1.03 (0.52, 2.02) 0.97 (0.44, 2.14) 
  Primary 1.00 1.00 
Parity   
  One child 1.33 (0.73, 2.44) 0.94 (0.51, 1.73) 
  Two or more children 0.57 (0.20, 1.61) 0.49 (0.12, 2.01) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 1.01 (0.52, 1.99) 0.77 (0.25, 2.36) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in 
the Next year 
  
  Unhappy 0.72 (0.37, 1.38) 0.56 (0.20, 1.58) 
  Happy 1.00 1.00 
Most Effective Method Used in 
3 Months Prior to Study  
  
  Hormonal 1.11 (0.78, 1.58) 1.30 (0.75, 2.27) 
  LARC 0.78 (0.075, 8.21) 2.81 (0.22, 35.39) 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 0.69 (0.39, 1.23) 0.53 (0.23, 1.25) 
  Abortion 1.00 1.00 
Arm of the Study   





Table 2-B5. Hazard ratios for baseline characteristics for injectable users (n=75)   
Characteristics Unadjusted HR 
 (95% CI)  
Adjusted HR 
(95%CI) 
Current Age  0.97 (0.85, 1.10) 1.01 (0.83, 1.22) 
Race/ Ethnicity   
  Black, Non-Hispanic 0.97 (0.55, 1.72) 0.77 (0.41, 1.48) 
  Hispanic 1.42 (0.72, 2.80) 0.95 (0.41, 2.20) 
  Asian/Others 2.15 (0.99, 4.66) 1.83 (0.21, 15.80) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 1.15 (0.58, 2.29) 1.21 (0.52, 2.79) 
  No insurance 1.07 (0.59, 1.94) 0.95 (0.40, 2.30) 
  Private 1.00 1.00 
Public Assistance    
 Yes 1.31 (0.71, 2.40) 1.67 (0.49, 5.67) 
 No 1.00 1.00 
Partner type    
  None 3.90 (2.34, 6.49) 4.16 (2.14, 8.09) 
  Casual  2.94 (1.75, 4.92) 4.43 (2.04, 9.61) 
  Primary 1.00 1.00 
Parity   
  One child 1.19 (0.64, 2.24) 1.88 (0.97, 3.64), 
.062 
  Two or more children 1.44 (0.20, 3.06) 0.75 (0.22, 2.63) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.58 (0.31, 1.10) 0.44 (0.20, 0.99) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in 
the Next year 
  
  Unhappy 0.87 (0.47, 1.60) 1.12 (0.43, 2.88) 
  Happy 1.00 1.00 
Most Effective Method Used in 
3 Months Prior to Study  
  
  Hormonal 0.89 (0.50, 1.59) 1.11 (0.60, 2.05) 
  LARC 3.11 (1.87, 5.19) 2.78 (0.34, 22.98) 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 0.71 (0.38, 1.33) 0.65 (0.31, 1.37) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.67 (0.37, 1.20) 0.86 (0.48, 1.57) 










Table 2-B6. Hazard ratios for baseline characteristics of implant users (using no-depression 
versus any-depression, n=50)   
Characteristics Unadjusted HR (95% CI)  Adjusted HR (95%CI) 
Current Age  0.81 (0.60, 1.09) 0.81 (0.44, 1.49) 
Race/ Ethnicity   




  Hispanic 3.00 (0.94, 9.58) 13.89 (0.05, 3712.99) 




  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.81 (0.36, 1.80) 1.37 (6.95e-6, 271964.3) 
  No insurance 4.43 (0.71, 27.53) 0.35 (0.008, 14.84) 
  Private 1.00 1.00 
Public Assistance    




 No 1.00 1.00 
Partner type    
  None 0.70 (0.14, 3.56) 0.17 (0.005, 5.41) 




  Primary 1.00 1.00 
Parity   
  One child 1.71 (0.53, 5.45) 2.83 (0.19, 42.96) 
  Two or more children 1.70 (0.49, 5.90) 8.26 (0.07, 952.64) 
  No children 1.00 1.00 
Number of Prior Abortions   




  No abortion 1.00 1.00 
Happiness about 
Pregnancy in the Next year 
  
  Unhappy 0.45 (0.14, 1.42) 1.08 (0.07, 16.10) 




Most Effective Method 
Used in 3 Months Prior to 
Study  
  
  Hormonal 1.40 (0.49, 3.97) 2.93 (0.23, 37.10) 
  LARC 3.83 (0.90, 16.33) 5.87 (0.28, 123.79) 
  None/Condoms 1.00  1.00  
 Service at Enrollment 
Visit 
  
  Family planning 1.62 (0.40, 6.52) 2.30 (0.002, 2097.43) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.89 (0.25, 3.17) 3.13 (0.18, 55.64) 






Table 2-B7. Hazard ratios for baseline characteristics for IUD users (n=125) 
Characteristics Unadjusted HR (95% CI)  Adjusted HR 
(95%CI) 
Current Age  0.91 (0.78, 1.07) 0.88 (0.70, 1.12) 
Race/ Ethnicity   
  Black, Non-Hispanic 1.64 (0.58, 4.64) 1.83 (0.48, 6.96) 
  Hispanic 1.04 (0.48, 2.28) 0.93 (0.44, 1.95) 
  Asian/Others 0.42 (0.05, 3.49) 0.48 (0.06, 3.78) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.74 (0.25, 2.17) 0.68 (0.12, 3.73) 
  No insurance 1.19 (0.63, 2.26) 1.17 (0.57, 2.43) 
  Private 1.00 1.00 
Public Assistance    
 Yes 0.85 (0.40, 1.83) 0.78 (0.27, 2.25) 
 No 1.00 1.00 
Partner type    
  None 1.18 (0.51, 2.73) 1.13 (0.50, 2.56) 
  Casual  0.93 (0.20, 4.33) 0.86 (0.13, 5.59) 
  Primary 1.00 1.00 
Parity   
  One child 1.83 (0.88, 3.80) 1.29 (0.68, 2.47) 
  Two or more children 1.20 (0.57, 2.54) 0.92 (0.37, 2.29) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.79 (0.38, 1.68) 1.09 (0.46, 2.62) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in 
the Next year 
  
  Unhappy 0.64 (0.30, 1.38) 0.53 (0.19, 1.49) 
  Happy 1.00 1.00 
Most Effective Method Used in 
3 Months Prior to Study  
  
  Hormonal 0.75 (0.37, 1.50) 0.70 (0.28, 1.73) 
  LARC 2.36 (0.99, 5.64) 2.78 (0.85, 9.13) 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 0.69 (0.32, 1.50) 0.50 (0.19, 1.32) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.81 (0.38, 1.71) 1.005 (0.42, 2.41) 





Table 2-B8. Hazard ratios for baseline characteristics for initiation of a low effectiveness 
method at baseline (n=92)  
Characteristics Unadjusted HR (95% CI)  Adjusted HR 
(95%CI) 
Current Age  1.02 (0.91, 1.15) 1.10 (0.97, 1.25) 
Race/ Ethnicity   
  Black, Non-Hispanic 0.44 (0.20, 0.99) 0.42 (0.20, 0.88) 
  Hispanic 1.07 (0.65, 1.75) 0.81 (0.43, 1.53) 
  Asian/Others 0.96 (0.45, 2.05) 0.74 (0.32, 1.68) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 1.37 (0.72, 2.62) 1.63 (0.80, 3.29) 
  No insurance 0.85 (0.54, 1.34) 0.77 (0.48, 1.23) 
  Private 1.00 1.00 
Public Assistance    
 Yes 0.94 (0.60, 1.48) 0.73 (0.43, 1.23) 
 No 1.00 1.00 
Partner type    
  None 1.29 (0.59, 2.81) 1.13 (0.45, 2.85) 
  Casual  1.26 (0.52, 3.04) 0.87 (0.36, 2.10) 
  Primary 1.00 1.00 
Parity   
  One child 0.60 (0.27, 1.34) 0.76 (0.31, 1.84) 
  Two or more children 3.71 (2.76, 4.99) 6.23 (2.06, 18.82) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.68 (0.40, 1.16) 0.63 (0.39, 1.04) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in 
the Next year 
  
  Unhappy 0.99 (0.62, 1.58) 1.13 (0.66, 1.94) 
  Happy 1.00 1.00 
Most Effective Method Used in 
3 Months Prior to Study  
  
  Hormonal 1.98 (1.06, 3.70) 1.31 (0.68, 2.53) 
  LARC 4.04 (2.23, 7.34) 4.16 (1.72, 10.08) 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 1.46 (0.94, 2.27) 1.39 (0.81, 2.40) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 1.22 (0.77, 1.93) 1.37 (0.81, 2.30) 





Table 2-B9. Hazard ratios for baseline characteristics for initiation of a moderate 
effectiveness method at baseline (n=399) 
Characteristics Unadjusted HR  
(95% CI)  
Adjusted HR 
(95%CI) 
Current Age  1.00 (0.95, 1.06) 0.98 (0.93, 1.04) 
Race/ Ethnicity   
  Black, Non-Hispanic 1.10 (0.85, 1.41) 1.02 (0.80, 1.30) 
  Hispanic 1.11 (0.86, 1.43) 1.08 (0.81, 1.43) 
  Asian/Others 0.67 (0.41, 2.05) 0.73 (0.43, 1.23) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.86 (0.67, 1.10) 0.69 (0.49, 0.97) 
  No insurance 0.95 (0.72, 1.25) 0.99 (0.77, 1.27) 
  Private 1.00 1.00 
Public Assistance    
 Yes 1.11 (0.86, 1.45) 1.38 (0.98, 1.95) 
 No 1.00 1.00 
Partner type    
  None 1.76 (1.26, 2.46) 1.67 (1.19, 2.35) 
  Casual  2.10 (1.59, 2.76) 2.11 (1.54, 2.89) 
  Primary 1.00 1.00 
Parity   
  One child 1.38 (1.07, 1.80) 1.38 (1.01, 1.88) 
  Two or more children 1.07 (0.70, 1.64) 1.11 (0.68, 1.82) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 1.18 (0.93, 1.50) 1.06 (0.77, 1.47) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in the 
Next year 
  
  Unhappy 0.81 (0.62, 1.06) 0.80 (0.61, 1.04) 
  Happy 1.00 1.00 
Most Effective Method Used in 3 
Months Prior to Study  
  
  Hormonal 1.01 (0.78, 1.30) 1.13 (0.86, 1.48) 
  LARC 1.16 (0.64, 2.11) 1.11 (0.53, 2.33) 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 0.76 (0.62, 0.94) 0.79 (0.61, 1.02) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.84 (0.67, 1.04) 0.86 (0.70, 1.04) 





Table 2-B10. Hazard ratios for baseline characteristics for initiation of a high effectiveness 
method at baseline (n=175)  
Characteristics Unadjusted HR  
(95% CI)  
Adjusted HR 
(95%CI) 
Current Age  0.90 (0.78, 1.03) 0.90 (0.74, 1.08) 
Race/ Ethnicity   
  Black, Non-Hispanic 1.41 (0.50, 3.93) 1.61 (0.47, 5.56) 
  Hispanic 1.35 (0.72, 2.53) 1.21 (0.51, 2.85) 
  Asian/Others 0.28 (0.04, 2.15) 0.30 (0.03, 2.82) 
  White, Non-Hispanic 1.00 1.00 
Insurance Status   
  Medicaid/State insurance 0.73 (0.28, 1.88) 0.78 (0.27, 2.24) 
  No insurance 1.47 (0.86, 2.54) 1.38 (0.83, 2.29) 
  Private 1.00 1.00 
Public Assistance    
 Yes 0.62 (0.30, 1.28) 0.69 (0.36, 1.33) 
 No 1.00 1.00 
Partner type    
  None 1.06 (0.50, 2.24) 1.04 (0.48, 2.29) 
  Casual  0.83 (0.17, 3.96) 0.78 (0.12, 4.99) 
  Primary 1.00 1.00 
Parity   
  One child 1.85 (0.96, 3.57) 1.28 (0.65, 2.53) 
  Two or more children 1.33 (0.78, 2.27) 1.21 (0.51, 2.88) 
  No children 1.00 1.00 
Number of Prior Abortions   
  One or more 0.56 (0.26, 1.21) 0.67 (0.33, 1.35) 
  No abortion 1.00 1.00 
Happiness about Pregnancy in the 
Next year 
  
  Unhappy 0.58 (0.31, 1.09) 0.72 (0.32, 1.59) 
  Happy 1.00 1.00 
Most Effective Method Used in 3 
Months Prior to Study  
  
  Hormonal 0.85 (0.48, 1.51) 0.96 (0.47, 1.97) 
  LARC 2.56 (1.20, 5.47) 2,40 (1.10, 5.27) 
  None/Condoms 1.00  1.00  
 Service at Enrollment Visit   
  Family planning 0.80 (0.44, 1.48) 0.61 (0.28, 1.35) 
  Abortion 1.00 1.00 
Arm of the Study   
 Intervention 0.81 (0.43, 1.52) 1.04 (0.50, 2.33) 





Chapter 5:  Study Three 
 
Title: Association between adolescents’ experience of depression onset and 
teenage pregnancy; Does the timing of depression onset matter? 
Abstract 
Objective: To examine the independent association between timing of first 
depressive episode relative to age at sexual debut and first teenage pregnancy. 
Methods: We used survival analysis to estimate the incidence rates of first teenage 
pregnancy among 1,016 girls 13-18 years old participating in the National 
Comorbidity Survey – Adolescent Supplement. We used age at first sexual 
intercourse to define the timing of depression onset as a four-level variables including 
no depression onset before pregnancy or end of the study, depression onset before age 
at first sex, depression onset at age at first sex, and depression onset after age at first 
sex and at or before age at first pregnancy or end of the study. We then applied Cox 
proportional hazards models to examine the independent association between the 
timing of depression onset the hazards of first teenage pregnancy. Results: We found 
that compared to girls with no depression onset during the study period (IR: 
10.05/100 girls-year, 95% CI 8.96, 12.39), those with depression onset at age at first 
sex (IR: 17.33/100 girls-year, 95% CI 10.06, 29.84) had higher incidence of 
becoming pregnant, however this difference was not statistically significant. 
Examining the Cox proportional hazards models, we found that adolescent girls with 
depression onset in the same year as their sexual debut (HR: 2.73, 95% CI 1.07, 6.97) 




experience of depressive symptoms. Conclusion: Timing of first depressive episode 
relative to age at first sexual intercourse plays a role in teenage pregnancy. Future 
studies should further investigate the effect of depression on contraceptive behavior at 






According to the latest national data from 2011, the pregnancy rate among 
adolescent girls 15-19 years old in the United States was 55 pregnancies per 1000 
adolescent girls, a 21% decrease from 2008 (Finer & Zolna, 2016). Despite this 
decline, the rate of teenage pregnancy in the US is still higher than that in other 
developed countries and racial and regional disparities still exist (Amin, Decesare, 
Hans, & Roussos-Ross, 2017; Sedgh, Finer, Bankole, Eilers, & Singh, 2015; 
Department of Health and Human Services, 2016). Furthermore, 75% of pregnancies 
in this age group in 2011 were unintended (Finer & Zolna, 2016), which presents a 
great public health concern (Scally, 2002).  
Teenage pregnancy poses unique challenges to adolescent mothers and their 
children. Adolescents are more likely to have shorter inter-pregnancy intervals than 
adult women (Katz et al., 2011) and thus more likely to experience repeated 
pregnancies before entering adulthood (Morbidity and Mortality Weekly Report, 
2013). A systematic review of studies on teenage pregnancy indicate that 
approximately 19% and 40% of teens become pregnant again within 12 and 18 
months, respectively (Meade & Ickovics, 2005). In addition to repeat pregnancy, 
pregnancies carried to term during adolescence are associated with adverse outcomes 
for the teen mother including pregnancy complications, less educational attainment, 
lower employment opportunities, and perinatal depression (Bahk, Yun, Kim, & 
Khang, 2015; Chang, Schwarz, Douglas, & Horon, 2009; Chiquero, 2010; Ferre, 
Gerstenbluth, Rossi, & Triunfo, 2013; Gipson, Koenig, & Hindin, 2008; Lanzi, Bert, 




born preterm, having low birth weight, developing behavioral problems, having 
academic disadvantages, being maltreated, and becoming teen mothers (Chen et al., 
2007; Furstenberg, Brooks-Gunn, & Morgan, 1987; Langille, 2007).   
One of the psychological factors that has been shown to be associated with 
adolescent behaviors leading to pregnancy is depression. Depression is associated 
with a younger age at the onset of sexual experience, non-use or inconsistent use of 
contraception, low compliance with the contraceptive methods, alcohol consumption 
before having sex, and ambivalence about becoming pregnant—all of which may 
place adolescent girls at a higher risk for experiencing teenage pregnancy (Brooks, 
Harris, Thrall, & Woods, 2002; DiClemente et al, 2001; Hall et al, 2014; Lehrer et al., 
2006; Panova, Kulikov, Berchtold, & Suris, 2016; Wellings et al., 2013; Zink, 
Shireman, Ho, & Buchanan, 2002).  
On the national level, the lifetime and 12-month prevalence of major 
depressive disorder (MDD) among adolescent girls aged 13-18 years are 15.9% and 
10.7% respectively (Avenevoli, Swendesen, He, Burstein, & Merkangas, 2015; 
National Comorbidity Survey, Appendix Table 2, N.D.). More strikingly, 
approximately 23% of girls 15-16 years have already had a lifetime experience of 
depression (Kessler et al., 1998). 
  A body of research has focused on the effect of depression on pregnancy 
among adolescent girls, however, the findings are inconsistent (Bennett, Culhane, 
McCollum, & Elo, 2006; Hall, Richards, & Harris, 2017; James-Hawkinds, Denardo, 
Blalock, & Mollborn, 2014; Kessler et al., 1997; Mollborn & Morningstar, 2009; 




McSweeney, 2009). One study found that depressive symptoms during adolescence 
were significantly associated with an unintended first pregnancy in young adulthood 
(James-Hawkinds, Denardo, Blalock, & Mollborn, 2014). Similarly, several other 
studies found that depressive symptoms were associated with a greater risk of 
pregnancy among teenage girls (Hall, Richards, & Harris, 2017; Kessler et al., 1997; 
Takahashi et al., 2012). In contrast, two studies found no association between 
depression and pregnancy in adolescent girls (Bennett et al., 2006; Tenkku et al., 
2009).    
Fifty percent of adolescents experiencing a first depressive episode experience 
an episode within the next two years and 75% within the next five years (Garland & 
Solomons, 2002). Furthermore, for many girls, adolescence marks the initiation of 
sexual intercourse (Finer & Philbin, 2014), which can place them at risk for teenage 
pregnancy. Since depression is associated with a younger age at first sex, to elucidate 
the relationship between depression and subsequent pregnancy during adolescence, 
the timing of the first depressive episode with respect to age at first sex may be an 
important factor to consider.  
Present study 
The current study investigated the association between depression onset and 
subsequent teenage pregnancy using the National Comorbidity Survey Adolescent 
Supplement (NCS-A), which includes estimates of the DSM-IV in a sample of 
nationally representative adolescent girls. While prior studies investigating the 
association between depression and teenage pregnancy have often treated age at first 




use information on age at first sex to define the timing of the first depressive episode 
by considering when the onset occurred relative to age at first sex. Therefore, the 
objective of this study is to examine the association between a first depressive 
episode occurring before, at, or after age at first sex and the likelihood of having a 
teenage pregnancy among girls aged 13-18 years old.  
Material and Methods 
Data source and study population 
NCS-A is a nationally representative cross-sectional study of 10,123 
adolescents aged 13-18 years in the United States, designed to estimate the lifetime 
and current prevalence, onset age, course of development, and comorbidity of DSM-
IV disorders, and to identify risk and protective factors associated with each disorder. 
The core diagnostic interviews are based on the modified version of the World Health 
Organization (WHO) Composite International Diagnostic Interview (CIDI), which is 
a fully structured diagnostic interview designed for use by trained interviewers 
(Merikangas, Avenevoli, Costello, Koretz, & Kessler, 2009). Other behavioral factors 
and likely correlates of mental disorders were also assessed. A detailed description of 
the background, measures, and study design of NCS-A is published elsewhere 
(Kessler et al., 2009a; Kessler et al., 2009b). Briefly, between February 2001 and 
January 2004, adolescents from household and school-based samples were 
interviewed by professional interviewers using computer assisted personal interviews 




Political and Social Research and Institutional Review Board approval for this study 
was obtained by the University of Maryland, College Park.  
Because the focus of this study is the first experience of teenage pregnancy, 
our study population was restricted to female participants who reported ever having 
sex after the age of 10 (n=1131). 
Measures 
Outcome: Incidence of First Teenage Pregnancy 
Incidence of first teenage pregnancy during the study period was defined 
based on answers to the following questions from the survey by girls with sexual 
intercourse onset after the age of 10: 1) how old were you when you had your first 
child, and 2) how old were you the first time you had a miscarriage, stillbirth or 
abortion. A continuous variable for the age at first pregnancy was created using 1) the 
age at first childbirth if the adolescents had no miscarriages, stillbirths, or abortions; 
2) the age at first miscarriage, stillbirth, or abortion if the adolescents had no 
childbirths; and 3) the minimum age for girls who had reported an age for both 
childbirth and miscarriage, stillbirth, or abortion. Adolescents reporting an age for 
childbirth, miscarriage, stillbirth, or abortion younger than their age at the interview 
(end of the study) were classified as having experienced a teenage pregnancy. 
Adolescents who did not report an age for childbirth, miscarriage, still birth, or 
abortion until the interview date (end of the study) were right censored. 
Exposure: Timing of First Depressive Episode 
First depressive episode was defined with respect to adolescents’ age at sexual 




this information, we classified participants into four depression categories including: 
1) no depressive episode onset before pregnancy or at the time of interview if not 
pregnant by interview (end of the study), 2) depressive episode onset before age at 
first sex, 3) depressive episode onset at age at first sex, and 4) depressive episode 
onset after age at first sex and at or before age at first pregnancy (if pregnant by 
interview) or age at interview (if not pregnant by interview).  
 
Covariates 
Based on the literature, we examined the effects of the following baseline 
characteristics which have been shown to be associated with teenage pregnancy 
(Dehlendorf, Rodriguez, Levy, Borrero, & Sterinauer, 2010; Hall et al., 2017; World 
Health Organization, 2014): race/ethnicity (non-Hispanic white, non-Hispanic black, 
Hispanic, Others); marital status (married/cohabitating vs. never married); regional 
residency (urban, rural, other urban); age at first sex; participants’ parental education 
(less than high school, high school graduate, some college, college graduate or 
higher); and participants’ mothers’ age at the time of giving birth to the participants 
(greater than 19 vs. 19 or less).  
Analyses  
We compared pregnant and non-pregnant participants on baseline covariates 
and timing of depression onset using weighted chi-square tests for categorical 
variables. The incidence rate of teenage pregnancy during study period was 




the study period by the total number of person-years accumulated in the study 
population.  
To examine the relationship between timing of first depressive episode and 
the hazard of first teenage pregnancy during the study period, we applied Cox 
proportional hazards models to account for censoring of participants who had not 
become pregnant by the end of study. We reconstructed time to pregnancy based on 
information on adolescents’ age at first sexual intercourse. Age at first sexual 
intercourse was considered as the origin for all participants and time was measured 
from that point on to the end of study which was the age at first pregnancy for those 
who became pregnant, or to the current age at interview if not pregnant by interview 
(end of study). We examined the association between timing of first depressive 
episode and the hazard of experiencing first teenage pregnancy using unadjusted and 
adjusted Cox proportional hazards models. Specifically, hazard ratios and 95% 
confidence intervals were computed using weighted proportional hazard ratios. 
Adjusted models accounted for all covariates that have shown to be associated with 
the teenage pregnancy based on the literature (Dehlendorf, et al., 2010; Hall et al., 
2017; World Health Organization, 2014) or those that were associated with either the 
teenage pregnancy or depression status in our sample at p< 0.05.  
We incorporated complex survey weights with proper cluster and strata 
variables according to the NCS-A guidelines to account for national 
representativeness of the sample (Kessler et al., 2009; Lee-Winn, Reinblatt, Mojtabai, 




We also conducted a supplementary analysis. We repeated the survival 
analysis for those who experienced the first depressive episode after the first sexual 
intercourse and in the same year as the first pregnancy (n=3). While in the main 
coding of depression, we classified those who had a first depressive episode at the 
same age as their first pregnancy in the last category as having first depressive 
episode after age at first sex and at or before pregnancy, in the supplementary 
analysis, we assumed that for these three adolescents the first depressive episode 
occurred after pregnancy, and thus classified them in the first depression category as 
having no depression. All analyses were conducted in STATA 14.  
Results  
From 1,016 adolescent girls in the weighted analytic sample, 140 experienced 
a first pregnancy during the study period. The total time at risk to the first teenage 
pregnancy was 1,324.276 person-years, with the median at risk time of one year 
ranging from 1 to 6 years. Table 3-1 presents the baseline characteristics of the entire 
sample and differences by pregnancy status. The mean age of participants at the time 
of the interview was 16.2 (SD= 0.11). The majority of participants (66%) identified 
as white non-Hispanic girls, were never married (96%), and resided in metropolitan 
areas (49%). Approximately 53% of teenagers had parents with a high school degree 
or less and 20% reported being born to a teenage mother. Participants’ average age at 
sexual debut was 14.9 (SD= 0.07) ranging from 11-18 years old. Among participants 
with an experience of first pregnancy, the mean age at first pregnancy was 15.54 
(SD= 0.16). Most participants did not have a depressive episode (70%), while 23% 




depressive episode at age at first sex, and 2.3% had their first depressive episode after 
age at their first sexual intercourse but before age at first pregnancy or before the 
interview for those with no pregnancy experience. For those who had had a first 
depressive episode during the study period (n=301), the mean age for the first 
depressive episode was 11.90 (SD= 0.26).   
Adolescent girls with an experience of a first pregnancy were more likely to 
be from a black non-Hispanic or Hispanic background (45.52% vs. 29.57%, 
p=0.005), were more likely to be married (14.50% vs. 2.06%, p<0.001), and in the 
lowest poverty index ration (30.61% vs. 12.09%, p=0.002) compared to their non-
pregnant counterparts. Although previous literature has shown that being born to a 
teenage mother is a strong predictor for experiencing teenage pregnancy (Langille, 
2007), in our sample, this was not the case (p=0.98).   
Table 3-2 represents the differences in baseline characteristics by depression 
onset categories. Participants in the four depression groups were only marginally 
different from each other with respect to maternal age at the time of giving birth to 
the teenage participants (p=0.064).  
The overall incidence rate of teenage pregnancy was 10.57/100 person-years 
(95% CI 8.96, 12.48). The incidence rate of teenage pregnancy was higher for girls 
experiencing first depressive episode at age at first sex (17.33/100 person-years, 95% 
CI 10.06, 29.84) than for those with no depression onset (10.05/100 person-years, 
95% CI 8.16, 12.39) but this difference was not statistically significant. The incidence 
rate of teenage pregnancy was 6.66/100 person-years (95% CI 5.00, 8.86) for white 




(IR: 18.54/100 person-years, 95% CI 14.09, 24.40). The incidence rate of teenage 
pregnancy did not differ between pregnant and non-pregnant girls based on other 
baseline characteristics (Table 3-3).  
The results of the crude and the adjusted Cox proportional hazard models for 
all covariates are illustrated in Table 3-4. In the unadjusted models, participants 
whose first depressive episode was in the same year as their first sexual intercourse 
had 2.53 times significantly higher hazard of becoming pregnant compared to those 
with no depressive episode onset (95% CI: 1.08, 5.96, p=0.034). There were no 
differences in hazard of pregnancy among adolescent girls who had a depression 
onset before or after the age at first sex compared to those with no depressive 
episodes (p-values >0.1).  
In the model adjusted for all covariates, the hazard of first teenage pregnancy 
remained significantly higher for girls with depression onset at the age of first sexual 
intercourse (aHR=2.65, 95% CI: 1.07, 6.57, p=0.04) than non-depressed girls. In 
addition to depression status, black, non-Hispanic girls (aHR=1.94, 95% CI: 1.15, 
3.27, p=0.01), and Hispanic girls (aHR= 1.77, 95% CI: 1.02, 3.09, p=0.04) had a 
higher hazard of experiencing first teenage pregnancy than their white, non-Hispanic 
counterparts. The hazard of teenage pregnancy decreased by 74% for non-married 
girls compared to those married/cohabitating (aHR=0.26, 95% CI: 0.13, 0.53, 
p<0.001).  
In the supplementary analysis, we reran the Cox proportional hazard models 
with the assumption that for girls who experienced their first depressive episode in 




and not as a predictor of pregnancy. Therefore, we coded these girls as not having a 
depression onset (n=3) during study period. The results were similar to the main 
analysis. In the adjusted model, adolescents with the first depressive episode at age at 
first sexual experience had 2.64 times higher hazard of becoming pregnant compared 
to their non-depressed counterparts (95% CI: 1.04, 6.73, p=0.041).  
Discussion 
Using a nationally representative sample of adolescent girls and time-to-event 
analysis, we investigated the association between the timing of depression onset 
relative to age at first sexual intercourse and the experience of first teenage 
pregnancy. We found that compared to those with no depression onset, girls whose 
depression onset occurred in the same years as their sexual debut were at an increased 
hazard of experiencing their first pregnancy during the study period.  
Initiation of sexual intercourse in adolescents marks an important event in the 
young women’s lives by placing them at risk for pregnancy. This is also the time 
when girls need to start thinking about their contraceptive behaviors and reproductive 
decisions. Although we did not examine the mechanisms by which depression onset 
at age at first sexual intercourse may lead to an increased risk for pregnancy, two 
explanations can be speculated. First, it is possible that for girls who experienced 
depression onset during the same year as their sexual debut, experiencing the 
depressive symptoms around the time of initiating sex may have directly led these 
girls to non-use or inconsistent use of a contraceptive method. Previous research has 
shown that teenage girls experiencing depression are less likely to use contraception 




2001; Francis et al., 2015; Hall et al., 2014; Hall et al., 2013a; Morrison et al., 2016). 
Second, they may have initiated sexual intercourse as a way to cope with their 
depression. In this scenario, engaging in sexual intercourse as a coping mechanism 
may mediate the relationship between depression and contraceptive behaviors, 
placing the girls at a higher risk for pregnancy. Future research therefore should 
further examine these relationships.  
This study offers a unique contribution to the existing body of literature in 
adolescent health. While previous studies have considered adolescents’ depression 
status at any point in time before occurrence of first pregnancy and have adjusted for 
the age at first sex in the regression model (Bennett, Culhane, McCollum, Elo, 2006; 
Hall, Richards, & Harris, 2017; Kessler et al., 1997; Takahashi et al., 2012), ours is 
the first to incorporate age at first sex in operationalization of the depression exposure 
by defining the timing of depression onset before, at, or after age at first sex and 
estimating the time to first pregnancy using Cox proportional hazards models. 
Considering in the United States, on average, young women experience sexual debut 
at some point during adolescence period (Finer & Philbin, 2014), and considering the 
association between depression and adolescents’ risky behaviors including 
unprotected sex and substance use before initiating sexual intercourse (Brooks, 
Harris, Thrall, & Woods, 2002; Hall, Moreau, Trussell, & Barber, 2013; Lehrer, 
Shrier, Gortmaker, & Buka, 2006), having information on when experiencing 
depression onset may have the most impact on adolescent girl’s risk for pregnancy 
can provide a more insightful understanding of how to prevent the negative outcomes 




The current study uses the data from the NCS-A, which is the only available 
nationally representative dataset with rich information on DSM-IV disorders 
including major and minor depressive disorders and their onset. The use of the CIDI 
depression diagnosis instrument in this survey eliminates limitations that depression-
screening tools may carry. Depressive symptoms’ screening instruments have only a 
limited validity in predicting DSM-IV depressive disorders, whereas CIDI is a 
validated depression diagnostic instrument (Andrews & Peters, 1998; Henkel, Mergl, 
Kohnen, Maier, Moller, & Hegerl, 2003).  
In addition to first depressive episode, black non-Hispanic (HR=2.00, 
CI=1.22, 3.28, p=0.007) and Hispanic adolescents (HR=1.76, CI=1.00, 3.09, 
p=0.049) had increased hazards of experiencing first pregnancy than white non-
Hispanic girls during the study period. Being born to a teenage mother has been 
shown to be one of the strong predictors of teenage pregnancy, however, in our 
sample there was no association between this covariate and teenage pregnancy among 
the adolescents (p>0.1). 
This study has some limitations that need to be considered when interpreting 
the findings. First, proximity of experiencing first depressive episode with respect to 
age at first sex was measured based on years. Therefore, for those who experienced 
depression onset in the same year as their sexual debut we do not know which one 
came first. Having information on the month of depression onset and sexual debut 
could help distinguish between girls who experienced depression onset first followed 
by their sexual debut and those who had their sexual debut first followed by 




same time as sexual initiation was associated with a higher hazard of first teenage 
pregnancy.  
 Second, although 75% of teenage pregnancies in the US are unintended 
(Finer & Zolna, 2016), and past research has shown depressive symptoms in 
adolescents to be associated with a feeling of ambivalence about pregnancy (Francis 
et al., 2015), young women’s pregnancy intentions have not been measured in this 
study and therefore we do not whether the pregnancies that occurred during the study 
period were unwanted or mistimed.   
Third, in this study we operationalized teenage pregnancy based on the 
participant’s self-reported age at which first childbirth and/or first miscarriage, 
stillbirth, or abortion occurred. However, knowing the time of conception (i.e. the 
date of last period) would enable us to determine the age at first pregnancy more 
accurately for participants in the study. Future studies can benefit from a prospective 
design in which participants are followed over time and information on their 
pregnancy status is collected through the usage of biomarkers or alternative ways that 
relying on participants’ memory and recall of the event.   
Fourth, in the current study we only used first depressive episode as the 
exposure and therefore we were unable to determine whether findings would be 
different for participants with multiple depressive episodes before pregnancy (if 
pregnant) or the interview date if not pregnant. Since research has shown that 
approximately half of adolescents experiencing a first depressive episode experience 




should examine whether experiencing multiple depressive episodes over time versus 
one time could change the risk of pregnancy during adolescence.   
Finally, we did not measure adolescents’ contraceptive behaviors in this study. 
Therefore, we cannot confirm whether or not depressed girls used contraception at the 
time of sexual intercourse that led to their pregnancy. Having information on 
contraceptive use of depressed adolescent girls at the time of sex could provide a 
better understanding of how depression may influence adolescent girls’ decision 
surrounding contraception and pregnancy. Future studies examining the effect of 
depression on teenage pregnancy should, therefore, investigate whether factors such 
as choice and patterns of contraceptive method use differ among depressed girls who 
are sexually active compared to non-depressed girls.  
Despite the limitations, the findings of this study indicate that not only 
presence or absence of depression during adolescence but when it occurs relative to 
sexual debut can influence first teenage pregnancy. These findings have implications 
for adolescents’ reproductive health by providing evidence for the significance of 
mental health on adolescents’ sexual and reproductive decisions. Therefore, these 
findings should be taken into account when addressing the issue of teenage pregnancy 
and mental health in adolescents.  
Given many girls become sexually active during adolescence, they should be 
fully educated about all available options and their effectiveness in pregnancy 
prevention. Even though long acting reversible contraceptives (LARC) are currently 
the most effective contraceptive methods for pregnancy prevention (Trussell, 2011), 




part attributable to factors such as teens’ lack of knowledge about the method and 
high insertion costs. Therefore, healthcare providers should encourage the use of 
LARC among all adolescent girls through educating them on the benefits of LARC 
methods and increasing their access to these methods by providing on-site, one-step, 
and free insertion of the devices. Furthermore, adolescents diagnosed with depression 
should be encouraged to delay sexual initiation until they have received treatment 
especially if they are on using any contraceptive methods. Furthermore, all children 
and teenagers should be educated on how to recognize the symptoms of mental health 
conditions such as depression in themselves and should be encouraged to inform their 
parents, school personnel, or their healthcare provider of their feelings. These types of 
practices can help all teenage girls especially who are experiencing depression to 
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Table 3-1. Baseline characteristics of the sample by pregnancy outcome 
Teenagers 
Characteristics 
n Weighted %  
  
Pregnancy Status, 
Weighted %  
 
P-value 







    0.038 
  No onset before 
pregnancy or end of 
study 
717 70.33 59.33 71.90  
  Onset before first sex 216 22.98 27.37 22.35  
  Onset at first sex   55   4.40 9.87   3.62  
  Onset after first sex 
at or before 
pregnancy or end of 
study 
  37   2.29 3.43   2.13  











Race/ Ethnicity     0.005 
  White, Non-Hispanic 559 65.88 50.73 68.05  
  Black, Non-Hispanic 228 19.17 27.74 17.94  
  Hispanic 191 12.40 17.78 11.63  
  Others   47   2.55   3.75   2.38  
Marital Status     <0.001 
  Married/cohabitating    46   3.62 14.50   2.06  
  Never married 979 96.38 85.50 97.94  
Poverty Index Ratio     0.002 
  <1.5 178 14.41 30.61 12.09  
  1.5 - ≤3.0 229 22.80 18.55 23.40  
  3.0 - ≤6.0  308 31.99 25.24 32.96  
 >6.0 310 30.80 25.59 31.54  
Residential Region      0.830 
  Metropolitan 454 49.01 48.21 49.12  
  Rural 247 16.08 14.62 16.29  
  Other 324 34.91 37.16 34.58  

















  Yes 141 12.53    
  No 884 87.47    








Mean Age at 
Depressive Onsetb 
(SD) 











     
Parental Education     0.391 
  Less than high 
school 
168 13.37 18.06 12.70  
  High school graduate 380 39.17 44.56 38.39  
  Some college 233 23.32 18.37 24.03  
  College graduate or 
more  
243 24.14 19.01 24.88  
 Mothers’ Age at 
Time of Giving Birth 
to participants  
    0.977 
  ≤19 197 20.08 20.54 20.02  
  >19 828 79.92 79.46 79.98  





Table 3-2. Bivariate analysis between timing of first depressive episode and covariates 
(Weighted N=1016) 














Race and Ethnicity     0.108 
  White, Non-Hispanic 65.84 70.17 62.19 31.12  
  Black, Non-Hispanic 20.41 11.33 20.58 56.83  
  Hispanic 11.33 15.74 14.26   8.48  
  Others   2.42   2.76   2.97   3.56  
Marital Status     0.491 
  Married/cohabitating    3.55   4.59   0.53   1.88  
  Never married  96.45 95.41 99.47 98.12  
Poverty Index Ratio     0.458 
  <1.5 14.90 11.02 26.54 10.41  
  1.5 - ≤3.0 24.10 19.28 14.51 33.81  
  3.0 - ≤6.0  31.75 35.10 22.17 26.88  
 >6.0 29.24 34.60 36.78 28.89  
Residential Region     0.116 
  Metropolitan 48.49 54.93 26.27 49.21  
  Rural 18.34 10.08 14.76   9.58  
  Other 33.17 34.99 58.96 41.22  













     
Parental Education     0.124 
  Less than high school 14.35   9.54 14.57 19.40  
  High school graduate 42.33 33.02 24.53 31.91  
  Some college 19.33 32.35 39.30 24.63  
  College graduate or 
more  
23.99 25.09 21.60 24.07  
Age Mother Gave 
Birth to Teenager 
    0.064 
  ≤19  17.48 30.55 7.68 18.98  






Table 3-3. Incidence rates for first teenage pregnancy  
Characteristics  Number of 
pregnant teenagers  
Girls-year Incidence rate*  
(95% CI) 
Overall 140 1324.28 10.57 (8.96, 12.48) 
Depression Onset status 
 No onset before 
pregnancy or end of the 
study 
  Onset before first sex 
  Onset at first sex 
  Onset after first sex & at 
or before pregnancy or 












10.05 (8.16, 12.39) 
11.15 (7.84, 15.85) 
17.33 (10.06, 29.84) 
8.33 (4.17, 16.66) 
Race/Ethnicity 
  White, Non-Hispanic 
  Black, Non-Hispanic 
  Hispanic 












6.66 (5.00, 8.86) 
18.54 (14.09, 24.40) 
12.45 (8.85, 17.51) 
11.54 (6.00, 22.17) 
Marital Status 
  Married/Cohabitating 








25.97 (16.76, 40.25) 
9.62 (8.04, 11.51) 
Poverty Index Ratio 
  <1.5 
  1.5 - ≤3.0 
  3.0 - ≤6.0 












19.28 (14.30, 25.99) 
9.61 (6.72, 13.75) 
6.20 (4.19, 9.18) 
10.88 (8.04, 14.72) 
Residential Region 
  Metropolitan 
  Rural 










11.87 (9.41, 14.98) 
8.24 (5.53, 12.30) 
10.34 (7.72, 13.85) 
Parental Education 
  Less than high school 
  High school graduate 
  Some college  












14.80 (10.52, 20.81) 
11.22 (8.62, 14.62) 
8.81 (6.12, 12.68) 
8.15 (5.42, 12.27) 
Mothers’ Age at Time of 
Giving Birth to Teens  
  ≤19 











14.16 (10.07, 19.92) 
9.81 (8.11, 11.85) 





Table 3-4. The unadjusted and adjusted hazard ratios between the timing of first depressive 
episode and first pregnancy (n=1016) 




Timing of Depression Onset   
  Onset before 1st sex 1.45 (0.84, 2.49) 1.51 (0.81, 2.80) 
  Onset at 1st sex 2.53 (1.08, 5.96) 2.73 (1.07, 6.97) 
  Onset after 1st sex before 1st 
pregnancy or end of the study 
1.01 (0.38, 2.70) 1.06 (0.35, 3.26) 
  No onset before 1st pregnancy or 
end of the study 
1.00 1.00 
Race and Ethnicity   
  Black, Non-Hispanic 1.85 (1.21, 2.83) 2.00 (1.22, 3.28) 
  Hispanic 1.92 (1.30, 2.83) 1.76 (1.00, 3.09) 
  Others 1.63 (0.55, 4.85) 1.36 (0.44, 4.19) 
  White, Non-Hispanic 1.00 1.00 
Marital Status   
  Never married  0.32 (0.18, 0.57) 0.26 (0.13, 0.51) 
Married/cohabiting 1.00 1.00 
Poverty Index Ratio   
  <1.5 2.34 (1.31, 4.18) 1.80 (0.90, 3.59) 
  1.5 - ≤3.0 0.89 (0.44, 1.79) 0.83 (0.42, 1.64) 
  3.0 - ≤6.0  0.84 (0.44, 1.60) 0.84 (0.41, 1.69) 
  >6.0 1.00 1.00  
Residential Region   
  Rural 0.84 (0.51, 1.40) 1.19 (0.65, 2.15) 
  Other 0.93 (0.62, 1.39) 1.09 (0.74, 1.61) 
  Metropolitan 1.00 1.00 
Age at First Sex 0.99 (0.83, 1.20) 1.08 (0.87, 1.33) 
Parental Education   
  Less than high school 1.46 (0.59, 3.64) 0.96 (0.37, 2.49) 
  High school graduate 1.40 (0.58, 3.31) 1.19 (0.46, 3.07) 
  Some college 0.97 (0.32, 2.96) 0.71 (0.22, 2.27) 
  College graduate or higher 1.00 1.00 
Age Mother Gave Birth to 
Teenager 
  
  ≤19 1.13 (0.61, 2.09) 0.99 (0.55, 1.79) 
  >19 1.00 1.00 





Chapter 6:  Discussion  
 
The overarching objective of this interdisciplinary dissertation was to 
investigate the independent association between depression (independent variable) 
and women’s contraceptive behaviors, and teenage pregnancy (dependent variables). 
Each study explored a specific aspect of this relationship including contraceptive 
method choice, contraceptive method discontinuation, and teenage pregnancy in three 
different populations of reproductive age women shown to have an elevated risk for 
unintended pregnancies. Specifically in the first study, the association between pre-
abortion depressive symptoms and post-abortion choice of contraceptive method was 
examined among a sample of women seeking abortion services. Women seeking 
abortion services are at a higher risk for future abortions due to an unintended 
pregnancy compared to those seeking other reproductive health services (Upadhyay et 
al., 2012). In the second study, the sample consisted of low-income women seeking 
services at community reproductive health clinics. Women with lower income are 
more likely to have unintended pregnancies than women with higher incomes (Finer 
& Zolna, 2016; Jones & Kavanaugh, 2011). Lastly, the third study used a sample of 
sexually active adolescent girls and since the prevalence of unintended pregnancies 
among adolescent girls is high investigating the effects of depression on pregnancy 
was warranted. Together these three studies provide empirical support for the 
theoretical model proposed in the introduction (Chapter 1) on mechanisms through 





What follows is a brief summary of the main findings from the three studies, 
the contribution of the findings to the literature, and how the findings can be 
explained by the proposed theoretical model, limitations and suggestions for future 
research, and the overall implications for public health and practice.  
Summary of Major Findings 
The key findings from the three studies in this dissertation are in line with the 
hypothesis that depression—or depressive symptoms—would be associated with 
women’s contraceptive behaviors and teenage pregnancy. Specifically, we found that 
1) more pre-abortion depressive symptoms were associated with choosing a less 
effective rather than a moderately or a highly effective contraceptive method; 2) 
experiencing baseline and history of elevated depressive symptoms was associated 
with a higher likelihood of discontinuation for specific contraceptive methods but 
these associations did not reach statistical significance when examining all 
contraceptive methods combined; and 3) depression onset at the same age as sexual 
debut was associated with a higher hazard of teenage pregnancy. In addition to 
depression, we found partner characteristics including the number of sexual partners 
in the past and the type of sexual partner (primary, casual, or no partner) to be 
significantly associated with women’s contraceptive behaviors.  
These findings further emphasize the critical role depression plays in 




Contribution to the Literature 
This research adds to the existing but limited body of literature on how 
depression influences women’s contraceptive behaviors and teenage pregnancy in 
several ways. First, this dissertation enriches the existing knowledge in the field by 
emphasizing that timing of depression may play a critical in women’s contraceptive 
behaviors and reproductive decision-making. Specifically, the findings of this study 
indicate that not only the presence or the absence of depression or depressive 
symptoms but also when they exhibit themselves (their timing) in the course of 
women’s lives, can predict how women make decisions regarding contraception and 
pregnancy. For instance, as illustrated in the second study of this dissertation, the 
effect of elevated depressive symptoms occurring only once in time (either at the 
baseline of the study or in the past only) versus occurring both in the past and at the 
baseline of the study (which could be more indicative of chronic depression) was 
associated with a higher likelihood of contraception discontinuation. Similarly, as 
shown in the third study, hazard of experiencing teenage pregnancy increased for 
girls when depression onset occurred at the same age as their sexual debut, compared 
to their non-depressed counterparts.  
Second, only a few studies have examined women’s choice of contraceptive 
method in relation to depressive symptoms. The current study is the second study to 
investigate the association between pre-abortion depressive symptoms and women’s 
contraceptive choice after they have undergone contraceptive counseling. Compared 
to the one previously performed study among women seeking abortion services, the 




women’s contraceptive choice or depressive symptoms in an effort to reduce the 
possible confounding effect of those factors on the relationship, and in turn draw a 
more comprehensive picture of the relationship between depression and women’s 
contraceptive choice.  
Third, this study is one of the only studies to date to examine the relationship 
between elevated depressive symptoms and women’s contraception discontinuation, 
incorporating two depression measures, including baseline level of depressive 
symptoms at the time of method initiation, and history of elevated depressive 
symptoms, in the operationalization of the exposure. This allowed for differentiating 
the effect of elevated depressive symptoms occurring only once in time versus 
occurring at least twice (which is more indicative of chronic depression) on 
contraceptive method continuation.  
Finally, from a methodological perspective, this dissertation contributes to the 
literature by using time-to-event analysis to assess the association between 
depression, women’s contraceptive discontinuation and teenage pregnancy (Chapters 
4 and 5). Unlike ordinary logistic regression, time- to-event analyses reflect the time 
until an event of interest occurs. In addition to providing relative effect estimates, we 
used time-to-event analysis to predict survival time for contraceptive discontinuation 
and teenage pregnancy among women with and without depression. Finally, in the 
presence of censoring—a phenomenon where survival time is unknown due to loss to 
follow-up—ordinary logistic regression analyses provide biased estimates of the 
events of interest. Using time-to-event analysis, we accounted for censoring by 




conditional on participants’ survival over time, utilizing information on censored 
individuals only while they are at risk for the events of interest (George, Seals, & 
Aban, 2014). These strengths optimize the utilization of available information on time 
to contraceptive discontinuation or teenage pregnancy in relation to depression status 
and provide an insight into the role of mental health in teenage reproductive health.  
Interpretation of the Findings using the Theoretical Model 
Although this study did not examine the mechanisms through which 
depression or depressive symptoms may influence women’s contraceptive behaviors 
and reproductive decision-making, the major findings of this dissertation provide 
indirect support for the proposed theoretical model and the findings can be explained 
by the theoretical mechanism. Depressive mood triggered by different environmental 
stressors may interrupt the person’s ability to adapt to adverse situations. When the 
individual is unable to reserve such an emotional state, it may lead to increased 
dysphoria and in turn negatively influence the cognitive, emotional, and behavioral 
aspects of the individual’s life (Lewinsohn, Rohde, & Seeley, 1998). This state may 
manifest itself through symptoms such as low motivation to perform different tasks, 
low sense of control over future life events, low sense of self-efficacy to care for 
oneself, and focusing on the negative aspect of things all of which may influence the 
decision-making process (Joornann & Vanderlind, 2014; Minnix, Blalock, Marani, 
Prokhaorov, & Cinciripini, 2011). Therefore, the decision on which method of 
contraception to choose may be hampered in women experiencing these depressive 
symptoms compared to non-depressed women. Lower motivation may inhibit women 




more personal effort to maintain the regimen (e.g. remembering to take a pill every 
day, going to the provider to get a shot). In addition, depressed women focus on the 
negative perceived side effects of contraception, which may further influence the 
decision surrounding contraceptive method choice and continuation. Women with 
elevated depressive symptoms have been shown to focus more on the negative 
perceived side effects of hormonal contraceptive methods such as weight gain and 
mood changes (Hall et al., 2012). This may mean that the contraceptive effectiveness 
is not prioritized when women face the decision of contraceptive continuation. These 
speculations were confirmed by the findings from our studies where women with 
more depressive symptoms were more likely to choose a method of low effectiveness 
and the continuation rates of specific methods decreased in women with elevated 
depressive symptoms. These were indeed methods that require additional effort to 
maintain compared to other methods (patch and Depot-Provera shot in the adjusted 
models, and the ring and the pill in the unadjusted models). Similarly, depressed 
adolescent girls may experience low self-efficacy and low motivation in their 
contraceptive behaviors and in turn become ambivalent towards becoming pregnant, 
which may lead them to non-use or inconsistent use of contraception at the time of 
sexual intercourse onset (Carvajal et al., 2014; Francis et al., 2015). Our findings also 
confirmed these speculations.  
As mentioned preciously, of all the covariates examined in the three studies 
partner characteristics were independent predictors of women’s contraceptive choice 
and discontinuation. These findings suggest that women’s choice of contraception or 




characteristics of their relationship with their sexual partner. Women who have 
multiple sexual partners may choose to use condoms as a measure to protect 
themselves from not only an unintended pregnancy but also sexually transmitted 
infections.  Similarly, women who have no sexual partner or a casual sexual partner 
may discontinue their contraceptive method at a higher rate than those with a primary 
partner as a result of not having sexual intercourse on a regular basis and not 
anticipating engaging in sexual activity. Therefore, the presence or absence of a 
sexual partner and the nature of women’s relationship with their partners seems to be 
related to women’s contraceptive behaviors independent of women’s mental health.  
Limitations and Future Research Directions  
There are also some limitations to this dissertation research that need to be 
addressed. In the first study (Chapter 3), we were unable to distinguish between 
transient versus chronic states of depression. Measuring depressive symptoms at a 
single point in time makes it difficult to distinguish between transient depressive state 
elevated by factors related to the situation versus a more chronic depressive state 
independent of the woman’s feeling at the time of survey. In the second study 
(Chapter 4), we addressed this limitation by using information on current and past 
depressive symptoms to create the depression variable to be able to distinguish 
between women’s experience of depression in the past only, in the present only, or 
both in the past and the present (indicative of a more chronic condition). In this 
design the information about the past experience of depressive symptoms was 
collected retrospectively which could be susceptible to recall bias. Additionally, there 




between the past and present times. Future studies, therefore, should consider a 
longitudinal design where women are followed overtime and their depressive 
symptoms are measured not only at the clinic before undergoing an abortion 
procedure or contraception initiation but also before they experience pregnancy or 
leave the reproductive clinic. Such information can help establish a mental health 
timeline for women and better understand the nature of depression and its influence 
on their contraceptive behaviors.  
Research has shown that teenagers who live in low-income households, reside 
in rural areas, have parents with low levels education, and are born to teenage 
mothers are at higher risk of experiencing pregnancy (Dehlendorf, Rodriguez, Levy, 
Borrero, & Sterinauer, 2010; Hall et al., 2017; WHO, 2014). There are also factors 
such as substance use, unprotected sexual intercourse, and experiencing child abuse 
and neglect that have been shown to be associated with teenage pregnancy (Garwood, 
Lara, Melissa, Katie, & Brett, 2015; Jaccord, 2009; Salas-Wright, Vaughn, Ugalde, & 
Todic, 2015). In our study, we were unable to use information on such factors as the 
majority of data was missing for adolescents’ contraception, substance use, and 
sexual violence. Having information on adolescents’ contraceptive and substance use 
as well as sexual violence could enrich the study by allowing us to better understand 
how adolescents with a depression onset at the age of sexual debut would behave at 
the time of sex compared to their non-depressed counterparts and how these factors at 
the time of having sex may influence their likelihood for becoming pregnant. 
Research and data collection on reproductive and sexual health of adolescents is 




research should explore alternative ways to that used in NCS-A to gather information 
on sensitive subjects from adolescents. Utilizing technology used by teenagers such 
as online anonymous surveys through which they would feel more comfortable 
sharing their experiences could be a way to address this issue. Furthermore, the WHO 
has a list of guidelines that could help researchers improve data collection from 
adolescents (World Health Organization, 2018). 
As mentioned earlier, the theoretical model proposed in this dissertation may 
help explain the possible mechanism by which depressive mood can influence 
women’s decisions surrounding contraceptive behaviors, consequently placing them 
at risk of pregnancy. However, we did not measure the elements of these mechanisms 
such as women’s low motivation, low self-efficacy, or negative affectivity in this 
study. Therefore, measuring factors such as low motivation and low self-efficacy 
through which depressive state is manifested in a person, can provide a systematic 
support for the proposed theoretical model and can enrich the findings of studies by 
providing a more in-depth picture of how depression can influence women’s 
reproductive decision-making process.   
Lack of prospective population based cohorts with rich information on the 
mental and reproductive health of women in the United States is a limitation of this 
area of research. For instance, NCS-A is a great source of rich information on 
adolescent mental health. However, it does not contain sufficient information on 
adolescent girls’ contraceptive behaviors and pregnancy outcomes. Also, the cross-
sectional deign of this dataset may limit our ability to make claims about causality. 




for Health Statistics, 2017) have rich information on women’s contraception, 
reproductive health and fertility but not measurements of depression.  Conducting 
longitudinal population-based studies with information on both mental and 
reproductive health can provide researchers with a great resource to investigate the 
effect of mental health on women’s reproductive health in a more in-depth manner.  
Implications for Public Health  
 As evident by the findings from this dissertation, addressing women’s mental 
health in reproductive health settings is necessary in an effort to decrease the rate of 
unintended and teenage pregnancies in the United States, especially among 
populations at a high risk for unintended pregnancy including low-income women, 
those with previous experience of abortions, and adolescent girls. This objective can 
be accomplished in different ways. First, Quality Family Planning guidelines 
recommended by the CDC and the Office of Population Affairs can be modified to 
include provisions of depression screening in reproductive health settings for all 
women as part of determining clients’ needs during routine reproductive health visits 
(Gavin, Pazol, & Ahrens, 2017). Second, the Title X Family Planning Program could 
fund provisions of mental health screening at Title X clinics. Funds could be used for 
training reproductive health practitioners at these clinics to screen, detect and treat 
women at risk for depression or to make referrals to mental health providers. These 
provisions at the federal and state levels can create change in reproductive and family 
planning practices serving populations of women including low-income and 




Implications for Practice  
The importance of mental health in women’s reproductive life has been 
globally recognized (World Health Organization, 2009), but gaps in the translation of 
this knowledge into practice still exist. As awareness surrounding the association 
between women’s mental health and reproductive health continues to grow, there are 
opportunities to influence and improve the current practices around contraceptive 
counseling and family planning. This dissertation provides further evidence for the 
significance of the link between women’s mental health, their contraceptive behaviors 
and their reproductive health trajectories. Interventions that systematically integrate 
mental health and reproductive health can reduce unintended pregnancies and 
optimize contraceptive use in the at risk population of women with mental health 
issues.  
Mental Health Screening in Reproductive Health Setting 
Reproductive health settings including family planning and abortion clinics 
are settings where women make decisions about contraception and their reproductive 
health together with their healthcare providers. Therefore, these settings are optimal 
for screening women for mental health issues and the healthcare providers can play a 
critical role in women’s decisions surrounding contraception and future reproductive 
planning (Dehlendorf et al., 2010; Dehlendorf et al., 2013; Wyatt et al., 2014).  
Although reproductive healthcare providers acknowledge the importance of 
mental health, lack of knowledge or training may impede them from evaluating 




2015). Therefore, reproductive healthcare providers should be fully trained in 
recognizing signs and symptoms of depression in their clients and taking further 
actions in assisting clients in needs of mental health services (Hall et al., 2015). 
Ideally, depression-screening instruments such as CES-D should be routinely used to 
detect individuals’ current risk for depression. Reproductive health physicians should 
provide these women with adequate in-house treatment at to address the condition 
where possible. However, it should be recognized that reproductive healthcare 
providers have a limited amount of time and the training to be able to complete such 
instruments during patient-doctor sessions and offer in-house treatment. Therefore, 
screener questions can be asked during the sessions that would help detect women at 
risk for mental health, minimizing the time constraints. Women at risk for depression 
should then be referred to specialists for further examination and also be connected to 
community resources to help them with management of their condition. Information 
on women’s mental health history, and important risk factors associated with mental 
health should also be obtained as part of their health history at reproductive health 
settings and be considered by the physician during the counseling sessions.  
Contraceptive counseling sessions should be tailored to the needs of 
individual women, and healthcare providers should realize the impact they have on 
women’s reproductive decisions (Branden, 1998). The methods of communication 
between the healthcare provider and the individual women should go beyond simply 
delivery of the information. The healthcare providers should recognize depression 
signs and symptoms (e.g. low motivation and low self-efficacy, and focusing more on 




contraceptive behaviors including choice of a less effective contraceptive method, 
discontinuation of the method (Garbers et al., 2011; Hall et al., 2012), and views 
about pregnancy (Frost & Darroch, 2008). The communication should include 
opportunities for women to ask questions. The healthcare provider should ensure that 
the information is not just conveyed but is understood by the patient. This could be 
accomplished by asking women open-ended question about their reproductive plans. 
The healthcare provider should try to address all the concerns depressed women may 
have regarding different contraceptive methods and their side effects, while 
remaining vigilant about negative affectivity in the patient’s interpretation of these 
side effects, and provide them with accurate information on which contraception 
options are available, which ones are most effective in pregnancy prevention, side 
effects associated with each method, and specific regimen associated with the use of 
each method. 
Reproductive counseling in mental health settings 
Similar to reproductive health physicians, mental health specialists should 
recognize the implications of women’s mental health on contraceptive behaviors and 
reproductive decision. They should be educated on different contraceptive methods 
and their characteristics and effectively convey the information to women whose first 
point of contact with the health care system is the mental health setting. If in-house 
counseling is not possible, mental health specialist should make referrals to the 
reproductive health providers.  
These considerations and actions illustrate the importance of a direct and 




to help minimize the effect of depression on women’s contraceptive decision-making 
and to help them make informed decisions that best serve their needs and lifestyle and 
in turn increase women’s compliance to the contraceptive method they have chosen.  
Contraceptive counseling for adolescents  
Contraceptive counseling practices can be applied to all women of 
reproductive age, including teenagers. However, there are characteristics unique to 
adolescents that should be recognized and addressed during contraceptive counseling. 
The role of healthcare providers especially pediatricians in addressing the mental and 
reproductive health needs of adolescents is very important (Ott, Sucato, & Committee 
on Adolescence, 2014). Therefore, an effective communication between the 
healthcare provider and the adolescent is critical. Contraceptive decision-making that 
suits an adolescent’s needs could be reached through a heightened communication 
and trust between the doctor and the patient (Carvajal, Giola, Mudafort, Brown, & 
Barnet, 2017). Research has shown that pediatricians are seen as a trusted source of 
information for information on sexual health (Jones & Biddlecom, 2011; Ott, 
Rosenberger, McBride, & Woodcox, 2011). Therefore, pediatricians should be fully 
trained to identify the signs and symptoms of depression in adolescents and make 
referrals to specialists for those teens at risk for developing depression if treatment 
options are not available at the pediatrician’s office. When it comes to adolescents’ 
reproduction, physicians should recognize that teenagers may have a strong 
perception about the benefits of childbearing and that depression may lead women to 
feel ambivalent about pregnancy, both of which may influence their contraceptive 




should routinely talk to teenagers about their reproductive health plans and 
contraception.  
Research has shown that compared to young adults, adolescents have lower 
levels of awareness about availability of contraception and less knowledge on specific 
methods (Craig, Dehlendorf, Borrero, Harper, & Rocca, 2014). Also, despite being 
the most effective contraceptive methods for pregnancy prevention, the LARC usage 
is still low among adolescents (Romero et al., 2015).  Therefore, healthcare providers 
should acknowledge that adolescents may not be fully aware of all available 
contraceptive methods, their effectiveness levels and most effective contraception for 
pregnancy prevention (LARC methods), side effects of different methods, and 
specific regimen required for each method. Additionally, use of dual methods for 
prevention of sexually transmitted infections should also be discussed with adolescent 
as they may have multiple sexual partners. Physicians should also identify the barriers 
that adolescent may face in accessing different contraceptive methods and facilitate 
the provision of the methods to adolescents. Therefore, providers should not only 
convey the information about contraceptive methods to teenagers but they also need 
to ensure that the adolescents understand the information and can easily access the 
methods.  
In addition to physician offices, another setting for educating adolescents on 
sexual and reproductive health is the sex education program at schools. Teaching 
teenage girls about contraceptive behaviors and contraceptive options, most effective 
methods for pregnancy prevention, and other risk factors associated with unprotected 




Furthermore, teaching adolescents to recognize signs and symptoms of depression in 
themselves and to communicate that with school personnel is also important and 
should also be a priority for schools.  
Conclusion 
Investigating the effects of depression on women’s contraceptive behaviors 
and teenage pregnancy was the main focus of this dissertation. The results of this 
research demonstrated that the timing of depression plays an important role in 
women’s contraceptive decision-making. Integration of mental health and 
reproductive health are warranted in the effort to optimize pregnancy outcomes in 
women at increased risk for depression. The implications of this research suggest that 
there is a need for more effective communication between reproductive health 
providers and patients, taking into consideration depressed women’s subjective 
consideration of the topics of reproductive health, contraceptive choice and 
contraceptive compliance. Further research will be required to evaluate the nature of 
patient-physician interaction at reproductive and mental health settings in the effort to 
address the contraceptive and reproductive needs of women with mental health 














Figure 1. Possible Mechanisms to Explain the Effects of Depression on Women’s Reproductive Behaviors and Unintended or 
Teen Pregnancy. The dashed lines indicate the three associations examined in this dissertations. “Yes” indicates the presence 
of a significant association. The “No” for the outcome of contraceptive discontinuation indicates the lack of a significant 
association when all methods were included in analyses, but it was in the expected direction (such that more depressive were 
associated with a higher hazard of discontinuation).   
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